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Shelterin is a multiprotein complex that prevents DNA damage signaling at
chromosome ends. In its absence, DNA repair pathways are activated that can
promote the fusion of dysfunctional telomeres resulting in chromosomal
instability. The work presented here aims to understand how telomeres are
protected from these pathogenic repair pathways.
The first part of this thesis is focused on the DNA damage response factor
53BP1, a key regulator in double strand break (DSB) repair pathways in
mammalian cells. By influencing key regulatory events at and near DNA ends,
53BP1 plays an important role in the decision between non-homologous endjoining (NHEJ) and homologous recombination (HR). Telomeres lacking the
shelterin protein TRF2 have proven a versatile system for studying 53BP1 in
DSB repair since 53BP1 protects dysfunctional telomeres from resection and
promotes their mobility. Analysis of separation of function mutants of 53BP1 has
identified the domain that is responsible for promoting the mobility of DSBs. Cells
expressing 53BP1ΔMOB showed reduced levels of NHEJ at dysfunctional
telomeres and damage foci roamed a smaller part of the nucleus. But which

53BP1 interacting factors are responsible for mediating the increased mobility
remains unclear.
The second part of this thesis aims to elucidate the DNA repair pathways
that are activated when the shelterin component TRF1 is absent. The results
provide tantalizing evidence that sister telomeres can fuse via the alternativeNHEJ (a-NHEJ) pathway when replication forks reach the end of the
chromosome in cells that are deficient in TRF1. To prevent chromosome
instability, mammalian cells appear to employ the Holliday Junction resolvase
Gen1, which is capable of cleaving cruciform DNA structures that can be formed
when telomeres fuse. The deletion of Gen1 from TRF1 null cells resulted in the
accumulation of chromatin bridges and isochromosomes, indicative of genomic
instability. The results presented here are of relevance to studies of human
cancer cells since the presence of critically short telomeres induces sister
telomere fusions via a-NHEJ. It is possible that replication stress underlies these
fusion events and that Gen1 has evolved as a mechanism to counteract the
consequences of chromosomal fusion events at telomeres.
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Chapter 1: Introduction

1

1.1 Mammalian DNA damage response pathways
1.1.1 DNA damage
The integrity of the DNA in each cell in the human body is under constant attack
from thousands of DNA insults every day (Hoeijmakers, 2009). These lesions can
block transcription and replication and can lead to mutations and large
chromosomal aberrations if not accurately repaired (Jackson and Bartek, 2009).
To counteract the consequences of DNA damage, cells have developed complex
repair mechanisms to safeguard the integrity of the genome. Defects in these
pathways leave cells highly sensitive to DNA damaging agents and are linked to
different types of human disease. Furthermore, genome instability resulting from
defective DNA repair pathways forms the basis for nearly all types of cancer. A
good understanding of the different DNA damage response pathways and their
interplay is therefore essential.
Cells are subject to different types of DNA damage including nicks, gaps,
single stranded breaks (SSBs), double-stranded breaks (DSBs) and base
modifications. Distinct DNA repair mechanisms have evolved to sense and repair
each of these lesions. Small base modifications such as deamination or
depurination can be repaired through mismatch repair (MMR) or base excision
repair (BER). More bulky DNA adducts are repaired via nucleotide-excision repair
(NER) whereas SSBs can be repaired via distinct single-strand break repair
pathways (SSBR). Ionizing radiation (IR), replication fork collapse or reactive
oxygen species (ROS) can form DNA DSBs which can be repaired via
2

nonhomologous

end-joining

(NHEJ)

or

homologous

recombination

(HR)

depending on the stage of the cell cycle.
Key to orchestrating these different DNA repair pathways are members of
the phosphatidylinositol 3-kinase-like family of protein kinase (PIKKs) family
(ATM kinase, ATR kinase and to a lesser extend DNA-PK), which coordinate
rapid and potent signal transduction pathways to initiate repair (Harper and
Elledge, 2007). ATM, ATR and DNA-PK are threonine/serine kinases that
recognize a common motif, which is their target threonine or serine followed by a
glutamine residue (S/TQ site). While this consensus target motif might indicate
redundancy, each kinase has a specific function and a different but overlapping
set of substrates (Matsuoka et al., 2007). Moreover, ATM and DNA-PK respond
to DSBs whereas ATR kinase is activated upon single-stranded DNA formed
during replication stress and upon resection of DSBs (Fig. 1.1). Phosphorylation
of S/TQ sites in specific target proteins results in the recruitment of a variety of
effector proteins that together orchestrate repair of the DNA lesion or activate
apoptotic and senescent pathways if the damage is too severe. Activation of ATM
and ATR also triggers cell-cycle checkpoints through activation of Chk1 and
Chk2 (Sanchez et al., 1997; Matsuoka et al., 1998; Chaturvedi et al., 1999; Liu et
al., 2000; Matsuoka et al., 2000). These kinases phosphorylate the Cdc25 family
of phosphatases thereby preventing their activity. This leads to cell-cycle arrest in
G1 or G2/M as Cdc25 proteins are responsible for activation of cyclin-dependent
kinases (CDKs) which control cell cycle progression

3

Figure 1.1 ATM and ATR activation
(A) ATM is activated by the MRN complex, which rapidly binds to DSBs. Upon activation, ATM
phosphorylates histone H2AX recruiting MDC1 which propagates the γH2AX signal. MDC1 itself
further stimulates ATM activation, resulting in signal amplification. (B) A crucial step for ATR
activation is RPA binding to ssDNA resulting in the recruitment of ATR via its binding partner
ATRIP. An additional step is needed to activate ATR. The most studied factor is TopBP1, which is
recruited to the ssDNA/dsDNA junction via the 9-1-1 complex. A second pathway occurs via
ETAA1, which directly binds RPA away from the ssDNA/dsDNA junction and has a similar ATR
activating domain as TopBP1.
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(Sanchez et al., 1997; Costanzo et al., 2000; Mailand et al., 2000). The delay in
cell cycle progression ensures damaged DNA is not transmitted to daughter cells
by allowing time for accurate repair. ATM and ATR also activate the p53 tumor
suppressor gene to further halt cell-cycle progression and activate proapoptotic
or senescence pathways when the DNA damage is extensive (Tibbetts et al.,
1999; Shieh et al., 2000).

1.1.2 ATM kinase and DSB repair
DSBs are generated when both strands of the double helix are broken in close
proximity. DSBs can arise inadvertently when replication forks collapse or by
DNA damage inducing agents such as ionizing radiation or radiomimetic drugs
(Jackson and Bartek, 2009). But DSBs are also formed during normal
physiological processes such as programmed immune receptor rearrangements
in lymphocytes during V(D)J recombination and class switch recombination
(CSR) events (Dudley et al., 2005).
An initiating step for DSB repair is sensing of the lesion by the Mre11Rad50-Nbs1 (MRN) complex. MRN is a multifaceted complex that is required for
several DNA repair pathways and its widespread functions are not yet fully
understood on a molecular level (Stracker and Petrini, 2011). Among its many
functions, MRN can act as DSB sensor, tether broken ends together and provide
nucleolytic processing of the DNA ends (Lee et al., 1998; Nelms et al., 1998; de
Jager et al., 2001; Mirzoeva and Petrini, 2001; Hopfner et al., 2002; Mimitou and
5

Symington, 2008; Zhu et al., 2008). Importantly, MRN is essential for the
recruitment and activation of ATM at DSBs by promoting monomerization and by
acting as cofactor for the catalytic activity of ATM (Carney et al., 1998; Stewart
et al., 1999; Lim et al., 2000; Uziel et al., 2003; Lee and Paull, 2004; Lee and
Paull, 2005; Paull, 2015).
The Mre11 nuclease forms the core of the MRN complex and harbors both
exonuclease and endonuclease activity to initiate resection, the latter of which is
stimulated by interaction with CtIP (Sartori et al., 2007; Mimitou and Symington,
2008; Zhu et al., 2008; Wang et al., 2013). The directionality of the exonuclease
activity however is towards the break in the 3’-5’ direction, opposite of polarity
required for resection. The MRN complex therefore only performs the resection
initiation step but its activity is thought to be important for the clearance of
adducts and blockages from DNA ends, such as topoisomerases or Ku (Mimitou
and Symington, 2008; Zhu et al., 2008; Hartsuiker et al., 2009; Garcia et al.,
2011; Stracker and Petrini, 2011; Deshpande et al., 2016).
Once MRN has activated ATM kinase, the DNA damage response
pathway is activated at DSBs (Fig. 1.1). A key initial function of ATM is
phosphorylation of histone variant H2AX on serine 139, which rapidly spreads
over a large chromatin domain surrounding the DBS site (Rogakou et al., 1998;
Burma et al., 2001). Key to propagating the γH2AX signal is Mediator of DNA
damage Checkpoint 1 (MDC1), which directly binds γH2AX as well as ATM and
the MRN complex thereby further stimulating their activation (Stewart et al., 2003;
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Lee et al., 2005; Lou et al., 2006; Chapman and Jackson, 2008). Besides
propagating the γH2AX signal, MDC1 recruits the E3 ubiquitin ligase RING finger
8 (RNF8) and other proteins that eventually result in the recruitment of 53BP1
and other DNA repair proteins, which will be discussed in more detail in Chapter
1.2.

1.1.3 Classical and Alternative NHEJ
Repair of DSBs occurs mainly via two repair pathways in eukaryotic cells:
classical NHEJ (c-NHEJ) and HR (Fig. 1.2 and 1.3). The prevailing model in
mammalian cells is that most clean, blunt breaks are rapidly repaired by NHEJ in
all stages of the cell cycle, in a process that depends on binding of DNA ends by
Ku70/80 (Ku) and ligation by DNA ligase VI (Lig4). In S/G2, repair switches to
HR, which uses the newly replicated sister chromatid as template for accurate
repair. The decisive factor between these two pathways is resection of the 5’
ends since HR requires annealing to a homologous template strand.
C-NHEJ is a rapid, reliable, error-free repair mechanism when executed
properly and is initiated by loading of Ku onto broken ends (Fig. 1.2)(Lieber,
2010). Ku is a highly abundant ring-shaped heterodimer (Ku70 and Ku80) with
high affinity for duplex DNA and the complex rapidly slides onto both ends of the
break. There, it serves as docking site for core repair factors such as DNA-PKcs,
XRCC4, DNA Lig4, Artemis, XRCC4-like factor (XLF) and PAXX, which help
stabilize the repair complex and ligate the broken ends together (Lieber, 2010;
7

Waters et al., 2014; Ochi et al., 2015; Xing et al., 2015). Not all DNA ends are
directly compatible for end-joining by c-NHEJ due to chemical modifications at
the break site originating from the source of damage. Therefore several
accessory proteins, such as the Artemis nuclease, are recruited to remove
damaged bases, hairpins or other obstructions. This allows c-NHEJ to function
on a wide range of DNA end substrates (Chang et al., 2016).
C-NHEJ has long been considered an error-prone repair pathway because
it does not rely on a homologous sister template to repair the lesion and small
deletions at the junction can occur. However, more recently a different
mammalian NHEJ pathway has been attributed to mutagenic repair that does not
rely on Ku or Lig4. This pathway employs Poly[ADP-ribose] polymerase 1
(PARP1) and DNA Ligase III (Lig3), relies on extensive microhomology at the
break site and is known as alternative NHEJ (a-NHEJ) (Fig. 1.3)(Boboila et al.,
2010; Simsek et al., 2011; Frit et al., 2014; Pannunzio et al., 2014). This pathway
operates when core components of the c-NHEJ machinery are missing, such as
Ku or Lig4 (Kabotyanski et al., 1998; Verkaik et al., 2002; Wang et al., 2003;
Weinstock et al., 2007). Mechanistically, a DSB is recognized by PARP1 in the aNHEJ pathway, a step normally inhibited by Ku (Wang et al., 2006). Endresection by MRN, CtIP and Exonuclease1 (Exo1), DNA2 and Bloom’s syndrome
helicase (BLM) are then thought to expose sufficient microhomology to allow aNHEJ to take place, although the precise mechanism remains unclear. The
Werner syndrome protein (WRN) has also been implicated in resection together
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Figure 1.2 Pathways for c-NHEJ and a-NHEJ
c-NHEJ is initiated by Ku loading onto the DNA ends, where it serves as docking sites for
additional proteins such as DNK-PKcs, XRCC4 and Artemis that help with end-processing steps if
required. The final ligation step is done by DNA ligase 4.
a-NHEJ occurs in absence of cNHEJ components and requires microhomology surrounding the
DSB (in red). The break is recognized by PARP1, followed by limited end-resection by the MRN
complex and CtIP. Upon annealing of the exposed microhomology domains, Polθ fills in any gaps
while Lig3 performs the final ligation step.
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with DNA2 (Sturzenegger et al., 2014). However, it is thought that WRN limits the
a-NHEJ pathway by suppressing MRN and CtIP although the precise
mechanisms are not well understood (Shamanna et al., 2016). Importantly, aNHEJ has been linked to pathological repair of DSBs resulting in large deletions,
insertions and whole chromosomal translocations (Yan et al., 2007; Simsek and
Jasin, 2010; Simsek et al., 2011).
There is significant controversy whether a-NHEJ represents a distinct
back-up repair pathway or merely pathological processing that occurs when cNHEJ fails (Deriano and Roth, 2013; Frit et al., 2014; Pannunzio et al., 2014).
The reason behind this controversy is that a-NHEJ is highly versatile regarding
the proteins involved in the process. For example, DNA ligase 1 (Lig1) can
replace Lig3 when the latter is absent (Paul et al., 2013). Furthermore, no
physiological relevant function has been uncovered for a-NHEJ, except as
backup where others fail. However, given the importance of a-NHEJ in
pathological situations, a better understanding of both NHEJ pathways remains
important, whether a-NHEJ represents a physiological pathway or not.

1.1.4 Homologous Recombination
Errors during DNA replication give rise to DSBs in S/G2 of the cell cycle that are
preferentially repaired using the homologous template to ensure accurate repair
without loss of genetic information (Fig. 1.3). Central to HR is end-resection,
which is initiated by the MRN complex together with CtIP followed by more
10

extensive resection by Exo1, and DNA2 together with BLM and WRN (Sartori et
al., 2007; Mimitou and Symington, 2008; Nimonkar et al., 2008; Zhu et al., 2008;
Sturzenegger et al., 2014).

Replication Protein A (RPA) rapidly binds the

resulting long 3’ single-stranded overhang and has a stabilizing and protective
function. For HR to proceed, RPA has to be displaced by Rad51 in a process
stimulated by BRCA2 (Baumann et al., 1996; Wong et al., 1997; Davies et al.,
2001; Jensen et al., 2010). The Rad51 coated filament catalyzes homology
search and strand invasion into a homologous region forming a D-loop, where it
forms a primer for new DNA synthesis from using the homologous template to
initiate repair.
Completion of HR can proceed via two pathways ending in crossover (CO)
or non-crossover (NCO). First, synthesis dependent-strand annealing (SSDA)
allows the extended ssDNA to dissociate from the D-loop and anneal back to the
other ssDNA end resulting in NCO (Nassif et al., 1994). In a separate pathway
called double-strand break repair (DSBR), the other end of the DSB end is
captured in the D-loop forming an intermediate structure with a double Holliday
junction (dHJ) (Szostak et al., 1983). Processing of this dHJ can involve
dissolution by the BLM helicase resulting in harmless NCO. However, the dHJ
can also be cleaved by resolvases such as SLX1/SLX4 and Mus81 or Gen1
resulting in NCO or CO. This potential for CO events is toxic for cells as it can
lead to loss of heterozygosity (Moynahan and Jasin, 2010). Presumably,
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Figure 1.3 Homologous recombination
In S/G2, DSB are preferentially repaired via HR since a homologous template is available. Central
to HR is extensive resection by the MRN complex together with CtIP, Exo1, BLM and DNA2. The
ssDNA is coated by RPA, which is replaced by Rad51 in a process dependent on BRCA2. Rad51
catalyzes strand invasion into the homologous template forming a D-loop structure, and DNA
synthesis from the homologous template occurs. From here, two separate pathways can occur. In
SDSA, the newly synthesized strand dissociates from the D-loop and anneals back to the other
ssDNA yielding a NCO. In DSBR, the second end of the DSB is captured in the D-loop creating
an intermediate structure with a dHJ. Dissolution can take place by the BLM helicase (not shown).
Alternatively, resolution can occur if resolvases cleave the dHJ resulting in either NCO or CO
depending on orientation of the cleavage.
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SSDA or dissolution by BLM is more prevalent as CO events are suppressed in
mitotic cells (Stark and Jasin, 2003).

1.1.5 ATR kinase activation and replication stress
Whereas ATM is dispensable for cell viability, deletion of ATR kinase is lethal,
signifying its broad contribution to the DNA damage response (Brown and
Baltimore, 2000; Cortez et al., 2001; Brown and Baltimore, 2003). ATR is
activated in every S-phase to respond to stalled and collapsed replication forks
and regulates origin firing as well as checkpoint activation to prevent premature
mitosis in presence of damage (Costanzo et al., 2003; Pichierri and Rosselli,
2004; Woodward et al., 2006). The binding of RPA to ssDNA is a crucial step in
the activation process of ATR (Fig. 1.1). RPA is a highly conserved heterotrimeric
complex consisting of 70, 32 and 14 kDa subunits that bind ssDNA with high
affinity using four OB (oligonucleotide/oligosaccharide binding) folds. The role of
RPA is to stabilize the unwound ssDNA, prevent and remove secondary
structures and interact with DNA processing proteins to form an appropriate
response to ssDNA (Wold and Kelly, 1988; Wold, 1997; Chen et al., 2013). ATR
recognizes ssDNA bound RPA together with its interaction partner ATRinteracting protein (ATRIP) (Cortez et al., 2001; Zou and Elledge, 2003). But this
interaction alone is not sufficient to activate ATR, as it requires an ATR-activating
domain (AAD) containing protein to accomplish this (MacDougall et al., 2007).
The most studied ATR activating protein is TopBP1, which is recruited to the
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junction of ssDNA and dsDNA via the Rad9-Rad1-Hus1 (9-1-1) complex and
RHINO (Bermudez et al., 2003; Kumagai et al., 2006; Delacroix et al., 2007;
Cotta-Ramusino et al., 2011). Recently, a second pathway for ATR activation
was described in mammalian cells with the discovery of a second AADcontaining protein ETAA1 (Bass et al., 2016; Haahr et al., 2016). In contrast to
TopBP1, ETAA1 binds RPA directly and activates ATR in response to replicative
stress but not in response to DSB-inducing agents. Furthermore, activation of
ATR by ETAA1 causes phosphorylation of distinct ATR substrates as in
response to TopBP1, indicative of parallel pathways. The ability of ETAA1 to
activate ATR away from the ssDNA/dsDNA junction might signify an ability to
propagate the activation of ATR over long stretches of ssDNA although concrete
evidence for this idea is lacking.

1.1.6 ATR regulates origin firing
Once activated at a DNA lesion or a stalled replication fork, ATR phosphorylates
a multitude of substrates (Matsuoka et al., 2007). Most notably, ATR activates
Chk1 via phosphorylation of Ser317 and Ser345, often used as a marker of ATR
activation (Walworth and Bernards, 1996; Liu et al., 2000). Chk1 phosphorylates
CDC25 to prevent entry into mitosis. Chk1 activation also slows replication by
limiting global dormant origin firing (Tercero and Diffley, 2001). However, near
the stalled fork the ATR pathway has an opposite effect and promotes dormant
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origin firing via activation of PLK1 and CDC45 (Woodward et al., 2006; Ge et al.,
2007; Ibarra et al., 2008).

1.1.7 Fork stabilization by ATR
An important function of ATR lies in its ability to stabilize the replication fork,
preventing its collapse and the formation of a DSB (Lopes et al., 2001; Tercero
and Diffley, 2001). The precise mechanism through which ATR stabilizes the
replication fork is still poorly understood. It may involve retaining components of
the replisome at the replication fork since DNA polymerases alpha (Pol α) and
epsilon (Pol ε ) are lost in absence of ATR signaling (Cobb et al., 2003; Lucca et
al., 2004).
After stabilizing the fork, DNA repair and restart of the replication fork
takes place. Depending on the type of damage, ATR phosphorylates and recruits
different DNA repair enzymes that regulate phosphorylation of H2AX and
recruitment 53BP1, the RecQ helicases BLM and WRN, BRCA1 and many
others. Together these enzymes repair the DNA lesion and reinitiate DNA
replication at the fork.

1.1.8 Crosstalk between the ATM and ATR pathway
Although ATM and ATR respond to different DNA structures and have many
distinct substrates, there is some redundancy between the pathways such as
checkpoint activation and H2AX phosphorylation (Ward and Chen, 2001;
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Matsuoka et al., 2007). Furthermore, there is significant crosstalk between the
pathways as ATM can be activated at DSBs generated at collapsed replication
forks and ATR is activated by ssDNA after end-resection at DSBs. What appears
to be a defining factor in the cellular response to damage is the kinetics of
activation of either pathway.
ATM is rapidly activated at DBSs but resection in S/G2 causes a switch
from ATM to ATR activation as a result of ssDNA formation. Interestingly, several
studies showed that ATR activation in response to IR induced DSBs requires
ATM and the MRN complex (Cuadrado et al., 2006; Jazayeri et al., 2006; Myers
and Cortez, 2006). Absence of either ATM or MRN reduces the levels of RPA foci
formation indicative of limited end-resection. A key step by which ATM activates
ATR is by stimulating initial CtIP dependent resection to form ssDNA.
Additionally, ATM recruits and phosphorylates TopBP1, the ATR activating
protein (Yoo et al., 2007). Once activated, ATR phosphorylates CtIP at T818, a
modification that stabilizes chromatin bound CtIP and promotes robust resection
(Peterson et al., 2013). Secondly, ATR mediated activation of Chk1 is essential
to activate the G2/M checkpoint and prevents cells from entering mitosis with
damaged DNA (Brown and Baltimore, 2003). Chk2 also enforces the G2/M
checkpoint, but regulates a more immediate effect whereas long-term arrest is
maintained more by Chk1 (Brown and Baltimore, 2003; Rainey et al., 2008).
Conversely, the role of the ATM kinase at stalled replication forks is less
understood. Mostly, ATM is activated when ATR signaling is compromised and
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replication forks collapse to form DSBs (Chanoux et al., 2009). The role of ATM
might be similar to its general DSB repair functions to promote repair of the
collapsed replication fork (Cimprich and Cortez, 2008). Interestingly, replication
stress results in the formation of 53BP1 nuclear bodies in the next G1, in a
process that depends on the activation of ATM kinase (Harrigan et al., 2011;
Lukas et al., 2011). The function of these structures remains elusive but they are
thought to shield broken or unreplicated DNA from the previous S-phase allowing
their repair before the next S-phase. They are present at low frequency in
unperturbed cells and often form at Common Fragile Sites (CFS), regions of the
genome that are difficult to replicate, further indicating that these 53BP1 nuclear
bodies are the result of aberrant replication.

1.2 The role of 53BP1 in the DNA damage response pathway
1.2.1 53BP1 is a key regulator in the DNA damage response pathway
53BP1 was initially discovered as a p53 interacting protein required for activation
of the tumor suppressor protein (Iwabuchi et al., 1994; Iwabuchi et al., 1998).
However, 53BP1 is much better known for its key role in regulating c-NHEJ and
HR at DSBs (Panier and Boulton, 2014; Zimmermann and de Lange, 2014). The
role of 53BP1 in regulating DSB repair emerged from work on immunoglobulin
gene rearrangements, damaged telomeres and DSB repair defects in BRCA1deficient cells (Ward et al., 2003; Ward et al., 2004; Difilippantonio et al., 2008;
Dimitrova et al., 2008; Bunting et al., 2010; Bothmer et al., 2011; Lottersberger et
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al., 2013). Collectively, the data revealed 53BP1 as a multifaceted protein that
controls the choice between c-NHEJ and HR by influencing key regulatory events
at and near DNA ends. In particular, 53BP1 promotes c-NHEJ and contributes to
lethal mis-repair of DSBs in BRCA1-deficient cells by inhibiting 5’ end resection
(Fig. 1.4). The results also suggested that 53BP1 promotes c-NHEJ by
increasing the mobility of damaged telomeric chromatin and by mediating
synapsis of DNA ends in CSR (Difilippantonio et al., 2008; Dimitrova et al., 2008).
The role of 53BP1 in c-NHEJ is evident in BRCA1-deficient cells. Upon
inhibition of PARP1, transient nicks in DNA primarily resulting from base-excision
repair (BER) are not repaired resulting in DSBs in S phase. In BRCA1-deficient
cells, HR does not repair these breaks because BRCA1 promotes the 5’
resection needed for HR. Instead, 53BP1-dependent c-NHEJ leads to aberrant
chromosome structures such as radials (Moynahan et al., 1999; Snouwaert et al.,
1999; Cao et al., 2009). Evidence from several systems revealed that the
mechanism by which 53BP1 acts is through inhibition of DNA resection by
CtIP/MRN (Bouwman et al., 2010; Bunting et al., 2010). Absence of 53BP1 can
rescue the embryonic lethality of BRCA1-deficiency and represses the formation
of radial chromosomes in PARPi-treated cell lacking BRCA1 (Bothmer et al.,
2011).
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1.2.2 Structure of 53BP1
53BP1 is a large 1972 amino acids protein that has no enzymatic activity of its
own. Instead, 53BP1 functions as a scaffold to recruit DNA repair proteins to
damaged chromatin. 53BP1 contains several functional domains as shown in
Figure 1.5. The C-terminus of 53BP1 contains a Tudor domain and an ubiquitin
dependent recruitment (UDR) motif responsible for binding damaged chromatin
through interaction with H4K20me2 and H2AK15ub respectively (Huyen et al.,
2004; Fradet-Turcotte et al., 2013). The C-terminus also contains tandem BRCT
domains that are important for DNA repair in heterochromatin and for the
interaction with p53, but not for the promotion of NHEJ (Noon et al., 2010;
Bothmer et al., 2011; Lottersberger et al., 2013; Cuella-Martin et al., 2016). The
C-terminus of 53BP1 furthermore contains an oligomerization domain that
contributes to optimal recruitment of 53BP1 to chromosome internal DSBs but is
dispensable for recruitment to telomeres (Bothmer et al., 2011; Lottersberger et
al., 2013). Nuclear localization of 53BP1 is promoted by the NLS signal in the
center of the protein. 53BP1 also contains a PRMT1-methylated, glycine-arginine
rich (GAR) domain and a dynein light chain 8 (LC8) binding motif, but the function
of these domains is still unknown (Adams et al., 2005; Lo et al., 2005).
Importantly, the N-terminus of 53BP1 contains 29 S/TQ sites that are
phosphorylated by ATM and ATR in a DNA damage responsive fashion. While
the S/TQ sites are not needed for 53BP1 recruitment to DSBs, its has been
shown that phosphorylation is required for all of its known functions since they
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Figure 1.4 Functions of 53BP1
The main role of 53BP1 is to promote NHEJ. It does so via distinct methods. First, 53BP1 recruits
Rif1 to block end resection in G1. BRCA1/CtIP counteracts Rif1 in S/G2 to allow for HDR to
occur. 53BP1 also promotes NHEJ by stimulating the mobility of damaged chromatin through the
LINC complex and cytoplasmic microtubules. Finally, 53BP1 recruits PTIP although the precise
function of this interaction is not well understood. Possibly, PTIP is required for end-trimming of
incompatible ends for NHEJ.

Figure 1.5 Structure of 53BP1
53BP1 binds to chromatin with its Tudor and UDR domain. It contains an NLS signal for nuclear
localization and two BRCT domains in the very C-terminus. The LC8 domain binds dynein and
the oligo domain is required for oligomerization. The C-terminus furthermore contains a GAR
domain with an unknown function. Importantly, the N-terminus contains 28 S/TQ sites (red) that
can be phosphorylated by ATM or ATR kinase and recruit proteins such as PTIP and Rif1 to
DSBs.
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serve as docking sites for interacting proteins such as Rif1 and PTIP (Anderson
et al., 2001; Rappold et al., 2001; Bothmer et al., 2011; Lottersberger et al., 2013;
Zimmermann et al., 2013). While the function of some interaction partners is
known, the role of most binding proteins remains poorly defined.

1.2.3 Recruitment of 53BP1
The precise molecular mechanisms by which 53BP1 accumulates at sites of DNA
damage has only recently been defined. It was long known that 53BP1
recognizes H4K20me2 with its tandem Tudor domain (Botuyan et al., 2006).
However, this chromatin mark is constitutive and does not distinguish damaged
sites from the rest of the genome. How 53BP1 forms foci specifically near DSBs
was shown recently by the identification of the UDR motif that binds ubiquitylated
H2K15. The signaling cascade that is initiated by ATM mediated phosphorylation
of H2AX establishes this mark (Fig. 1.6). MDC1 is recruited to phosphorylated
H2AX, which in turn recruits the E3 ubiquitin ligase RNF8/UBC13 complex (Huen
et al., 2007; Mailand et al., 2007). The major substrates for RNF8 and UBC13
were long unknown. Recently it was discovered that RNF8 and UBC13 catalyze
K63-linked polyubiquitylation of the linker histone H1 at DSB sites (Thorslund et
al., 2015). This mark is recognized by yet another E3 ubiquitin ligase, RNF168,
which is responsible for the ubiquitylation of H2A at K13/K15, the latter of which
is recognized by 53BP1 (Doil et al., 2009; Stewart et al., 2009; Mattiroli et al.,
2012; Fradet-Turcotte et al., 2013). Thus, 53BP1 functions as a bivalent reader of
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histone modifications and is recruited through a multistep signaling cascade that
allows for signal amplification or modification when needed.
Another determinant for recruitment of 53BP1 to sites of damage is the
oligomerization domain of 53BP1. A 53BP1 mutant lacking this domain is
incapable of foci formation at IR induced DSBs and is defective in CSR in
lymphocytes (Ward et al., 2006; Zgheib et al., 2009; Bothmer et al., 2011).
However, this mutant localizes to dysfunctional telomeres and is capable of
partially promoting c-NHEJ at these sites (Lottersberger et al., 2013). Likely, the
primary function of the oligomerization domain is to form dimers of 53BP1 as it
can be replaced by an ectopic dimerization or tertramerization domain without
loss of foci formation (Zgheib et al., 2009; Wilson et al., 2016).
Interestingly, the pathway recruiting 53BP1 is suppressed during mitosis
(Giunta et al., 2010; Orthwein et al., 2014). MDC1 is still bound to γH2AX but
RNF8 is no longer recruited due to phosphorylation of RNF8 at Thr198 by CDK1
(Orthwein et al., 2014). In support of this model, a RNF8 T198A mutant is
insensitive to CDK1 activity and is able to form foci throughout mitosis whereas
the phosphomimetic T198E mutant is incapable of foci formation in interphase
cells or mitosis. However, although the T198A mutant restores RNF8 recruitment
to DSBs in mitosis, it fails to recruit 53BP1. A second inhibitory pathway acts
directly on 53BP1 to suppress its localization to DSBs. Specifically, CDK1 and
PLK1 phosphorylate T1609 and S1618 in mitosis, two sites located in the UDR
motif of 53BP1 (Orthwein et al., 2014). Thus, 53BP1 focus formation is inhibited
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Figure 1.6 Recruitment of 53BP1 to DSBs
53BP1 is recruited in response to a signaling cascade that starts with MRN accumulation at a
DSB. MRN activates ATM kinase, which phosphorylates H2AX. This γH2AX forms a docking site
for MDC1, which in turn recruits the ubiquitin ligaseRNF8 and UCB13. RNF8 catalyzes
ubiquitylation of H1 resulting in the recruitment of RNF168. This ubiquitin ligase induces
ubiquitylation of lysine15 on H2A, which is recognized by the UDR domain of 53BP1. The Tudor
domain of 53BP1 furthermore binds the H4K20me2 group that is constitutively present on H4
independent of DNA damage.
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in mitosis by inhibitory phosphorylation of both RNF8 and 53BP1 itself. Why does
53BP1 need to be so strictly suppressed during mitosis? Interestingly, restoring
53BP1 foci formation in mitosis by using phosphomutants resulted in genome
instability. These cells were highly sensitive to low dose of IR and showed high
rates of micronuclei formation. Furthermore, these cells were prone to sister
telomere fusions suggesting spontaneous DSB repair at telomeres. It was
speculated that telomeres are transiently uncapped during mitosis thus requiring
the inactivation of DSB repair to mitigate this threat to genome integrity (Orthwein
et al., 2014).

1.2.4 Regulation of end-resection in mammalian cells
One of the mechanisms by which 53BP1 promotes c-NHEJ is by blocking 5’ end
resection at broken ends in a cell-cycle dependent manner (Fig. 1.4) (Bothmer et
al., 2010; Bunting et al., 2010). Resection is initiated in mammalian cells upon
ATM activation by the MRN complex together with the CtIP (Sartori et al., 2007;
Buis et al., 2008; Wang et al., 2013). In absence of CtIP, RPA foci do not form
after IR and ATR is no longer recruited to DSBs indicating resection is inhibited
(Sartori et al., 2007). CtIP is thought to activate the endonuclease activity of MRN
to create a nick upstream of the DSB site. The 3’-5’ exonuclease activity of MRN
towards the DNA end then creates a substrate for more extensive resection by
Exo1 or DNA2 with BLM/WRN (Gravel et al., 2008; Nimonkar et al., 2008;
Nimonkar et al., 2011; Tomimatsu et al., 2012; Sturzenegger et al., 2014). This
initial processing step my MRN and CtIP is especially important with chemically
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blocked ends, such as those arising after IR, whereas at clean ends MRN mainly
functions to recruit other factors of the resection machinery (Buis et al., 2008;
Nimonkar et al., 2011).
The function of 53BP1 to block extensive resection by CtIP and Exo1 was
first shown in CSR in lymphocytes (Bunting et al., 2010; Bothmer et al., 2011;
Bothmer et al., 2013). Subsequent studies from several groups identified Rif1 as
the effector, which is recruited to 53BP1 in an ATM/ATR phosphorylation
dependent manner. Rif1 was shown as to be the main factor by which 53BP1
blocks CtIP-initiated resection at DSBs in G1 therefore promoting c-NHEJ while
blocking HR (Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Diaz et al.,
2013; Feng et al., 2013; Zimmermann et al., 2013). In S/G2, this inhibition of
resection is counteracted by BRCA1, which displaces 53BP1, to allow resection
and HR with the sister template to occur. Elegant studies revealed the
mechanisms by which this cell cycle depended block to resection is achieved
(Escribano-Diaz et al., 2013). In G1, when c-NHEJ is the pathway of choice,
53BP1/Rif1 inhibit binding of BRCA1 at DSBs. Upon entry into S/G2, CDK1
phosphorylates CtIP creating a CtIP/BRCA1 complex that displaces 53BP1/Rif1
from damage foci to allow resection to take place. In absence of BRCA1 or when
the interaction between CtIP and BRCA1 is lost, 53BP1/Rif1 form foci in S/G2
and inhibit resection and repair via HR. Conversely, in absence of 53BP1,
BRCA1 and CtIP locate to DBSs in G1 thereby promoting resection and inhibiting
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c-NHEJ. As such, this regulatory circuit between 53BP1 and BRCA1 controls
repair pathway choice.
The importance of pathway choice can easily be seen in BRCA1 deficient
cells treated with PARP1 inhibitors (PARPi). Upon treatment, nicks in the DNA
are not repaired causing DSBs in S-phase. In BRCA1 deficient cells, these DBSs
are repaired by c-NHEJ resulting in aberrant chromosome structures such as
radials (Moynahan et al., 1999; Snouwaert et al., 1999; Cao et al., 2009).
Deletion of 53BP1 rescues the lethality of PARPi and restores HR, suggesting
that the main function of BRCA1 is displacement of 53BP1 in S/G2 (Bunting et
al., 2010; Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Diaz et al.,
2013; Feng et al., 2013; Zimmermann et al., 2013).
How Rif1 blocks resection or competes with BRCA1 is still unclear.
Genetic screens aimed to find factors that alleviate the synthetic lethality of
PARPi and BRCA1 recently discovered MAD2L2 (also called REV7) as a protein
that functions downstream of Rif1 to block resection (Boersma et al., 2015; Xu et
al., 2015). MAD2L2 is a component of the translesion polymerase Zeta (Polζ) but
its role in blocking end resection was found to be independent of this function.
MAD2L2 localizes to sites of DNA damage in an ATM/53BP1/Rif1-dependent
manner but a direct interaction could not be found. The N-terminal HEAT repeats
of Rif1 were shown to be required for localization of MAD2L2 to DSBs. This is
consistent with the fact that this domain is necessary for the interaction of Rif1
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with 53BP1, confirming that MAD2L2 functions downstream of 53BP1/Rif1
(Escribano-Diaz et al., 2013; Boersma et al., 2015).
Another factor implicated downstream of 53BP1 in resection control is
PTIP (Fig. 1.6). The N-terminal S25 of 53BP1 is phosphorylated in an ATM
dependent manner and required for the interaction with PTIP (Munoz et al.,
2007). However, the importance of the interaction with 53BP1 is poorly
understood and PTIP does not require 53BP1 to localize to sites of damage
(Gong et al., 2009; Wu et al., 2009). Furthermore, PTIP has been suggested to
play a role in HR since loss of PTIP results in cell cycle arrest in S-phase due to
unrepaired DSBs (Wang et al., 2010). The function of PTIP is even more
complex with regards to c-NHEJ. While loss of PTIP had no effect on CSR in B
cells, radial formation in PARPi-treated BRCA-/- cells was diminished in absence
of PTIP (Callen et al., 2013). Perhaps this phenotype reflects an S-phase specific
role for the interaction of PTIP with 53BP1 as PARPi results in nicks during DNA
replication whereas CSR occurs in G1.

1.2.5 53BP1 mediated chromatin mobility
Although loss of Rif1 suppresses NHEJ at dysfunctional telomeres and in CSR,
the effect is not as severe as loss of 53BP1, indicating that other factors
downstream of 53BP1 are required. A second function for 53BP1 in regulating cNHEJ is promotion of chromatin mobility upon DNA damage (Fig. 1.4) (Dimitrova
et al., 2008). Live-cell imaging has shown that telomeres become more mobile
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and occupy larger territories when TRF2 is removed, which renders telomeres
dysfunctional and activates ATM kinase. This increase in mobility is dependent
on the N-terminal S/TQ sites of 53BP1, as a phosphorylation mutant (53BP1Δ28)
was unable to promote mobility. However, neither Rif1 nor MAD2L2 is required
for this effect (Zimmermann et al., 2013; Boersma et al., 2015). The effect of
53BP1 on mobility is not limited to dysfunctional telomeres as IR-induced DSBs
show an ATM dependent increase in mobility in G1 as well (Krawczyk et al.,
2012; Neumaier et al., 2012; Becker et al., 2014). However, other studies have
shown that I-SceI induced DSBs are immobile unless Ku is removed (Soutoglou
et al., 2007).
Preliminary data from the de Lange lab had pointed to the possibility that
53BP1 acts through the LINC (Linker of Nucleoskeleton and Cytoskeleton)
complex and uses kinesin-mediated movement on microtubules to increase the
mobility of damaged telomeres. The LINC complex is composed of Sun proteins
(including Sun1 and Sun2 in mammals) that span the inner nuclear membrane
(INM) and associate with KASH (Klarsicht, Anc-1, Syne1 homology) domain
containing proteins situated in the outer nuclear membrane (ONM) (Mejat and
Misteli, 2010). Mammalian KASH proteins include the nesprins and the KMS
proteins, which can link to microtubules with kinesins and dynein. Experiments
suggest the involvement of Sun1, Sun2, Nesprin-4, and the kinesin components
KIF3A, KIF5B, and Klc1. Using shRNAs against these proteins, telomere fusions
are diminished by 30-50%. Importantly, the mobility of damaged chromatin is
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diminished in a Sun1/2 deficient background to the same extent as in the
absence of 53BP1. How 53BP1 connects to the LINC complex and which S/TQ
sites are required remains unknown.

1.3 The structure and function of telomeres
1.3.1 Telomeres protect the end of linear chromosomes
Telomeres are nucleoprotein structures containing of short tandem repetitive
sequences that cap the natural ends of linear eukaryotic chromosomes. In
mammalian cells, telomeres consist of 5’-TTAGGG-3’ repeats that can be 10-15
kb (human) to 20-50 kb (mouse) in length, ending with a 3’ overhang (de Lange
et al., 1990; Lejnine et al., 1995). Electron microscopy has shown that telomeres
are organized in large lariat-like t-loop structures that are formed by strand
invasion by the 3’ overhang (Griffith et al., 1999; Nikitina and Woodcock, 2004). A
telomere specific protein complex, shelterin, together with telomerase protects
the telomere from two threats that arise at chromosome ends: the end-replication
and end-protection problem (Fig. 1.7).
The end-replication problem arises due to the inability of the DNA
replication machinery to fully replicate the 3’ ends of linear DNA. Replicative
polymerases function in the 5’ to 3’ direction and require a free 3’ hydroxyl group
to initiate synthesis of nascent DNA. At the leading-strand the DNA polymerase
move in the same direction as the replication fork allowing the replication until the
end. At the lagging-strand, the DNA is synthesized in opposite direction of the
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Figure 1.7 Shelterin protects chromosome ends
(A) The six protein shelterin complex binds telomeric DNA via TRF1 and TRF2. The function of
each shelterin in blocking DNA damage pathways is shown on the right. (B) Shelterin and
particularly TRF2 keep the telomeric DNA in a T-loop configuration. This physically hides the DNA
end from recognition by the MRN complex and protects against ATM activation. Loss of TRF2
results in T-loop unwinding and activation of ATM kinase and NHEJ at the chromosome end.
Adapted from Doksani and de Lange 2014 (Doksani and de Lange, 2014).
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replication fork resulting in short stretches of nascent DNA, Okazaki fragments,
which are initiated at RNA primers that provide the free 3’ hydroxyl group. The
RNA primers are subsequently removed and the Okazaki fragments ligated
together. Yet, the removal of the very last RNA primer produces a gap at the end
of the lagging strand, incompletely replicating the 3’ end. This causes telomeres
to gradually shorten during every cell division, eventually resulting in loss of
genetic information thus limiting the replicative potential of the cell (Hayflick,
1965; Watson, 1972; Olovnikov, 1973). Additionally, nucleolytic processing of the
3’ overhang adds to the end-replication problem. Leading end DNA synthesis
results in blunt ends that require processing by Apollo and CST to produce the 3’
overhang (Wu et al., 2010; Wu et al., 2012).
The end-protection problem refers to the possibility of the chromosome
end to be recognized as a DSB that could initiate apoptosis or inappropriate
repair via the DDR pathway.

1.3.2 Telomerase counteracts the end-replication problem
To counteract telomere erosion, most eukaryotic cells possess a specialized
enzyme called telomerase. The presence of a specialized enzyme capable of
replicating the terminal TTAGGG repeats was first shown and isolated in
Tetrahymena (Greider and Blackburn, 1985). Subsequent studies revealed
telomerase as a ribonucleoprotein that uses a catalytic subunit with reverse
transcriptase activity (TERT) to synthesize TTAGGG repeats from an RNA
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primer, TERC (Greider and Blackburn, 1987; Greider and Blackburn, 1989;
Lingner et al., 1997; Nakamura et al., 1997). Telomerase is highly regulated
during development, being active in germline tissue but not somatic cells (Kim et
al., 1994). This ensures a limited lifespan of normal somatic cells, with telomeres
shortening every cell division. The inactivation of telomerase in somatic cells
represents an important tumor suppressor pathway to limit immortalization of
cells. Indeed, about 90% of tumor biopsies tested have reactivated telomerase
(Kim et al., 1994). The remaining 10% of tumors may either lack telomere
maintenance or rely on a recombination based mechanism, Alternative
Lengthening of Telomeres (ALT), to prevent loss of telomeric sequences (Bryan
et al., 1997; Dunham et al., 2000). The fact that all tumor cells possess some
mechanisms to prevent telomere attrition illustrates the importance of telomeres.

1.3.3 Shelterin protects against the end-protection problem
The end-protection problem emerged from landmark studies by Herman Muller
and Barbara McClintock in the 1930’s and 1940’s (Muller, 1938; McClintock,
1941). First, Muller observed that induced chromosomal translocations and
rearrangements never occurred at chromosomes ends, which he called
telomeres. He concluded that the terminal “gene” must have a protective function
by sealing the chromosome end. Barbara McClintock independently found that
broken chromosomes are prone to fusions and rearrangement, but that the
natural ends of chromosomes are somehow protected from this genetic
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instability. We now know that a protective telomere specific protein complex,
shelterin, associates with chromosome ends (Palm and de Lange, 2008).
Shelterin associates with telomeres through TRF1 and TRF2, which bind
specifically to double stranded TTAGGG repeats. POT1 (POT1a and POT1b in
mice) binds the single stranded TTAGGG repeats that are present in a 50-400 nt
TTAGGG repeat 3’ overhang at the telomere terminus. POT1 is connected to
TRF1 and TRF2 through two other shelterin components, TIN2 and TPP1. A
sixth component, Rap1, binds to TRF2.
Studies using telomeres lacking components of shelterin or the entire
complex revealed how shelterin represses different deleterious damage
pathways that are activated at unprotected DNA ends (Fig. 1.7a) (Palm and de
Lange, 2008; Sfeir and de Lange, 2012; Doksani and de Lange, 2014). TRF2
represses ATM activation and c-NHEJ by sequestering telomeres in a t-loop
configuration (van Steensel et al., 1998; Griffith et al., 1999; Karlseder et al.,
1999; Celli and de Lange, 2005; Doksani et al., 2013). This conformation is
proposed to inhibit loading of Ku70/80 and the MRN complex onto DNA ends,
steps that are essential for initiation of c-NHEJ and ATM signaling, respectively
(Lieber, 1999; Walker et al., 2001; Lee and Paull, 2004). TRF2 has long been
implicated in t-loop formation, but only recent STORM imaging techniques have
enabled direct evidence for this in vivo (Doksani et al., 2013). These experiments
have shown that TRF2 is the sole shelterin component involved in t-loop
formation.
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TRF1 has similar domain architecture as TRF2 but its main function lies in
promoting telomere replication (Sfeir et al., 2009; Zimmermann et al., 2014). The
telomeric TTAGGG sequence poses a problem for the replication machinery,
similar to common fragile sites (CFS) elsewhere in the genome. Upon deletion of
TRF1, multiple telomeric signals are observed at a single chromatid end,
indicative of replication problems and fork stalling in the telomeric DNA can be
observed by DNA combing. Furthermore, ATR kinase is activated at telomeres
lacking TRF1 in a process that requires progression through S-phase, consistent
with a role for TRF1 in replication. The mechanism by which TRF1 supports
replication is not completely understood, but involves recruitment of BLM and
Rtel1 helicases to unwind G-quadruplexes that are formed by telomeric TTAGGG
sequences (Sfeir et al., 2009; Vannier et al., 2012; Zimmermann et al., 2014).
In contrast to TRF1 and TRF2, POT1 binds the single stranded DNA in the
telomeric overhang. Interestingly, humans and mice differ with regards to POT1.
Where mouse telomeres require two distinct paralogs, POT1a and POT1b, the
function of these proteins is carried out by one POT1 protein in human cells
(Hockemeyer et al., 2006). POT1 has several functions at telomeres. First of all it
shields the single stranded overhang from RPA binding and unwanted ATR
activation (Hockemeyer et al., 2005; Hockemeyer et al., 2006; Denchi and de
Lange, 2007; Gong and de Lange, 2010). Furthermore, POT1 (POT1b) is
required for postreplicative processing of telomeres by blocking excessive
resection by the Apollo nuclease (Wu et al., 2012). Leading-strand DNA
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synthesis results in blunt ended telomeres that are at risk for ATM activation and
NHEJ. TRF2 recruits Apollo to process the leading ends into minimal overhang
that enables the t-loop configuration. In absence of POT1b, resection by Apollo
and also Exo1 is extreme (Wu et al., 2010). Besides its inhibitory effect on Apollo,
POT1 (POT1b) recruits CST to regulate the overhang length at the telomere end.
CST-mediated fill-in synthesis corrects the extended overhang created by Exo1
(Wu et al., 2012; Takai et al., 2016). Another role for POT1 lies in telomere length
control as POT1 is thought to block access of telomerase to single stranded
overhangs (Loayza and de Lange, 2003). POT1 is therefore a negative regulator
of telomere length.
Rap1 binds TRF2 but unlike TRF2 it has no role in the repression of ATM or
c-NHEJ. However, deletion of Rap1 in a Ku70/80-/- background revealed a role
for Rap1 in repressing HR, similarly as seen previously seen for POT1a and
POT1b (Palm et al., 2009; Sfeir et al., 2010). Shelterin as well Ku70/80 thus
block HR at telomeres, perhaps to ensure greater protection.

1.3.4 TRF2 prevents ATM activation and NHEJ
By sequestering telomeres in the t-loop configurations, TRF2 is thought to inhibit
loading of Ku and MRN at the end. Indeed, when TRF2 is deleted from mouse
embryonic fibroblasts (MEFs), ATM is rapidly activated as indicated by Chk2
phosphorylation and accumulation of 53BP1, MDC1 and γH2AX in foci that
overlap with telomeres called telomere dysfunction induced foci (TIFs) (Karlseder
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et al., 1999; Takai et al., 2003; Celli and de Lange, 2005; Dimitrova and de
Lange, 2006; Denchi and de Lange, 2007). NHEJ is unleashed when TRF2 is
missing causing telomere end-to-end fusions that are visible as chromosome
trains on metaphase spreads. These chromosome fusions occur mostly in G1
and are fully dependent on ATM, Lig4 and Ku, supporting their dependency on
NHEJ and DNA damage signaling (Smogorzewska et al., 2002; Celli and de
Lange, 2005; Celli et al., 2006; Konishi and de Lange, 2008). Furthermore,
53BP1 mediated mobility of chromatin and inhibition of end resection are
required for these telomere fusions, which are drastically reduced in absence on
53BP1 (Dimitrova et al., 2008; Lottersberger et al., 2013; Zimmermann et al.,
2013). The resection that occurs at telomeres when TRF2 is deleted in absence
of 53BP1 is dependent on ATM and CtIP (Lottersberger et al., 2013). Similar to
chromosome internal DSBs, 53BP1 recruits Rif1 and MAD2L2 to suppress
extensive end-resection (Zimmermann et al., 2013; Boersma et al., 2015).
TRF2 binds specifically to telomeric DNA through a C-terminal SANT/Myb
domain and forms homodimers with its N-terminal TRFH domain (Palm and de
Lange, 2008). TRF2 furthermore contains a Gly/Arg rich domain Basic domain in
its N-terminus that can bind and stabilize dHJs that can be formed at the base of
the t-loop by branch-migration (Fouche et al., 2006; Poulet et al., 2009). While
the t-loop is required for protection against NHEJ and ATM activation, the dHJs
can be cleaved by Holliday junction resolvases resulting in excision of the t-loop
and loss of telomeric DNA (Wang et al., 2004). Expression of a TRF2 mutant
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lacking the Basic domain results in t-loop excision and telomere shortening, while
NHEJ is still suppressed (Wang et al., 2004; Saint-Leger et al., 2014).

1.3.5 TRF1 is required or telomere replication
Studies in yeast and mammals have shown that telomere replication mostly
originates from the subtelomeric regions (Makovets et al., 2004; Sfeir et al.,
2009). Therefore, leading-strand replication produces the G-rich strand whereas
the C-rich strand is made by lagging-strand synthesis. However, the repetitive
telomeric sequence poses a problem for the replication machinery as the G-rich
DNA can form G-quadruplexes (G4), a secondary structure held together by G-G
Hoogsteen base-pairing (Henderson et al., 1987). Fork stalling is frequently
observed in telomeric sequences and treatment of cells with G4-stabilizing drugs
induces ATR activation and telomeric aberrations (Miller et al., 2006; Salvati et
al., 2007; Rizzo et al., 2009; Sfeir et al., 2009). Interestingly, fork stalling also
occurs when the telomeric sequence is located internally in chromosomes,
further indicating that the DNA sequence itself forms a problem for the replication
machinery (Miller et al., 2006; Bosco and de Lange, 2012).
TRF1 is required to aid replication fork progression through telomeric DNA
(Martinez et al., 2009; Sfeir et al., 2009). Deletion of TRF1 from MEFs results in
frequent fork stalling in telomeric sequences and activation of an ATR signaling
cascade, and the appearance of fragile telomeres. The fragile telomeres are

37

reminiscent of fragile sites that arise at other genomic regions that are
challenging to replicate.

1.3.6 Fragile sites
Two different types of fragile sites have been described in human cells. Rare
fragile sites are only present in certain individuals that have expansions of
genomic repeat regions such as Fragile X syndrome (Kremer et al., 1991). In
contrast, all individuals have common fragile sites (CFSs), which represent
regions of the genome that are late to replicate or have a low density of
replication origins. As a result, CFSs are often incompletely replicated at the
onset of mitosis. Fragile sites manifest as breaks and gaps on metaphase
chromosomes, especially upon treatment with drugs that affect replication such
as aphidicolin, which blocks DNA synthesis by inhibiting polymerase alpha. The
inherent genetic instability of CFSs is thought to be a driving force in the onset of
cancer because many chromosome translocations and rearrangements in tumors
originate from CFSs (Hecht and Glover, 1984; Hellman et al., 2002; Le Tallec et
al., 2011; Ozeri-Galai et al., 2012). The mechanisms of genetic instability at
CFSs are not very well understood. Secondary structure formation at CFSs could
be a causative factor for their instability (Durkin and Glover, 2007). Upon
replication stress, single stranded DNA formed ahead of the DNA polymerase
upon uncoupling from the replicative helicase could form a secondary structure
resulting in fork stalling and breakage. Consistent with this model, loss of
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enzymes that remove secondary structures, such as the RecQ helicases BLM
and WRN, increases fragile site expression (Pirzio et al., 2008). More recent
studies challenged this model and postulated that it is the lack of replication
origins that cause CFSs instability (Ozeri-Galai et al., 2011). CFSs are thought to
replicate late in S-phase and additional delay upon treatment with aphidicolin
results in incomplete replication (Le Beau et al., 1998; Pelliccia et al., 2008).
Another contributing factor to CFS expression is thought to be a collision
between transcription and replication forks (Helmrich et al., 2011). Likely, all
these pathways play a varying role in CFS expression, which could explain why
expression levels of CFSs differ between cell types. One unifying factor in CFSs
expression is the observation that replication is not finished at these sites,
yielding DNA structures with replication intermediates at the onset of mitosis.

1.3.7 Fragile site cleavage prevents anaphase bridges
Cleavage of CFSs was long thought to cause genetic instability, but this view was
recently challenged by two studies indicating that cleavage by Mus81-Eme1 is
actually protective (Naim et al., 2013; Ying et al., 2013). The structure-specific
endonuclease Mus81-Eme1 was shown to localize to CFSs at the onset of
mitosis and cleave replication intermediates, triggering the appearance of the
characteristic breaks and gaps associated with CFSs. Unexpectedly however,
depletion of Mus81-Eme1 caused more severe genetic instability due to
accumulation of anaphase bridges and mitotic failure. Thus, cleavage of under39

replicated DNA by Mus81-Eme1 appears to be beneficial to cells as it helps sister
chromatid disjunction and prevents the formation of anaphase bridges. The gaps
and breaks in DNA caused by Mus81-Eme1 cleavage are protected in 53BP1
nuclear bodies in the next G1 to allow for their repair (Lukas et al., 2011).
The anaphase bridges that appear at CFSs, especially when Mus81 is
missing, are not always detectable with conventional DNA dyes. These bridges
are called ultrafine bridges (UFBs) and can be visualized by immunofluorescent
staining of either BLM or PICH (Chan et al., 2009; Naim and Rosselli, 2009). The
presence of BLM on these UFBs is dependent on PICH and provides cells with a
final attempt to resolve unrepaired DNA intermediates before anaphase (Chan et
al., 2007).

1.3.8 TRF1 recruits BLM to prevent fragile telomeres
It is not completely understood how TRF1 promotes faithful telomere replication.
TRF1 lacks enzymatic activity and is assumed to function by recruiting additional
proteins to aid fork progression. Two proteins of interest are BLM and RTEL1,
since telomere fragility is seen upon shRNA mediated depletion of these proteins
(Ding et al., 2004; Lillard-Wetherell et al., 2004; Sfeir et al., 2009). Recent studies
have shown that BLM interacts with TRF1 and that this interaction is required to
prevent telomere fragility, specifically on the telomere replicated by lagging
strand DNA synthesis (Zimmermann et al., 2014). The lagging-strand TTAGGG
template is particularly prone to G-quadruplex formation. Since BLM possesses
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G-4 unwinding activity, it is likely that TRF1 recruits BLM to unwind Hoogsteen
bonding between guanines in the lagging-strand template and thus prevents
telomere fragility (Sun et al., 1998; Huber et al., 2002). How TRF1 prevents
leading-strand telomere fragility remains unknown but might require RTEL1.

1.3.9 TRF1 prevents the formation of sister associations
A separate phenotype that emerges upon deletion of TRF1 are sister
associations (SA), which are visible as fused sister telomeres in metaphase
spreads. However, the molecular nature of SA is not yet known. They are not
fused by c-NHEJ, as deletion of Lig4 has no effect on their prevalence (Sfeir et
al., 2009). SAs are also not dependent on the interaction of TRF1 with BLM and
therefore likely form through a mechanism distinct from fragile telomeres
(Zimmermann et al., 2014). The only known contributing factor to the formation of
SAs is the activation of ATR kinase. When ATR is depleted from TRF1 null cells,
the frequency of SAs is significantly reduced (Sfeir et al., 2009). Supporting this
model, it was shown that TRF1 uses the interaction with TIN2/TPP1 and POT1 to
prevent sister associations (Zimmermann et al., 2014). POT1a is thought to
compete with RPA for binding single-stranded TTAGGG repeats and thereby
prevent ATR activation. However, activation of ATR alone is not sufficient to form
SAs as deletion of TPP1 or POT1 by itself results in only low levels of SAs
(Hockemeyer et al., 2006; Kibe et al., 2010). Thus, TRF1 deletion combined with
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ATR activation is required for the formation of SAs indicating that it requires an
activity that occurs at a stalled replication fork.

1.3.10 Dysfunctional telomeres as a model for DNA damage response pathways
All six shelterin protein repress different components of the DNA damage
response, from c-NHEJ and HR to ATM and ATR activation (Sfeir and de Lange,
2012). Conditional deletion of shelterin proteins has therefore emerged as useful
model system to study DNA damage response pathways. There are several
advantages of using shelterin depletion over traditional drug or irradiation
induced DNA damage. First, the defined location of the DNA damage allows for
separation of the damaged DNA from the rest of the chromatin. This allows the
use of molecular techniques such as telomere overhang assays, ChIP and other
physical assays to study the effect of DNA damage. Secondly, the highly specific
function of shelterin components allows studying DNA damage pathways
separately from one each other, a feat difficult to accomplish with drugs or
irradiation which often stimulate a more complex response. However, care should
be taken before extrapolating results from telomere specific studies to other sites
in the genome without appropriate controls.
For the purpose of this thesis, telomeres lacking TRF2 will be used to
study the role of 53BP1 in promoting chromatin mobility. Telomeres devoid of
TRF2 were previously successfully used to shown the role of 53BP1 in the cNHEJ pathway and in blocking extensive end-resection (Dimitrova et al., 2008;
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Lottersberger et al., 2013; Zimmermann et al., 2013). Furthermore, deletion of
TRF1 will be used to analyze the role of 53BP1 at sites of replication stress and
to analyze the molecular activities underlying sister telomere associations.
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Chapter 2: 53BP1 dissociation of function mutants
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2.1 Introduction
It is known that 53BP1 is a key regulator in the decision between NHEJ and HR
at DSBs. However, specifically how 53BP1 promotes NHEJ is not completely
understood. One mechanism by which 53BP1 stimulates NHEJ is via inhibition of
end-resection using its interaction with Rif1. However, loss of Rif1 does not
reduce NHEJ to the same extend as loss of 53BP1 indicating other factors are
involved (Zimmermann et al., 2013). We also know that 53BP1 promotes NHEJ
by stimulating the mobility of damaged chromatin but the molecular mechanisms
are not well understood (Dimitrova et al., 2008). Preliminary data from the de
Lange lab has shown that the 53BP1-mediated mobility involves cytoplasmic
microtubules since it is diminished upon treatment with nocodazole, which
depolymerizes

microtubules.

Furthermore,

treatment

of

cells

with

the

microtubule-stabilizing drug Taxol also reduced the mobility of dysfunctional
telomeres. In addition, it was shown that the effect of 53BP1 on mobility involves
the LINC complex (LInker of Nucleoskeleton and Cytoskeleton), which spans the
inner and outer nuclear membranes (INM and ONM) (Starr and Fridolfsson,
2010). The LINC complex is composed of Sun proteins (Sun1 and Sun2) in the
INM that interact with nesprins spanning the ONM. The nesprins connect to the
cytoskeleton, including microtubules, through interactions with kinesins amongst
other proteins. How 53BP1 connects to the LINC complex is unknown.
The function of the interaction between PTIP and 53BP1 remains
controversial. Loss of PTIP has no effect on CSR in B cells but radial formation in
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PARPi-treated BRCA-/- cells is diminished in absence of PTIP. This was
attributed to increased resection after loss of PTIP (Callen et al., 2013). At
telomeres, fusions were reduced in PTIP-/- MEFs treated with an shRNA against
TRF2, which was speculated to be due to the increased resection. However,
these experiments were done with a TRF2 shRNA and in PTIP-/- MEFs and it is
unclear if these results represent a function of PTIP downstream of 53BP1.
53BP1 uses its N-terminal S/TQ phosphorylation sites to interact with
proteins that perform essential functions in DNA repair, such as Rif1 and PTIP. A
proteomics screen in B cells identified hundreds of proteins that interact with the
S/TQ sites in a damage inducible way, but the relevance of most of these factors
remains unknown (Di Virgilio et al., 2013).
The first part of my thesis is focused on understanding the role of
phosphorylation dependent interaction partners of 53BP1 in regulating DNA
repair. Telomeres depleted of TRF2 are used as a model system since 53BP1
mediated NHEJ results in extensive telomere fusions that are easily visible in
metaphase spreads. Furthermore, resection can be analyzed with telomere
overhang assays using a telomere specific probe.

2.2 Results
2.2.1 Generation of 53BP1 mutants
To study the role of 53BP1 interaction partners, a panel of mutant 53BP1 alleles
was generated in which clusters of the 28 S/TQ sites are mutated to alanine.
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Figure 2.1 Gibson cloning of 53BP1 mutant alleles
Mutant 53BP1 alleles were created from 53BP1

WT

and 53BP1

Δ28

via Gibson cloning. Primer pairs

were designed containing short overlap with each other. One pair (black) was used to do a PCR
around the plasmid copying the backbone and most of the 53BP1
(red) on the 53BP1

Δ28

WT

construct. A second PCR

vector copies part of the N-terminal region containing mutated S/TQ

residues. The two PCR products are isolated and ligated together using Gibson cloning
dependent on the overlap between the primer pairs. This strategy allows mixing parts of the
53BP1

WT

and 53BP1

Δ28

constructs
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Figure 2.2 53BP1 mutant alleles
(A) Schematic of 53BP1 and the mutant alleles. (B) Co-IP in 293T cells expressing MYC-tagged
PTIP and FLAG-tagged 53BP1. Co-IP demonstrates that the interaction between 53BP1 and
PTIP is lost with 53BP1

Δ28

and 53BP1

ΔPTIP

but not with the other alleles. Left panel shows input

DNA and the co-IP using FLAG antibody is shown on the right. Immunoblot was done with
antibodies against 53BP1 and MYC.
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These mutants were generated via Gibson cloning using WT and 53BP1Δ28 as
template allowing the exchange of different parts of the plasmids (Fig. 2.1). This
approach was taken since 53BP1 is a very large construct that hinders regular
cloning protocols. Constructs were sequenced throughout to verify the correct
change. All constructs contain a C-terminal FLAG-tag for IP and western blotting
and lack the C-terminal BRCT domains, which were previously shown to be
dispensable for NHEJ at telomeres (Lottersberger et al., 2013). These constructs
will collectively be called S/TQ mutants or specifically named for their mutant
domain. The different mutants are shown in Fig. 2.2a.
For 53BP1ΔPTIP, the first 4 S/TQ sites were mutated to alanine based on
previous studies that showed these to be required for the interaction with PTIP
(Munoz et al., 2007; Callen et al., 2013). Co-IP experiments with FLAG tagged
53BP1 and myc-tagged PTIP showed that the interaction with PTIP was indeed
lost in the 53BP1ΔPTIP mutant but not the other alleles (Fig. 2.2c). The interaction
between 53BP1 and Rif1 was previously mapped to 7 S/TQ sites in a central
domain of 53BP1, in a mutant called 53BP1Δ3 (Callen et al., 2013) (Fig. 2.3a).
However, this mutant still displayed residual Rif1 binding at telomeres after
deletion of TRF2 (Fig 2.3a). Therefore a different subset of mutant 53BP1 alleles
was created in which additional domains of S/TQ sites were mutated (Fig. 2.3b).
The interaction between 53BP1 and Rif1 was examined by analyzing Rif1
recruitment to 53BP1 by IF-FISH at dysfunctional telomeres in TRF2F/F53BP1-/-
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Figure 2.3 Rif1 recruitment to 53BP1
Δ3

(A) Schematic of 53BP1 WT and 53BP1 , which is supposedly deficient in Rif1 recruitment
(Callen et al., 2013). Right panel shows Rif1 (white) recruitment to 53BP1 (red) by IF-FISH upon
expression of the constructs in TRF2

F/F

53BP1

-/-

MEFs, 72 h after deletion of TRF2. Rif1 is still

Δ3

recruited to 53BP1 . For clarity, panels with DAPI and telomere FISH signals are not shown in
these images, but 53BP1 localizes to telomeres. (B) Generation of additional 53BP1 mutant
constructs, shown on left. The domains of mutated S/TQ sites are depicted at the bottom. For
example, 53BP1

Δ1,2

has S/TQ sites in both domain 1 and 2 mutated to alanine. Right panel shows

IF-FISH of Rif1 (white) recruitment to 53BP1 (red) upon expression of constructs in
F/F

TRF2 53BP1

-/-

MEFs, 72 h after deletion of TRF2. The interaction between 53BP1 and Rif1 is

only lost in mutants that have both domain 2 and 3 mutated or in the complete phosphorylation
mutant 53BP1

Δ28

(highlighted in red).
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Figure 2.4 53BP1 mutant alleles localize to telomeres
(A) Schematic of 53BP1 and the mutant alleles. (B) 53BP1 constructs were expressed in
F/F

TRF2 53BP1

-/-

MEFs and localization analyzed via IF-FISH at 72 h after deletion of TRF2. IF-

fish shows 53BP1 (green) recruitment to telomeres (white). Rif1 (red) localizes to 53BP1 foci
except in cells expressing the 53BP1

Δ28

or 53BP1

ΔRif1

alleles. Numbers on the right represent the

quantification of the average percentage of cells with >5 53BP1 or 53BP1/Rif1 foci at telomeres
from 3 independent experiments.
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cells expressing the mutant 53BP1 alleles. Interestingly, only the 53BP1 alleles
that have the S/TQ sites mutated in both domain 2 and 3 showed complete loss
of Rif1 recruitment (Fig. 2.3b). The precise interaction between Rif1 and 53BP1
was further mapped by mutating subsets of the S/TQ sites in this region.
Especially S176 and S178 appeared to be required for Rif1 foci formation. The
resulting 53BP1ΔRif1 allele contains 7 mutated S/TQ sites (different from 53BP1Δ3)
and has lost all interaction with Rif1 (Fig. 2.4a and 2.4b).
The 53BP1ΔMOB allele was initially generated to examine whether S/TQ
sites in this domain influence any of the known functions of 53BP1. As will be
described in detail in chapter 2.2.4, this mutant affected the ability of 53BP1 to
promote the mobility of dysfunctional telomeres and was thus called 53BP1ΔMOB.
Importantly, all S/TQ mutants expressed equally well in TRF2F/F53BP1-/- MEFs
and each localized to sites of damage (Fig. 2.2b and 2.4b).

2.2.2 Rif1 is the only factor downstream of 53BP1 controlling resection
53BP1 blocks CtIP-dependent end resection thereby promoting c-NHEJ in G1. At
telomeres, 53BP1 also blocks CtIP-independent end-resection by Exo1/BLM in
response to ATR activation upon loss of TPP1/POT1a/b (Kibe et al., 2016). In
absence of 53BP1, hyper-resection occurs at DSBs and dysfunctional telomeres
that inhibit c-NHEJ. The ability of 53BP1 to block resection is dependent on
phosphorylation of the S/TQ sites and Rif1 was identified as the main 53BP1
interacting factor responsible for this function (Di Virgilio et al., 2013;
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Zimmermann et al., 2013). To analyze if any 53BP1-S/TQ binding factors other
than Rif1 are required to block resection, the 53BP1 mutant alleles were
expressed in TRF2F/FLig4-/-53BP1-/- MEFs and resection was analyzed by
telomere overhang assays. These experiments are done in a Ligase 4 (Lig4)
deficient setting since telomere fusions would mask a defect in protection from
hyper-resection.
Telomere overhang assays are native in-gel hybridization assays that
enable quantification of the amount of ssDNA at telomeres (Fig. 2.5). Briefly,
genomic DNA is isolated and digested with AluI and MboI, which frequently
cleave anywhere in the genome except for the telomeric repeats. The generated
telomeric fragments are then separated on a gel, which is hybridized with a
telomere specific probe ([CCCTAA]4) under native conditions, resulting in a
quantifiable signal for the amount of ssDNA at telomeres. The gel is then
denatured and hybridized with the same telomeric probe to control for the total
amount of DNA in the lane allowing normalization of the ssDNA signal, as
explained in Figure 2.5. The measured ssDNA can be either internal or at the 3’
overhang. Treatment of the telomeric DNA with E. coli ExoI can distinguish
between these two possibilities since ExoI removes 3’ overhangs but does not
act on internal ssDNA. As it is already known that ssDNA formed after TRF2
deletion is solely at the 3’ overhang, ExoI treatment was not included in these
experiments (Celli and de Lange, 2005; Lottersberger et al., 2013).
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Figure 2.5 Schematic of telomere overhang assay
Genomic DNA is isolated and digested with AluI and MboI, which cannot cleave the telomeric
sequence. Isolated telomeric DNA is separated on by PFGE and hybridized under native
conditions with a telomere specific probe that binds to the ssDNA. The gel is then denatured and
hybridized with the same probe to quantify the total telomeric DNA present to allow normalization
of the amount of telomeric ssDNA to the total amount of telomeric DNA. To compare lanes, the
normalized ssDNA signal in a control lane is set to 1.0 and the treated sample is quantified
compared to this number. Figure provided by Titia de Lange.
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Figure 2.6 53BP1

ΔRif1

cannot protect telomeres from end resection

(A) Telomere overhang assay of MboI/AluI digested DNA from TRF2

F/F

-/-

Lig4 53BP1

-/-

MEFs

expressing the mutant 53BP1 alleles. Telomeric DNA was analyzed 96 h after Cre-mediated
deletion of TRF2 using the in-gel hybridization assay. Left panel shows native telomeric ssDNA
signal, right panel displays the denatured total amount of telomeric DNA as explained in Fig. 2.5
(B) Quantification of the overhang signal as in (A) from three independent experiments. Only the
values from the Cre-treated samples are shown. Numbers were obtained by normalizing the
native ssDNA signal to the total telomeric DNA signal in the denatured gel. The values of the Cretreated samples were obtained by comparison with the untreated control samples, which were set
to 1.0. Means and SDs from three independent experiments are shown. P-values were
determined compared to WT by a two-sided Students T-test (* p<0.05, ** p<0.01). (C) Western
blot control showing the equal expression level of the 53BP1 alleles and the deletion of TRF2.
Cells were harvested 72 h after deletion of TRF2 and antibodies against 53BP1 and TRF2 were
used.
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As expected, hyper-resection was observed in TRF2F/FLig4-/-53BP1-/MEFs upon deletion of TRF2 and expression of empty vector control and in cells
expressing 53BP1Δ28 (Fig. 2.6a-c). The overhang signal increased 2 to 2.5 fold,
similar to previous studies using TRF2F/FLig4-/-53BP1-/- MEFs (Dimitrova et al.,
2008; Lottersberger et al., 2013; Zimmermann et al., 2013). Cells expressing
53BP1ΔRif1 showed a similar overhang increase as 53BP1Δ28 suggesting that Rif1
is the only factor downstream of 53BP1 required to block end resection.
Furthermore, 53BP1ΔPTIP behaved as WT 53BP1 with regards to end resection
indicating that PTIP is not involved downstream of 53BP1 contrary to previous
reports (Callen et al., 2013). It is possible that PTIP is recruited independent of
53BP1 to inhibit end resection since these experiments were not done in a PTIP
deficient setting. However, other experiments from the lab using TRF2F/FLig4-/PTIP-/- MEFs indicate that PTIP does not affect resection at telomeres
contradicting this explanation (Lottersberger et al., 2015).

2.2.3 53BP1 mutant alleles promote varying levels of telomere fusions
53BP1 promotes c-NHEJ of dysfunctional telomeres via at least two distinct
mechanisms: blocking end-resection and stimulating chromatin mobility. To
understand which domain of 53BP1 is required to induce chromatin mobility and
whether other factors might be involved, the ability of the S/TQ mutants to induce
c-NHEJ was analyzed. These experiments were done in TRF2F/F53BP1-/- cells
expressing the S/TQ mutants and telomere fusion analyzed in metaphase
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Figure 2.7 Analysis of telomere fusions in cells expressing mutant 53BP1 alleles.
(A) Western blot control for the equal expression level of 53BP1 alleles and deletion of TRF2 from
F/F

-/-

MEFs 72 h after Cre. (B) Metaphase spreads of TRF2 53BP1 MEFs expressing mutant 53BP1
alleles. Cells were harvested 84 h after Cre-mediated deletion of TRF2. Metaphase spreads were
stained with DAPI (red) and a telomeric TelG FISH probe (green). (C) Quantification of the
percentage of telomere fusions. Results from 4 independent experiments are shown, each dot
represents a metaphase spread. Bars represent the median % of telomere fusions. P-values
determined by a two-sided Students T-test (* p<0.05, ** p<0.01, *** p<0.001).
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Figure 2.8 Analysis of telomere fusions in cells deficient for the LINC complex
(A) Immunoblot showing expression of 53BP1 alleles and Sun2 in TRF2
and TRF2

F/F

-/-

+/+

53BP1 Sun1 Sun2

+/+

F/F

-/-

-/-

53BP1 Sun1 Sun2

-/-

MEFs expressing the indicated mutant alleles of 53BP1. (B)

Telomere fusions of MEFs expressing 53BP1

WT

analyzed 84 h after deletion of TRF2. Bars

represent the median % of telomeres fused in 4 independent experiments. (C and D) Telomere
fusions of the mutant 53BP1 alleles in TRF2
+/+

Sun1 Sun2

+/+

F/F

-/-

-/-

-/-

F/F

53BP1 Sun1 Sun2 (C) and TRF2 53BP1

-/-

(D) MEFs. To allow comparison of telomere fusions in these two separate MEF

cell lines, the median fusion frequency in cells expressing WT 53BP was set to 100% (this is the
same data as in B). Telomere fusions of the mutant 53BP1 alleles were compared relative to the
fusion frequency in the cells expressing WT 53BP1. This allows correction for variability between
experiments. The frequency of telomere fusions was scored on metaphases harvested 84 h after
TRF2 deletion. Bars represent the median % of telomeres fused in 4 independent experiments;
each dot represents a metaphase spread. P-values determined by a two-sided Students T-test (*
p<0.05, ** p<0.01, *** p<0.001). (E) Schematic of the mechanisms by which 53BP1 promotes
NHEJ
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spreads 84 h after deletion of TRF2. As expected, telomeres of cells expressing
wild type 53BP1 became extensively fused after deletion of TRF2 whereas
expression of 53BP1Δ28 did not support c-NHEJ (Fig. 2.7a-c). Furthermore,
53BP1ΔRif1 displayed reduced levels of c-NHEJ while 53BP1ΔPTIP showed only a
mild fusion defect (Fig. 2.7b). Importantly, 53BP1ΔMOB showed a mild fusion
defect as well, even though this mutant is fully capable of blocking end-resection
(Figs. 2.7b and 2.6b).

2.2.4 Identification of the 53BP1 mobility domain
The mild fusion defect seen in 53BP1ΔMOB could be due to lack of the chromatin
mobility promoted by 53BP1. To test whether this was the case, telomere fusions
were analyzed in TRF2F/F53BP1-/-Sun1-/-Sun2-/- cells, which lack the LINC
complex and are therefore defective for DNA damaged induced chromatin
mobility (Lottersberger et al., 2015). If 53BP1ΔMOB is indeed responsible for
inducing chromatin mobility, expression of this mutant should behave as wild type
53BP1 with regards to c-NHEJ in cells lacking the LINC complex (Fig. 2.8e). This
experiment was carried out in TRF2F/F53BP1-/-Sun1-/-Sun2-/- and TRF2F/F53BP1-/Sun1+/+Sun2+/+ littermate controls expressing the S/TQ alleles (Fig. 2.8a). As
expected, the level of fused telomeres in cells expressing wild type 53BP1 was
lower in cells deficient in the LINC complex (Fig. 2.8b). Next, all S/TQ alleles
were analyzed in these two cell lines. To correct for variability between
experiments, the median level of fusion in cells expressing wild type 53BP1 was
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set to 100% in each set of parallel experiments and percent reduction was
calculated for the S/TQ mutants tested (Fig. 2.8c and d). This comparison to the
levels of fusions observed with wild type 53BP1 served as an internal control for
the timing of each experiment. Such a control is needed because in different
experiments, the timing of Cre mediated deletion can vary slightly. Since
telomere fusions represent a cumulative phenotype that is affected by the
duration of the TRF2 deficiency, variations in Cre timing can affect fusion
frequencies.
Interestingly, whereas telomere fusions were reduced in TRF2F/F53BP1-/Sun1+/+Sun2+/+ cells expressing 53BP1ΔMOB, this construct behaved similar to wild
type 53BP1 in TRF2F/F53BP1-/-Sun1-/-Sun2-/- cells (Fig. 2.8c-d). This suggests
that 53BP1ΔMOB harbors the S/TQ sites needed to induce chromatin mobility.
To test the effect of the 53BP1ΔMOB mutations further, the ability of this
mutant to induce chromatin mobility was studied via live cell imaging using the
same experimental settings as used previously to describe 53BP1 induced
chromatin mobility (Fig. 2.9a) (Dimitrova et al., 2008; Lottersberger et al., 2015).
Briefly, a stable cell line was created by expressing the Tudor and UDR domains
of 53BP1 fused to mCherry (mCherry-BP1-2) in TRF2F/F53BP1-/- cells. This
construct localizes to sites of damage but has no effect on DNA damage repair
since it lacks all other functional domains of 53BP1 (Dimitrova et al., 2008). Upon
deletion of TRF2, mCherry-BP1-2 localizes to telomeres and the dynamic
movement of telomeres can be tracked via live cell time-lapse imaging and the
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Figure 2.9 53BP1

ΔMOB

is deficient in stimulating chromatin mobility

(A) Experimental setup for analysis of telomere mobility. TRF2

F/F

-/-

53BP1 MEFs expressing a

mCherry-BP1-2 construct are used in time-lapse imaging experiments. This protein localizes to
damage sites upon deletion of TRF2. Z-stack images are acquired every 30 seconds during a 10
minute timelapse experiment. Figure adapted from Lotterberger et al. 2015. (B) Examples of
F/F

-/-

mCherry-53BP1 traces in TRF2 53BP1 cells expressing the indicated mutant 53BP1 alleles, as
described in A. (C) The MSD calculated from the traces of mCherry-BP1-2 foci from 3
independent experiments as described in A. (D) Percent of cells discarded from the analysis by
the parameters described in 2.2.4. Values represent mean and SD from the 3 experiments from C
and differences are not significant.
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Mean Square Displacement (MSD) measured from the track lengths (Fig. 2.9b).
Movies were 10 minutes long and the tracks were analyzed from 2D-maximum
intensity projected images since MEF nuclei are flat (2-4 μm in z compared to 1520 μm in x and y). The resulting traces can be corrected for nuclear rotation and
movement, but large-scale nuclear deformations, such as expansion, contraction
or twisting can confound the results. Therefore, cells showing extensive distortion
were discarded from the analysis according to parameters described in
Lottersberger et al. 2015 (Lottersberger et al., 2015). Briefly, extensive distortion
was measured by a shift in the geometrical center of the nucleus. Expansion and
contraction of nucleus was measured by the maximal difference between the
average distances of the foci from the geometrical center. For example, in an
expanding nucleus all foci would increase their distance from the geometrical
center. A folding or twisting nucleus was measured as groups of foci all moving in
the same direction. Arbitrary parameters were set for all these conditions and
cells were discarded based on whether their parameters were outside the set
thresholds. In most experiments, approximately half the nuclei passed the
selection criteria and where used for the mobility analysis. DNA damage
induction and 53BP1 status did not affect the frequency of discarded cells (Fig.
2.9d).
As expected, cells expressing 53BP1WT displayed the expected DNA
damage induced chromatin mobility with an MSD of 0.35 μm2 that is consistent
with previous measurements (Fig. 2.9c). The 53BP1Δ28 allele was defective and
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similar to an empty vector control showed an MSD of 0.25 μm2. Interestingly, the
MSD of 53BP1ΔMOB was also 0.25 μm2, similar to 53BP1Δ28 and the empty vector
control, indicating that this mutant has a complete defect in inducing chromatin
mobility (Fig. 2.9c). Together with the c-NHEJ results from LINC complex
deficient cells, the data argue that 53BP1ΔMOB indeed contains mutations in the
residues needed to promote chromatin mobility. Furthermore, 53BP1ΔPTIP had no
effect on stimulating chromatin mobility indicating that the mild fusion defect seen
with this mutant is due to a different function of 53BP1 (Fig. 2.7c).

2.2.5 No interaction detected between Sun1 and 53BP1
Although the experiments described above argue that 53BP1ΔMOB harbors the
S/TQ sites needed to promote mobility, it is unknown how 53BP1 connects to the
LINC complex on a molecular level. Previous experiments in the lab have shown
that Sun1 and Sun2 are redundant and therefore only the interaction with Sun1
was tested. To investigate whether an interaction exists between Sun1 and
53BP1, co-IP experiments were carried out in 293T cells overexpressing Sun1
and FLAG-tagged 53BP1WT or 53BP1Δ28. Overexpressed myc-PTIP was used as
positive control. Cells were irradiated or treated with zeocin to induce DNA
damage signaling and phosphorylation of 53BP1. An IP was performed using
antibodies against FLAG to pull down 53BP1 together with its interacting factors
(Fig. 2.10a and b). The results were inconclusive. An interaction was seen
between 53BP1 and Sun1 in some but not all experiments (compare Fig. 2.10a
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Figure 2.10 Interaction between 53BP1 and Sun1 is not consistently detected
(A) Co-IP of 53BP1, Sun1 and myc-PTIP in 293T cells using FLAG antibody. FLAG tagged
53BP1, Sun1 and myc-PTIP were transiently expressed in 293t cells. After irradiation with
10Gray, a co-IP was performed using FLAG antibodies and interacting factors visualized by
western blot with myc and Sun1 antibodies. An antibody against phosphorylated S/TQ sites was
used to demonstrate 53BP1 phosphorylation. (B) Co-IP of 53BP1, Sun1 and myc-PTIP in 293T
cells using FLAG antibody. FLAG tagged 53BP1, Sun1 and myc-PTIP were transiently expressed
in 293T cells. After treatment with/without zeocin, a co-IP was performed using FLAG beads and
interacting factors detected by western blot with myc and Sun1 antibodies. (C) Co-IP of 53BP1,
myc-Sun1 and myc-PTIP in 293T cells using myc antibody. FLAG tagged 53BP1, Myc-tagged
truncated Sun1 constructs and myc-PTIP were transiently expressed in 293T cells. After IP with
myc reactive antibody, interacting factors were visualized by immunoblot with 53BP1 and myc
specific antibodies. Schematics of the Sun1 constructs are drawn on the right. The full length
Sun1 construct is indicated at the top with LMNA interaction domain (blue), transmembrane
domain (green) and KASH domain (red) shown.
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and b). There was a correlation between the overexpression levels of Sun1 and
the amount recovered in co-IP suggesting that this might be non-specific binding
of Sun1 to the beads. The positive control, myc-PTIP, was pulled down
specifically by 53BP1WT but not 53BP1Δ28 in a zeocin inducible manner indicating
that the experimental setup was correct (Fig. 2.10a and b). To try to minimize
non-specific binding of Sun1, different wash buffers and magnetic beads were
used but the results remained inconclusive (see materials and methods for
details).
The reverse IP reaction was also attempted, using antibodies against the
myc-tag and western blotting for FLAG-53BP1 (Fig. 2.10c). The positive control,
myc-PTIP, was pulled down with 53BP1, but an interaction was not observed
with myc-Sun1. In these experiments, truncated versions of Sun1 were used in
addition to the full-length protein. Both a nuclear and luminal Sun1 mutant were
used, both lacking the transmembrane domain and thus soluble (Fig. 2.10c).
Possibly, the soluble nuclear truncation mutant of Sun1 interacts more strongly
with 53BP1 due to its localization throughout the nucleus. A luminal version of
Sun1 was used as a negative control since the interaction between 53BP1 and
Sun1 is not expected in the perinuclear space between INM and ONM. A
potential caveat to this experiment is that the nuclear or luminal localization of
these constructs was not verified. However, an interaction was not observed
between these constructs and 53BP1.
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Figure 2.11 Interaction between 53BP1 and endogenous Sun1 in MEFs
(A) Levels of endogenous Sun1 in MEFs lysed in 2x sample buffer. The MEFs are either
F/F

-/-

+/+

TRF1 53BP1 Sun1 Sun2

+/+

F/F

-/-

+/+

or TRF1 53BP1 Sun1 Sun2

+/+

as indicated. Two sampes of

each MEF line were analyzed on western blot stained with a Sun1 reactive antibody.
Immunoblot of TRF1

F/F

(B)

MEFs lysed in 0.5% NP40 and high salt concentrations (see materials and

methods for further details). Sun1 presence in soluble (S) and Pellet (P) fraction was visualized
by immunoblot with a Sun1 specific antibody. (C) Immunoblot of TRF1

F/F

MEFs lysed in high salt

lysis buffer with/without prior isolation of nuclei as indicated. Lysate was sonicated for 5 or 10
minutes. Sun1 extraction in the indicated fractions was visualized by western blot with Sun1
specific antibody. Immunoblot for tubulin suggests correct separation of fractions. (D) Co-IP of
53BP1 and Sun1 using FLAG-beads from TRF2

F/F

-/-

53BP1 MEFs expressing the indicated 53BP1

allele with a 3xFLAG tag at its C-terminus. Cells were harvested 72 h after Cre mediated deletion
of TRF2 or untreated control cells. MEFs were treated with/without DSP crosslinker prior to lysis
and sonication for 5 minutes as in C. A co-IP was performed using magnetic FLAG beads and
interacting factors detected by western blot with Sun1 and 53BP1 specific antibodies. (E) Same
experiment as in D, only now minimal interaction is seen between Sun1 and 53BP1.
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Since co-IP experiments with overexpressed Sun1 were unconvincing, the
experiments were carried out with endogenous Sun1 in MEFs. The rationale for
these experiments was that overexpressed nuclear envelope proteins often
accumulate in other cellular compartments where an interaction with 53BP1
might not be found. However, extraction of endogenous Sun1 is difficult since it is
not released in most common lysis buffers, unless 2xSample buffer is used (Fig.
2.11a and b). Different approaches were tested and the most consistent release
of Sun1 was found when nuclei were isolated and subsequently lysed in a high
salt lysis buffer followed by brief sonication (Fig. 2.11c). Cells were briefly treated
with dithiobis(succinimidylpropionate) (DSP) prior to IP, a reversible crosslinker
that reacts with primary amines in lysine residues to form stable amide bonds
(Lomant and Fairbanks, 1976). The DSP crosslinker was used to increase the IP
strength in case the interaction is transient. The addition of the reducing agent
dithiothreitol (DTT) to the sample buffer prior to western blot removes the
crosslinks to allow separation of proteins by SDS page. Furthermore, for these
experiments 3xFLAG tagged 53BP1 constructs were used to increase the
efficiency of the co-IP. The indicated 53BP1 constructs were overexpressed in
TRF2F/F53BP1-/- cells, which were treated with Cre 72 h prior to harvest. To
reduce potential background binding due to pelleting of large complexes,
magnetic anti-FLAG beads were used. However, an interaction between 53BP1
and Sun1 was still not consistently observed (Fig. 2.11d and e).
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2.2.6 Exploring a role for known 53BP1 interacting partners in chromatin mobility
It is possible that the interaction between 53BP1 and the LINC complex is either
transient or indirect, explaining why co-IP experiments failed to show an
interaction. To test whether known interaction partners of 53BP1 are involved in
chromatin mobility, a candidate list of proteins from a proteomics screen in Bcells was examined (Di Virgilio et al., 2013). Several Coiled-Coil DomainContaining (CCDC) proteins are found on this list, including CCDC124, CCDC9
and CCDC79. This is of interest given that during meiosis, CCDC proteins
connect telomeres to Sun1 (Shibuya et al., 2014). To test whether any of these
proteins are involved in 53BP1 mediated chromatin mobility, shRNAs were used
to knockdown CCDC124, CCDC9 or CCDC79 in TRF2F/F cells and telomere
fusions assessed 96 h after deletion of TRF2. Although the level of knockdown
was not assessed, none of the shRNA yielded a significant reduction in c-NHEJ
upon deletion of TRF2 (Fig. 2.12a and b). For CCDC9, a small reduction was
seen but knockdown of this protein significantly affected cell growth. Since
telomere fusions are a cumulative phenotype, the reduced cell growth is
expected to decrease telomere fusions and the results with the shCCDC9 are
therefore inconclusive. The shRNA against CCDC79 was also toxic to cells and
resulted in endoreduplication. Telomere fusions were therefore not assessed.
Another protein that surfaced in the proteomics screen for 53BP1 is
TopBP1. Despite the potentially confounding roles of TopBP1 in the ATR
mediated DNA damage response pathway and DNA replication, the effect of
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Figure 2.12 Telomere fusions upon depletion of potential 53BP1 and Sun1 interaction
partners
(A) Frequency of telomere fusions in TRF2

F/F

MEFs after shRNA mediated depletion of

CCDC124. Five independent shRNAs were used. Metaphase spreads were analyzed 96 h after
deletion of TRF2. Each dot represents a metaphase spread and bars represent the median % of
telomeres fused in one experiment. (B) Frequency of telomere fusions in TRF2

F/F

MEFs after

shRNA mediated depletion of CCDC9. Metaphase spreads were analyzed 96 h after deletion of
TRF2. Bars represent the median % of telomeres fused in one experiment. (C) Frequency of
telomere fusions in TRF2

F/F

MEFs after shRNA mediated depletion of TopBP1. Metaphases were

analyzed 96 h after deletion of TRF2. Bars represent the median % of telomeres fused in one
experiment. (D) Western blot from TRF2

F/F

MEFs after depletion of TOPBP1. Cells were

harvested 72 h after deletion of TRF2 and shRNA effectiveness analyzed with a TOPBP1 specific
antibody.
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Figure 2.13 Telomere CHIP
(A) Telomere ChIP performed in the indicated MEFs (top) 72 h after deletion of TRF2. ChIP was
done with the antibodies indicated on either sides and recovered telomeric DNA visualized by dotblot using a telomere specific probe (Sty11, TTAGGG). (B) ChIP samples from A were hybridized
on dot-blot with a BAMH1 probe to control for unspecific binding. (C) Quantification of the
recovered telomeric DNA in ChIP from A. Signals of telomeric DNA recovered with indicated
antibodies were normalized to the input and are given relative to the signal in no-Cre TRF2
cells. The Sun1 antibodies did not result in a ChIP signal and was therefore not quantified.
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F/F

shRNA-mediated knockdown of TopBP1 was analyzed (Kumagai et al.,
2006)}(Delacroix et al., 2007),. Whereas the knockdown of TopBP1 was efficient,
no reduction in telomere fusions was observed indicating that TopBP1 is not
required for NHEJ of telomeres depleted of TRF2 and thus is unlikely to
constitute the link between 53BP1 and the LINC complex (Fig. 2.12c and d).
In a final attempt to show an interaction between 53BP1 and the LINC
complex, a telomeric chromatin immunoprecipitation (CHIP) experiment was
done using Sun1 or Sun2 specific antibodies. As a positive control, antibodies
against TRF1 and 53BP1 were used. Whereas a DNA damage inducible
accumulation of 53BP1 was seen at telomeres, there was no increase in
telomeric DNA seen with Sun2 specific antibodies (Fig. 2.13a-c) and the Sun1
ChIP failed altogether. It thus remains unclear how 53BP1 connects to the LINC
complex.

2.2.7 Oligomerization domain of 53BP1
The C-terminus of 53BP1 contains an oligomerization domain that is required for
efficient IR-induced focus formation, although chromatin binding itself is partially
retained (Zgheib et al., 2009; Bothmer et al., 2011). The oligomerization domain
is also crucial for CSR in B cells but at dysfunctional telomeres, NHEJ is only
partially affected when this domain is deleted (Lottersberger et al., 2013). It was
previously shown that the oligomerization domain does not affect the ability of
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53BP1 to protect against resection and does not affect the mobility of
dysfunctional telomeres (Lottersberger et al., 2013).
To further understand the role of the oligomerization domain at
dysfunctional telomeres, a mutant 53BP1 allele was made in which the
oligomerization domain was deleted and the N-terminal S/TQ sites mutated to
alanine (53BP1ΔOligoΔ28) (Fig. 2.14a). This mutant and the control 53BP1 alleles
were expressed in TRF2F/F53BP1-/- cells and resection and telomere fusions
analyzed after Cre mediated deletion of TRF2 (Fig. 2.14b). As expected,
53BP1ΔOligoΔ28 behaved similar to 53BP1Δ28 with regards to blocking resection
since the interaction with Rif1 is lost in both mutants (Fig. 2.14c and d). The
overhang signal increased 2.5 fold upon expression of either 53BP1ΔOligoΔ28 or
53BP1Δ28 similar to the empty vector control. Next, telomere fusions were
analyzed on metaphase spreads. Interestingly, NHEJ was more strongly affected
in cells expressing the 53BP1ΔOligoΔ28 mutant compared to 53BP1ΔOligo or
53BP1Δ28 as telomere fusions in the 53BP1ΔOligoΔ28 expressing cells were reduced
to levels similar to empty vector control (Fig. 2.15). In contrast, cells expressing
the 53BP1Δ28 allele show residual telomere fusions with a small percentage of
metaphases containing significant telomere fusions (20-60% telomeres fused)
even though the median remains below 10% when analyzed 96 h after deletion
of TRF2. These cells with higher levels of telomere fusions are never observed in
empty vector control cells and are also not observed in cells expressing
53BP1ΔOligoΔ28.
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Figure 2.14 53BP1 oligo mutants
(A) Schematic of 53BP1 oligo mutants. (B) Western blot control for the equal expression level of
the 53BP1 oligo alleles and the deletion of TRF2. Cells were harvested 72 h after deletion of
TRF2 and antibodies against 53BP1 and TRF2 were used. C. Telomere overhang assay of
MboI/AluI digested DNA from TRF2

F/F

-/-

Lig4 53BP1

-/-

MEFs expressing the indicated 53BP1

alleles. Telomeric DNA was analyzed 96 h after Cre-mediated deletion of TRF2 using the in-gel
hybridization assay (Fig. 2.5). Left panel shows native telomeric ssDNA signal, right panel
displays the denatured total amount of telomeric DNA. (D) Quantification of the overhang signal
from three independent experiments. Only the values from the Cre-treated samples are shown.
Numbers were obtained by normalizing the native ssDNA signal to the total telomeric DNA signal
in the same lane in the denatured gel. The values of the Cre-treated samples were obtained by
comparison with the untreated control samples, which were set to 1.0. Means with SD from three
independent experiments are shown. P-values were determined compared to WT by a two-sided
Student’s t-test (* p<0.05, ns = non significant)
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Figure 2.15 Telomere fusions in MEFs expressing oligo mutants
F/F

Example of metaphase spreads from TRF2 53BP1

-/-

MEFs, expressing the indicated 53BP1

allele. Cells were harvested 96 h after Cre-mediated deletion of TRF2. Metaphase spreads were
stained with DAPI (red) and a telomeric TelG FISH probe (green). Quantification of the level of
telomere fusions is shown on the right. Bars represent median % of telomere fusions from 4
independent experiments, each dot represents a metaphase spread. P-values were determined
compared to WT with a two-sided Student’s t-test (* p<0.05, ** p<0.01, *** p<0.001).
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Interestingly, this reduction in NHEJ appeared to be due to an inability of
53BP1ΔOligoΔ28 to form foci at telomeres as shown in Fig. 2.16a (left panel).
Whereas the localization of 53BP1ΔOligo to telomeres was somewhat reduced
compared to wild type 53BP1, the 53BP1ΔOligoΔ28 mutant failed to localize
effectively explaining the behavior similar to the empty vector control. Of interest,
whereas 53BP1ΔOligo recruitment to dysfunctional telomeres was only mildly
disrupted, it could not localize to IR induced foci suggesting an alternative mode
of localization to telomeres (Zgheib et al., 2009; Lottersberger et al., 2013).
To further validate these results, TRF2F/F53BP1-/- cells expressing the
mutant 53BP1 alleles were irradiated and recruitment to γH2AX-marked sites
was analyzed 30 min later by IF (Fig. 2.16a, right panel). Upon irradiation, neither
53BP1ΔOligo nor 53BP1ΔOligoΔ28 was efficiently recruited to DSBs in agreement with
published experiments (Zgheib et al., 2009). Thus, whereas the oligomerization
domain is necessary for foci formation at IR-induced DSBs, 53BP1 can use an
alternative method to localize to telomeres in absence of the oligomerization
domain, and this recruitment requires a phosphorylation dependent interaction
partner of 53BP1.
To analyze which S/TQ sites might be required for localization of 53BP1 to
telomeres in absence of the oligomerization domain, a second subset of mutant
alleles was made with clusters of the S/TQ sites mutated to alanine (Fig. 2.16b).
These mutants were made prior to identification of the proper Rif1 binding site
but domain 2 and 3 contain the required sites for Rif1 binding, as explained in
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Figure 2.16 Localization of 53BP1 oligo mutants to telomeres is affected
F/F

(A) IF-FISH images of TRF2 53BP1

-/-

MEFs expressing the indicated 53BP1 construct. Left

panel shows recruitment of 53BP1 (FLAG tag, green) to telomeres (red) 72 h after deletion of
TRF2, recruitment of Rif1 is shown in yellow. The right panel shows the foci formation of the
53BP1 alleles (FLAG tag-red) 30 minutes after treatment with IR (10Gray). Staining for γH2AX
(green) indicates IR induced DSB formation. (B) Schematic of additional 53BP1 oligo mutants
created with subsets of the S/TQ sites mutated to alanine, similar to Fig. 2.3. (C) IF-FISH images
F/F

-/-

of TRF2 53BP1 MEFs expressing the additional 53BP1 constructs after deletion of TRF2 (left)
or IR (right), with the same experimental conditions as in A. (D) Quantification of 53BP1
recruitment to telomeres 72 h after deletion of TRF2. The percentage of cells with >5 53BP1 foci
at telomeres is shown, the values represent the mean and SEM from 2 independent experiments.
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Figures 2.2.1 and 2.3. Localization of these constructs to telomeres after deletion
of TRF2 was analyzed via IF-FISH (Fig. 2.16c and d). Preliminary data indicates
that the S/TQ sites needed for Rif1 binding are also required for localization of
53BP1 to dysfunctional telomeres in absence of the oligomerization domain since
the mutant lacking S/TQ sites in both domain 2 and 3 showed deficient 53BP1
recruitment (Fig. 2.16c and d). However, these are very preliminary results, which
need to be repeated before any conclusion can be made. Repeating this
experiment in a Rif1 deficient and proficient setting would ascertain that this
phenotype is dependent on Rif1 and not another interacting factor of 53BP1.

2.3 Summary of findings
The creation of a panel of mutant 53BP1 alleles enabled analysis of the function
of 53BP1 interaction partners in DNA repair at telomeres lacking TRF2. The
results indicate that the S/TQ domain needed for the Rif1 interaction is the only
domain required for inhibiting end resection downstream of 53BP1 (Fig. 2.6).
However, the 53BP1ΔRIF1 allele was not tested in TRF2F/F53BP1-/-Rif1-/- cells.
Thus even though the results suggest that Rif1 is the only factor downstream of
53BP1 required for blocking end resection, this cannot be fully confirmed based
on these experiments. Furthermore, the results suggest that PTIP is not required
to control end resection at telomeres since 53BP1ΔPTIP behaved as a wild type
allele in telomere overhang assays. Even though PTIP does not have a role in
preventing hyper resection, the telomere fusions are slightly delayed in cells
81

expressing 53BP1ΔPTIP (Fig. 2.7). It is possible that this reduction is due to the
role of PTIP in recruiting the Artemis nuclease that is required for end-trimming of
obstructed ends (Wang et al., 2014). Possibly, a subset of telomeres requires
Artemis mediated processing before NHEJ can occur explaining the lower levels
of telomere fusions in absence of PTIP.
The results also describe a separation of function mutant of 53BP1 that is
deficient in inducing chromatin mobility. Cells expressing the 53BP1ΔMOB allele
failed to induce chromatin mobility in live cell imaging experiments and had lower
levels of telomere fusions (Fig. 2.7 and 2.9). Furthermore, the reduction in
telomere fusions was absent in cells lacking SUN1/SUN2 indicating that
53BP1ΔMOB lacks activity in the same pathway as the LINC complex, confirming
that this domain contains the S/TQ sites that are required for mobility (Fig. 2.8).
Importantly, 53BP1ΔMOB had no effect on resection, firmly placing chromatin
mobility in a NHEJ-promoting pathway separate from resection (Fig. 2.6).
Unfortunately, attempts to show an interaction between the LINC complex
and 53BP1 were unsuccessful. Possibly, the interaction is transient and therefore
difficult to detect. Furthermore, antibodies against endogenous LINC complex
components are not very effective, hindering co-IP experiments.
Lastly, experiments using the 53BP1ΔOligoΔ28 mutant suggest that 53BP1
has a unique mechanism to efficiently accumulate at dysfunctional telomeres.
Whereas the oligomerization domain is required for optimal recruitment to IRinduced DSBs, this domain is dispensable at telomeres. However, a mutant
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lacking the oligomerization domain in combination with mutated S/TQ sites no
longer binds to dysfunctional telomeres (Fig. 2.16). These experiments suggest
that a 53BP1 interaction partner can replace the function of the 53BP1
oligomerization domain for accumulation at dysfunctional telomeres but not at
other sites of DNA damage. Preliminary data indicate that it might be Rif1 that is
required for this function, but further studies are needed to confirm this.
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Chapter 3: The nature of telomere sister associations formed
upon loss of TRF1
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3.1 Introduction
The main role for TRF1 at telomeres is to aid progression of the replication fork.
The telomeric TTAGGG repeat sequence represents a problem for the replication
machinery since the G-rich strand has the tendency to form G-quadruplexes
(G4), a secondary structure held together by Hoogsteen hydrogen bonds
(Henderson et al., 1987). In absence of TRF1, replication forks often stall in the
telomeric repeat array resulting in activation of the ATR signaling cascade
(Martinez et al., 2009; Sfeir et al., 2009). Fork stalling also occurs when the
telomeric sequence is located internally in chromosomes, further indicating that
the DNA sequence itself forms a problem for the replication machinery (Miller et
al., 2006; Bosco and de Lange, 2012). One consequence of TRF1 deletion is the
appearance of fragile telomeres, which appear as multiple telomeric signals on
chromosome ends in staining on metaphase spreads (Sfeir et al., 2009). Fragile
telomeres are thought to be similar to the breaks and gaps seen on metaphase
spreads at Common Fragile Sites (CFSs), which are regions of the genome that
are difficult to replicate and show ‘broken’ chromatin in metaphase cells after
treatment with aphidicolin (Hecht and Glover, 1984). Low dose aphidicolin
treatment induces the appearance of fragile telomeres similar to the expression
CFSs. TRF1 was shown to recruit BLM and possibly the RTEL1 helicase to
prevent G4-formation and fork stalling and aid the replication machinery (Sfeir et
al., 2009). A TRF1 mutant lacking the BLM interaction site displays increased
levels of fragile telomeres (Zimmermann et al., 2014). This fragility was observed
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primarily on telomeres formed by lagging strand DNA synthesis (lagging end
telomeres) indicating that BLM specifically functions to remove secondary
structures formed by the TTAGGG repeat array which is the template for lagging
strand DNA synthesis. However, loss of TRF1 results in both leading and lagging
strand fragility and how leading strand telomere fragility is prevented by TRF1 is
still unknown. Possibly, the RTEL1 helicase is involved in preventing telomere
fragility in the leading strand since BLM and RTEL1 prevent telomere fragility in
an additive manner (Vannier et al., 2012). RTEL1 contains a PCNA interacting
domain that is required for its ability to suppress telomere fragility but the
molecular details and function of this interaction are not yet understood (Ding et
al., 2004; Vannier et al., 2013).
A second phenotype observed after deletion of TRF1 is the formation of
telomeric sister associations (SAs) (Martinez et al., 2009; Sfeir et al., 2009).
These structures are visible on metaphase spreads as fused sister telomeres but
their molecular nature remains unclear (Fig. 3.1). They are not dependent on cNHEJ since an shRNA against Lig4 has no effect on their prevalence (Sfeir et al.,
2009). It is possible that SAs are formed via a-NHEJ, a relatively recently
described pathway that operates when core components of the c-NHEJ
machinery are missing, such as Ku or Lig4 (Kabotyanski et al., 1998; Verkaik et
al., 2002; Wang et al., 2003; Weinstock et al., 2007). In a-NHEJ, a DSB is
recognized by PARP1, a step normally inhibited by Ku (Wang et al., 2006). ANHEJ is furthermore thought to be dependent on microhomology at the junction
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Figure 3.1 TRF1 deletion phenotype
Metaphase spreads of TRF1

F/F

cells before (left) and 96 h after (right) Cre mediated deletion of

TRF1. Telomeres are in green (TelC FISH) and chromosomes in red (DAPI). Fragile telomeres
and sister associations are marked with an asterix and arrow respectively. Enlargements are
shown in the bottom right.
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that is exposed upon limited resection by the MRN complex and CtIP (Truong et
al., 2013). After annealing of the microhomology regions, fill-in synthesis occurs
by Polθ, which lacks proofreading capacity and is therefore prone to produce
mutagenic insertions (Mateos-Gomez et al., 2015). Ligation of the DSB is
independent of the c-NHEJ Lig4, but requires Lig3 or Lig1 instead (Frit et al.,
2014). Deletions are frequently observed in a-NHEJ and the pathway is
considered pathogenic and has been linked to chromosomal translocations in
cancer cells (Simsek and Jasin, 2010).
The telomeric 3’ overhangs of the TTAGGG repeat strand have
microhomology (2 bp/repeat) so that a-NHEJ could take place (Fig. 3.2a).
Interestingly, analysis of telomere fusion junctions in human tumors revealed the
presence of microhomology and fusions of critically short telomeres are
dependent on Lig3 and the a-NHEJ (Letsolo et al., 2010; Lin et al., 2010; Jones
et al., 2014). The molecular mechanism underlying these fusions is unknown and
why they occur by a-NHEJ instead of c-NHEJ remains unclear. Under normal
circumstances, a-NHEJ is strictly suppressed at telomeres by shelterin and Ku.
However, in the absence of the entire shelterin complex and Ku, a-NHEJ takes
place at telomeres as evidenced by chromosome type fusions dependent on Lig3
and Parp1 (Sfeir and de Lange, 2012; Mateos-Gomez et al., 2015). The a-NHEJ
pathway can thus be activated at telomeres that lack shelterin protection.
However, if SAs were telomeres fused via a-NHEJ, a covalent linkage
would be formed. Around 15-20% of chromosomes contain SAs after loss of
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TRF1 and as a result, isochromosomes should appear in the next metaphase if a
chromosome with sister fusions missegregates into one daughter cell and is
replicated (Fig. 3.2b). However, isochromosomes are not readily detected upon
deletion of TRF1 (Sfeir et al., 2009). It is therefore also possible that SAs
represent a different structure. Possibly, they are non-covalent interactions
resulting from replication intermediates formed upon fork stalling in the telomeric
sequence.
SAs are not simply a consequence of telomere fragility since loss of BLM
or expression of a TRF1 mutant lacking the BLM interaction domain does not
induce SAs although telomere fragility is observed (Zimmermann et al., 2014).
Instead, the prevalence of SAs appears to correlate with the level of ATR
activation. TRF1 inhibits ATR activation through its association with TIN2,
allowing TPP1/POT1 binding to the ssDNA that can arise at the replication fork
(Zimmermann et al., 2014). When TRF1 is removed from telomeres, TIN2 is no
longer effectively recruited to telomeres (Frescas and de Lange, 2014). However,
some residual TIN2 remains at telomeres through its interaction with TRF2, and
the associated TPP1 and POT1 are capable of protecting the 3’ overhang since
there is no evidence for a POT1 null phenotype when TRF1 is missing. But
apparently, the residual TRF2 bound TIN2 is not enough to block replication
associated ATR activation in cells lacking TRF1 since replication dependent ATR
activation is observed at telomeres (Sfeir et al., 2009). By enforcing the
interaction between TRF2 and TIN2, using a TIN2 fusion to the TRF2 binding
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Figure 3.2 Sister telomere fusions
(A) Microhomology within telomeres. Two telomere ends are shown with potential microhomology
shown in red. Upon 5’ resection of the ends, the TA-AT nucleotides can anneal explaining how
telomeres provide a substrate for a-NHEJ. (B) Model for the generation of an isochromosome
from a sister telomere fusion. When an entire chromosome with sister fusion (red) is
missegregated into one daughter cell, replication through the sister fusion in the next S-phase
would result in the formation of an isochromosome. Examples of potential isochromosomes from
MEF metaphases are shown on the right (DAPI in blue and telomeres in red (TelG). Note, mouse
chromosomes are acrocentric and the short arm thus appears to be absent.
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domain of RAP1, the localization of TIN2 to telomeres after deletion of TRF1 is
rescued. Expression of this TIN2 mutant completely represses the ATR activation
upon loss of TRF1 indicating that replication associated ATR activation is blocked
by TRF1 using TIN2 (and TTP1/POT1) (Zimmermann et al., 2014). Interestingly,
expression of this TIN2 mutant in TRF1 null cells does not rescue telomere
fragility whereas SAs are repressed (Zimmermann et al., 2014). This strongly
suggests that SAs require ATR activation. In agreement with this, shRNA
mediated knockdown of ATR represses SAs (Sfeir et al., 2009). However, ATR
activation at telomeres by itself is not enough to induce SAs as only low levels of
SAs are detected in a POT1 null setting (~3%), where ATR signaling occurs at
most telomeres (Hockemeyer et al., 2006; Denchi and de Lange, 2007). Low
levels of SAs are also observed after deletion of TPP1 (~3%) or TIN2 (~7%),
presumably due to the loss of POT1a/b (Kibe et al., 2010; Takai et al., 2011;
Frescas and de Lange, 2014). Thus, SAs require ATR activation but also a
replication associated event that is normally repressed by TRF1 since much
higher levels are seen after TRF1 loss (15%) compared to TIN2/TPP1/POT1 (37%). Possibly, the low levels of SAs observed upon loss of TIN2/TPP1/POT1 are
due to residual replication stress at telomeres that occurs even when TRF1 is
present.
In this chapter, I use a genetic approach to illuminate the nature of the
telomere associations formed upon loss of TRF1.

91

3.2 Results
3.2.1 PARP1 is required for Sister Associations
To examine whether the a-NHEJ pathway might create SAs, the role of PARP1
was tested. First, the PARP1 inhibitor (PARPi) olaparib was used to prevent
PARP1 function. For this experiment, TRF1F/F MEFs were first treated with Cre
and olaparib was added for the final 24 or 48 h prior to harvest, and 96 h after
deletion of TRF1. To test the efficacy of olaparib treatment, cells were briefly
treated with H202, which produces robust PARsylation. Samples were analyzed
by western blot and indeed, both 24 and 48 h of olaparib treatment completely
abolished the H202 induced PARsylation indicating that the PARPi treatment
worked (Fig. 3.3a). Metaphase spreads of cells treated with PARPi were
analyzed and SAs and fragile telomeres scored 96 h after Cre mediated deletion
of TRF1. Because the short arm of mouse chromosomes is too short to detect a
separation of the arms, both SAs and fragility were scored on long arm
chromosomes only for all experiments. Interestingly, PARPi treatment for 24 or
48 h significantly reduced the levels of SAs compared to untreated control cells
from around 15% to 8% (Fig. 3.3b). Telomere fragility was not affected by PARPi
and remained around 20% (Fig. 3.3c). To confirm that the reduction in SAs was
due to PARP inhibition and not a side effect of the olaparib treatment, PARP1
was depleted using shRNA. Two different shRNAs were used and western blot
analysis indicated knockdown of PARP1 (Fig. 3.3d). When metaphase spreads
were analyzed 96 h after deletion of TRF1, a similar reduction in SAs was
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Figure 3.3 PARP1 is required for the formation of SAs
(A) Western blot of TRF1

F/F

MEFs treated with olaparib. Cells were harvested at 72 h after

deletion of TRF1 with the indicated duration of olaparib (2 μM) treatment. MEFs were treated with
H2O2 prior to harvest when indicated and parsylation and TRF1 deletion visualized on western
blot with TRF1 and PAR reactive antibodies. (B) Frequency of SAs on metaphase spreads from
olaparib treated TRF1

F/F

MEFs 96 h after deletion of TRF1. Duration of olaparib treatment (2 μM)

is shown below. Bars represent median % of SAs from 5 independent experiments, each dot
represents a metaphase spread. (C) Frequency of telomere fragility on the metaphase spreads
from (B). Means and SD from 5 independent experiments is shown. (D) Western blot of shPARP1
treated TRF1

F/F

MEFs. Cells were harvested 72hrs after deletion of TRF1 and deletion of PARP1

and TRF1 visualized on western blot with indicated antibodies. (D) Frequency of SAs on
metaphase spreads from shRNA treated cells, 96 h after Cre. Bars represent the median % of
SAs from 3 independent experiments. (F) Frequency of telomere fragility on the metaphase
spreads from (E). Means and SD from 3 independent experiments is shown. P-values determined
by a two-sided Students T-test (* p<0.05, ** p<0.01, *** p<0.001, ns: not significant).
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observed as after the olaparib treatment (Fig. 3.3e and 3.3b). The frequency of
SAs was reduced to around 8% with both shRNAs against PARP1. Again,
telomere fragility was not affected upon depletion of PARP1 (Fig. 3.3f). The data
thus suggest that PARP1 activity is needed for the formation of SAs, implicating
the a-NHEJ pathway.
However, the activity of PARP1 in DNA repair is extensive and there are
additional explanations why PARP1 could be required for SAs. First of all, PARP1
is known for its role in BER where it detects ssDNA breaks and attracts repair
proteins (Dantzer et al., 2000). Furthermore, PARP1 has been implicated in HR
mediated restart of replication forks (Bryant et al., 2009). Thus, additional
experiments are needed to firmly establish the a-NHEJ pathway in the formation
of SAs.

3.2.2. Ligase 3 is involved in the formation of Sister Associations
To further examine whether a-NHEJ is involved in the formation of SAs, Lig3 was
deleted using shRNA because this ligase is an important component of the aNHEJ pathway (Simsek et al., 2011). Unfortunately, whereas the function of Lig3
in the nucleus is not essential, it has a vital role in mitochondria and cells without
Lig3 are not viable. Long-term shRNA-mediated depletion of Lig3 is therefore
toxic to cells and not achievable. To circumvent this problem, TRF1F/F cells were
first treated with Cre immediately followed by lentiviral infection with two different
shRNA. This allowed analysis of the effect of Lig3 depletion before cells are too
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Figure 3.4 Depletion of Lig3 reduces SAs
(A) Western blots of TRF1

F/F

MEFs treated with two different shRNA against Ligase 3. Cells were

harvested 72 h after deletion of TRF1 and analyzed on western blot with Lig3 and TRF1 reactive
antibodies. (B) Frequency of SAs on metaphase spreads from shRNA treated TRF1

F/F

MEFs 96 h

after deletion of TRF1. Bars represent median % of SAs from 3 independent experiments, each
dot represents a metaphase spread. (C) Analysis of telomere fragility on the metaphase spreads
from (B). Means and SD from 3 independent experiments is shown. P-values determined by a
two-sided Students T-test (*** p<0.001, **** p<0.0001, ns: not significant).
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Figure 3.5 Lig1 and Lig4 do not affect the frequency of SAs
(A) Western blots of TRF1

F/F

MEFs treated with three different shRNA against Ligase 1. Cells

were harvested 72 h after deletion of TRF1 and analyzed on western blot with Lig1 and TRF1
reactive antibodies. (B) Frequency of SAs on metaphase spreads from shRNA treated TRF1

F/F

MEFs 96 h after deletion of TRF1. Bars represent median % of SAs from 3 independent
experiments, each dot represents a metaphase spread. (C). Frequency of SAs on metaphase
F/F

spreads from TRF1 Lig4

+/+

and TRF

F/F

-/-

Lig4 MEFs 96 h after Cre. Bars represent median % of

SAs from one experiment. P-values determined by a two-sided Students T-test (ns: not
significant).
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sick for analysis. The proliferation rate of cells after shRNA against Lig3 is still
somewhat lower compared to control cells (~40% or ~20% fewer cells with
shRNA1 and 2 respectively, at time of harvest 2 days after plating). However, this
is not expected to affect the level of SAs as they are formed in the last S/G2
phase before analysis. SAs therefore do not represent a cumulative phenotype,
unlike the chromosome type fusions seen after TRF2 loss. A lower proliferation
rate is thus not expected to reduce the prevalence of SAs.
Western blot analysis indicates that both shRNA are effective in knocking
down Lig3 expression (Fig. 3.4a). Metaphase spreads were analyzed 96 h after
deletion of TRF1 and SAs and fragile telomeres were scored. Interestingly, both
shRNA against Lig3 significantly reduced the level of SAs to around 8% (Fig.
3.4b). No effect on the frequency of fragile telomeres was observed after
depletion of Lig3 (Fig. 3.4c). The reduction in SAs with the shRNA against Lig3 is
similar to the reduction seen with olaparib and the shRNA against PARP1 (Fig.
3.3b,e and Fig 3.4b).
Another ligase implicated in a-NHEJ is Ligase 1 (Lig1). This ligase has
been shown to mediate a-NHEJ in absence of Lig3 (and Lig4) and could thus be
involved in the formation of SAs (Liddiard et al., 2016; Lu et al., 2016). To
examine the role of Lig1, three different shRNA against Lig1 were tested in
TRF1F/F MEFs and SAs analyzed 96 h after deletion of TRF1. Western blot
analysis indicates good knockdown of Lig1 with all shRNA (Fig. 3.5a). However,
the levels of SAs were not affected by the absence of Lig1 (Fig. 3.5b). It is
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possible that Lig1 functions as a backup enzyme for Lig3. This was suggested in
earlier experiments where an effect for Lig1 in a-NHEJ was only seen in absence
of Lig3 (Liddiard et al., 2016). However, given that knockdown of Lig3 is toxic for
cells, the combined knockdown of Lig3 and Lig1 was not attempted.
Nevertheless, the results clearly establish that Lig1 is not involved in the
formation of SAs when Lig3 is present. Furthermore, as previously shown, SAs
were still present in TRF1F/FLig4-/- MEFs establishing that the fusions are not
formed via c-NHEJ (Fig. 3.5c) (Sfeir et al., 2009). The combined results of the
effect of PARP1 and Lig3 strongly suggest that SAs are formed via a-NHEJ.

3.2.3 Ku does not affect Sister Associations
The fact that telomeric sequences contain microhomology (Fig. 3.2a) and that aNHEJ can take place under certain circumstances supports the hypothesis that
SAs may represent a-NHEJ mediated fused telomeres. It was previously shown
that a-NHEJ takes places at telomeres when the entire shelterin complex is
missing (Sfeir and de Lange, 2012). However, the pathway was only fully
unleashed when Ku was absent. Ku prevents a-NHEJ by at least two
mechanisms. It prevents DNA resection and competes with PARP1 for DNA
binding thus inhibiting its activation (Wang et al., 2006). To test whether Ku has a
similar role in preventing a-NHEJ after TRF1 deletion, SAs were analyzed in
TRF1F/FKu70-/- MEFs. If Ku prevents a-NHEJ, SAs are expected to increase in
absence of Ku. Metaphase spreads of TRF1F/FKu70-/- cells were analyzed
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Figure 3.6 Ku does not affect SAs
(A) Western blot of TRF1

F/F

+/+

Tin2 Ku70

+/+

and TRF1

F/F

+/+

Tin2 Ku70

-/-

littermate MEFs. Cells were

harvested 72 h after deletion of TRF1 and analyzed with TRF1 and Ku70 reactive antibodies. (B)
F/F

+/+

Frequency of SAs on metaphase spreads from TRF1 Tin2 Ku70

+/+

F/F

+/+

and TRF1 Tin2 Ku70

-/-

MEFs 96 h after deletion of TRF1. Bars represent median % of SAs from 3 independent
experiments, each dot represents a metaphase spread. (C) Frequency of SAs on metaphase
F/F

spreads from TRF1 mTR

+/-

and TRF1

F/F

mTR

-/-

littermate MEFs 96 h after Cre. Bars represent

the median % SAs from one experiment. P-values determined by a two-sided Students T-test (ns:
not significant).
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together with Ku positive littermate controls (Fig. 3.6a and b). Unexpectedly, lack
of Ku did not significantly increase the level of SAs upon deletion of TRF1
indicating that Ku does not prevent a-NHEJ in this setting. Possibly, the presence
of TRF2 prevents Ku from acting at telomeres lacking TRF1 (Ribes-Zamora et
al., 2013). In vitro experiments suggested that TRF2 directly interacts with Ku to
prevent it from stimulating NHEJ. Thus, upon deletion of TRF1, Ku may continue
to be inhibited by TRF2 explaining why loss of Ku does not result in higher levels
of SAs.
Recently, unpublished experiments from the Boulton lab suggested a role
for the telomerase enzyme in the formation of fragile telomeres. In absence of
telomerase, the prevalence of telomere fragility upon RTEL1 deletion was
drastically reduced. To ascertain that SAs are not affected by telomerase,
metaphase spreads from cells deficient for mTR, the RNA component of
telomerase complex, were analyzed. Yet, SAs were unchanged in TRF1F/FmTR-/cells compared to littermate controls, suggesting that telomerase does not affect
their formation (Fig. 3.6c).

3.2.4 Anaphase bridges are seen upon deletion of TRF1
If SAs are truly fused telomeres, abnormalities should be visible during mitosis as
dicentric chromosomes form anaphase bridges, which can result in BreakageFusion-Bridge cycles (BFB) and genome instability (Maciejowski et al., 2015). To
analyze whether cells lacking TRF1 display abnormalities, the behavior of
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chromosomes in mitosis was examined using spinning-disk confocal imaging.
For these experiments, a TRF1F/F cell line was created that stably expresses
H2B-venus to allow visualization of chromosome dynamics in live cell imaging
experiments. Cells were imaged before and 72 h after deletion of TRF1 using a
Yokogawa spinning-disk confocal system and a Z-stack set of images was
acquired every 5 minutes. This experimental setup permits imaging adjacent
fields that are computationally stitched together to follow the fate of mitotic cells
(Stephens et al., 2011). Interestingly, more than 80% of mitotic cells displayed
anaphase bridges upon deletion of TRF1 versus only 20% of untreated control
cells (Fig. 3.7a and b). The high background of chromatin bridges in the no-Cre
control cells might be due to the repression of p53/Rb in these SV-40
immortalized MEFs, since these MEFs bypass cell cycle arrest upon DNA
damage.
TRF1 loss has previously been linked to mitotic abnormalities in a mouse
model of tissue specific TRF1 deletion (Martinez et al., 2009). When TRF1 was
conditionally deleted from epithelial cells, mice deficient for p53-/- spontaneously
developed squamous cell carcinomas in the tail and ear skin. These lesions
contained many multinucleated giant cells and anaphase bridges consistent with
chromosome segregation problems in TRF1 deficient cells. However, the reason
for the appearance of these anaphase bridges was not further analyzed.
The presence of anaphase bridges further suggests that SAs are fused
telomeres (Fig. 3.7a). However, one caveat of these experiments is that TRF1F/F
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Figure 3.7 Mitotic abnormalities after TRF1 loss
(A) Images of H2B-Venus marked chromatin of a mitotic cell from TRF1

F/F

MEFs left untreated

(top) or 72hrs after Cre. Image stills were taken from movies made on a confocal spinning disk
microscope with Z-stacks taken 5 minutes apart. (B) Analysis of the frequency of mitotic bridges
in movies from A. At least 60 mitotic cells were analyzed per condition. Numbers represent mean
and SDs from 3 movies per condition from 2 independent experiments.

103

MEFs also display low levels of chromosome type fusions after deletion of TRF1
that could explain the appearance of the mitotic abnormalities. Unfortunately,
these chromosome type fusions are still present in TRF1F/FLig4-/- and in TRF1F/F
MEFs depleted of Lig3. Therefore it is not possible to strictly ascertain that the
anaphase bridges upon deletion of TRF1 are the result of SAs or due to the low
level of chromosome type fusions present in these cells. Most metaphases
contain at least one chromosome type fusion 96 h after deletion of TRF1 but the
percentage of SAs is much higher (5-10 per metaphase). Analysis of the mitotic
cells in the movies of TRF1F/F cells after Cre suggests that multiple anaphase
bridges are present, arguing that they represent the SAs. However, it is difficult to
quantify the exact numbers with this imaging setup, hindering a direct correlation
with the numbers of SAs or chromosome type fusions. Possibly, imaging
experiments at very early time points after deletion of TRF1 would offer a solution
as chromosome type fusions will not have accumulated to such an extent.

3.2.5 PICH localizes to DNA bridges upon deletion of TRF1
Plk1-interacting checkpoint helicase (PICH) is a DNA translocase that is
activated by Plk1 during mitosis and is recruited to a special class of anaphase
bridges, ultrafine bridges (UFBs) (Baumann et al., 2007; Chan et al., 2007).
These bridges are not detectable with conventional DNA dyes but can be
visualized with antibodies to BLM and PICH. UFBs appear in every anaphase
between centromeres but are resolved as mitosis proceeds. These centromeric
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UFBs represent intertwined DNA structures that require decatenation by
Topoisomerase IIa (TopoIIa) and BLM, a process stimulated by PICH (Nielsen et
al., 2015). UFBs not only originate from centromeres but can also arise at fragile
sites and telomeres (Chan et al., 2009; Barefield and Karlseder, 2012). These
UFBs are increased in cells lacking BLM and are thought to represent replication
intermediates.
Since TRF1 loss induces anaphase bridging and replication stress, it is
possible that telomeric UFBs appear as a results of TRF1 deletion. In human
cells, a small increase in UFBs was detected when TRF1 was depleted by
shRNA from IMR90 cells but these results were difficult to interpret due to
concomitant telomere loss hindering the classification of telomeric UFBs versus
those at CFSs or centromeres (Barefield and Karlseder, 2012). Since mouse
telomeres are much longer then human telomeres, deletion of TRF1 in MEFs
might be a better experimental setup to examine the appearance of telomeric
UFBs.
Unfortunately, antibodies against mouse BLM or PICH are not available
for IF analysis since most of the prior work was done in human cells. To enable
visualization of UFBs, a GFP or RFP tagged PICH construct was therefore
generated (Fig. 3.8a). These constructs were stably expressed in TRF1F/F cells
and high expressing cells were isolated by FACS sorting (Fig. 3.8a). To show
that the N-terminal tag had no effect on PICH localization, cells were treated with
ICRF-193, a topoisomerase inhibitor that is known to induce centromeric UFBs.
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Figure 3.8 PICH localizes to anaphase bridges
(A) Schematic of PICH-RFP and PICH-GFP constructs (top) and FACS plots of the isolation of
TRF1

F/F

MEFs expressing these constructs by FACS sorting (bottom). The fraction of GFP high

and RFP high expressing MEFs were sorted. (B) Examples of PICH localization to anaphase
bridges in PFA fixed cells. Sorted PICH expressing TRF1

F/F

MEFs from A were treated with

ICRF93 (top) or analyzed 72 h after TRF1 deletion (bottom) by microscopy. DNA is stained with
DAPI and PICH is either RFP or GFP positive. (C) Example of a mitotic cell from live cell imaging
F/F

experiments of TRF1 PICH

RFP

H2B

venus

MEFs 72 h after deletion of TRF1. Z-stacks were taken 4

minutes apart on a confocal spinning disk microscope. (D) Quantification of the percentage of
cells with H2B-venus and PICH positive mitotic bridges before and 72 h after deletion of TRF1.
Values represent the mean from one experiment with at least 60 mitotic cells analyzed per
condition. All H2B-venus bridges have PICH staining and only few PICH only bridges are seen.

106

107

Indeed, PICH positive bridges were readily detected in anaphase cells upon
ICRF-193 treatment of TRF1F/F RFP-PICH expressing cells (Fig. 3.8b, top). To
examine the effect of TRF1 deletion, TRF1F/F GFP-PICH cells were treated with
Cre and mitotic cells analyzed IF 72 h later. Interestingly, PICH positive treads
were seen upon TRF1 loss, although their abundance was not as high compared
to treatment with ICRF-193 (Fig. 3.8b, bottom). To better understand the
dynamics of PICH positive anaphase bridges upon deletion of TRF1, H2B-venus
was expressed in TRF1F/F PICH-RFP cells to enable live cell imaging. Cells were
imaged 72 h after deletion of TRF1 on the Yokogawa spinning-disk confocal
system and images (Z-stack) were acquired every 4 minutes. Again, PICH
positive threads were detected in anaphase similar to live cell imaging or fixed
samples (Fig. 3.8c). Around 70% of anaphases analyzed displayed PICH
localization. However, most PICH positive threads contained histones as
indicated by the overlap with H2B-venus (Fig. 3.8d). Therefore, it is unclear
whether these bridges represent genuine UFBs or regular anaphase bridges.
Possibly, the resolution of the microscope is not sufficient to visualize UFBs using
this method. The PICH positive threads seen in fixed cells using regular imaging
suggests that more bridges might be present then detected in live cell imaging
experiments (compare Fig. 3.8b and 3.8c). The PICH structures seen in live cell
imaging show a speckled pattern compared to the full threads seen in fixed cells
indicating that microscope resolution might be an issue. However, even in fixed
cells, the PICH positive threads appear to overlap with DAPI signals suggesting
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Figure 3.9 PICH localizes to bridges after deletion of TRF2
F/F

(A) Example of a mitotic cell from a live cell imaging experiment of TRF2 PICH

GFP

H2B

venus

expressing MEFs 72 h after deletion of TRF2. Z-stacks were taken 4 minutes apart on a confocal
spinning disk microscope. (B) PICH recruitment to a chromatin bridge remaining after mitosis
from the same movie as in A.
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that they represent regular anaphase bridges instead of genuine UFBs (Fig.
3.8b).
To better understand the distinction between UFBs and regular anaphase
bridges, the effect of TRF2 loss was analyzed. Deletion of TRF2 results in
massive chromosome type fusion and the appearance of anaphase bridges but
there is no replication stress and telomeric UFBs are therefore not expected. A
TRF2F/F cell line was created expressing H2B-venus and PICH-RFP and high
expressing cells isolated by FACS sorting. Live cell imaging experiments were
done using the same conditions as for TRF1F/F cells using the Yokogawa
spinning-disk confocal system. Remarkably, deletion of TRF2 resulted in the
appearance of PICH positive threads similar to those seen upon TRF1 deletion
(Fig. 3.9a). In some cases, a PICH positive thread remained long after cell
division (Fig. 3.9b). Thus, it appears as though PICH is not just recruited to UFBs
but also to regular DAPI positive chromatin bridges formed upon telomere
dysfunction.
Because PICH recruitment was not specific to TRF1 deletion and
microscope resolution prohibits definitive analysis of telomeric UFBs by live cell
imaging, this line of experimentation was not continued. Therefore, it cannot be
concluded whether TRF1 loss leads to the appearance of UFBs at telomeres. It
would be interesting to repeat the experiment in fixed cells since the resolution of
PICH-GFP imaging appears to be higher.
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3.2.6 The role of 53BP1 at sites of replication stress
53BP1 is mostly known for its role in DSB repair. However, 53BP1 is also
recruited to sites of replication stress (Jowsey et al., 2007), including replication
stress at telomeres (Sfeir et al., 2009). While ATM is the main kinase that acts on
53BP1 in response to DSBs, phosphorylation by ATR occurs in response to UV
damage or loss of TRF1. Whether similar or different S/TQ sites are
phosphorylated in response to DSBs or replication stress remains unclear. At
DBSs, the main role for 53BP1 is to promote NHEJ by blocking extensive end
resection. However, stalled replication forks are not repaired by NHEJ and it is
therefore unclear what the role (if any) of 53BP1 is at these sites. It is possible
that 53BP1 only localizes to collapsed replication forks that have turned into
DSBs and have activated ATM kinase. However, 53BP1 is recruited to telomeres
in TRF1F/FATM-/- cells, arguing against this hypothesis (Sfeir et al., 2009).
Furthermore, phosphorylation of 53BP1 by ATR occurs independently of ATM
(Jowsey et al., 2007). A recent study from this lab provided evidence that 53BP1
is capable of blocking resection at telomeres in an ATR dependent manner (Kibe
et al., 2016). This was shown at cells lacking TPP1/POT1a/b, which are
incapable of protecting the 3’ overhang at telomeres. Deletion of 53BP1 from
these cells resulted in a hyper resection phenotype at telomeres. Interestingly,
this resection pathway was dependent on BLM and Exo1, instead of the ATM
mediated CtIP resection pathway. Furthermore, the results showed that 53BP1
recruits Rif1 to inhibit the ATR mediated resection pathway, similar to the
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Figure 3.10 Phosphorylation of 53BP1 upon TRF1 or TRF2 deletion
Western blot of 53BP1 isolated from TRF1

F/F

53BP1

-/-

F/F

and TRF2 53BP1

-/-

MEFs expressing

FLAG-53BP1. Cells were harvested 72 h after deletion of either TRF1 or TRF2 and 53BP1 was
isolated using FLAG-beads. Isolated 53BP1 was analyzed by western blot for phosphorylation
using an antibody specific for phosphorylated S/TQ sites. Total levels of 53BP1 were visualized
with a 53BP1 reactive antibody.
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situation at DSBs (Kibe et al., 2016). Whether there is a similar role for
53BP1/Rif1 in response to ATR activation at the replication fork remain unknown.
To analyze whether 53BP1 is phosphorylated in a different manner in
response to ATR activation versus ATM, a phosphorylation status of 53BP1 was
compared after TRF1 and TRF2 deletion. A FLAG-tagged 53BP1 wild type allele
was expressed in TRF1F/F53BP1-/- and TRF2F/F53BP1-/- cells. Upon deletion of
either TRF1 or TRF2, 53BP1 was isolated using FLAG antibodies to recover
53BP1. An immunoblot against 53BP1 or with an antibody specifically reactive
with phosphorylated S/TQ residues revealed the phosphorylation status of 53BP1
(Fig. 3.10). In absence of Cre, some background phosphorylation of 53BP1 is
detected in both TRF1F/F and TRF2F/F cells. Interestingly, whereas deletion of
TRF2 results in considerable S/TQ phosphorylation of 53BP1, this effect is much
less when TRF1 is deleted (Fig. 3.10). This could indicate that fewer sites are
phosphorylated in response to ATR activation but it is also possible that a smaller
fraction of the 53BP1 pool is affected after TRF1 deletion versus TRF2. This
experimental approach does not allow distinction between these two possibilities.
However, the results suggest that ATR does not affect 53BP1 phosphorylation as
strongly as ATM activation at telomeres.
To evaluate the role of 53BP1 at telomeres upon ATR activation,
TRF1F/F53BP1-/- MEFs were examined. The mutant 53BP1 alleles described in
Chapter 2 were expressed in these cells to enable analysis of 53BP1 function
(Fig. 3.11a). All 53BP1S/TQ alleles expressed equally well as shown by western
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Figure 3.11 53BP1 mutants in TRF1F/F53BP1-/- MEFs
(A) Schematic of the 53BP1 mutant alleles with the S/TQ sites illustrated in red (B) Immunoblot
F/F

-/-

showing the expression level of the 53BP1 mutant alleles in TRF1 53BP1 MEFs. Cells were
harvested 72 h after deletion of TRF1 and visualized on western blot with 53BP1 or TRF1 specific
antibodies. (C) Recruitment of 53BP1 and Rif1 to telomeres. Example of IF-FISH images from
F/F

-/-

TRF1 53BP1 MEFs expressing the indicated mutant 53BP1 allele. Cells were imaged 72 h
after deletion of TRF1. Telomeres are shown in red, 53BP1 in green and Rif1 in white.
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Figure 3.12 Telomere overhang gel in TRF1

F/F

-/-

53BP1 cells

(A) Telomere overhang assay of MboI/AluI digested DNA from TRF1

F/F

-/-

53BP1 MEFs expressing

the indicated mutant 53BP1 alleles. Telomeric DNA was analyzed 96 h after Cre-mediated
deletion of TRF1 using the in-gel hybridization assay. Left panel shows native telomeric ssDNA
signal, right panel displays the denatured total amount of telomeric DNA. Where indicated,
telomeric DNA was treated with Exo1 to remove ssDNA at the 3’ overhang. (B) Quantification of
the overhang signal as in (A) from two independent experiments. Numbers were obtained by
normalizing the native ssDNA signal to the total telomeric DNA signal in the same lane in the
denatured gel. The values of the Cre-treated samples were obtained by comparison with the noCre empty vector control lane, which was set to 1.0. Means and SDs from two independent
experiments are shown. (C) Western blot with 53BP1 and TRF1 reactive antibodies from
F/F

-/-

TRF1 53BP1 MEFs expressing the indicated 53BP1 allele. Cells were harvested 72 h after
deletion of TRF1.
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blot (Fig. 3.11b). Similar to the setting of TRF2 deletion, IF-FISH showed that
localization of 53BP1S/TQ to telomeres lacking TRF1 was not affected by mutating
the S/TQ sites (Fig. 3.11c). Furthermore, Rif1 was recruited to 53BP1 in cells
expressing 53BP1WT, 53BP1ΔPTIP, and 53BP1ΔMOB but not to 53BP1Δ28 or
53BP1ΔRif1, similar to the situation upon deletion of TRF2 (Fig. 3.11c).
TRF1 deletion itself does not unleash resection at the telomere end but
co-deletion of 53BP1 results in a mild hyper-resection phenotype (Sfeir et al.,
2009; Sfeir and de Lange, 2012). To confirm that resection is increased in
absence of 53BP1, a telomere overhang analysis was done in TRF1F/F53BP1-/cells expressing empty vector, 53BP1WT or 53BP1Δ28 (Fig. 3.12a-c). Samples
were analyzed with our without treatment with the E. coli ExoI 3’ exonuclease to
verify that the observed ssDNA is at the overhang and not telomere internal.
Indeed, all telomeric signals disappeared from the native gel upon treatment with
ExoI confirming that the ssDNA is at the telomere end (Fig. 3.12a and b). As
expected from experiments in TRF2F/F MEFs, expression of 53BP1WT allele was
able to rescue the mild hyper-resection phenotype seen in cells expressing
empty vector (Sfeir and de Lange, 2012). Moreover, 53BP1Δ28 was unable to
rescue the resection phenotype suggesting a similar role for 53BP1 (and Rif1) in
blocking resection at telomeres upon TRF1 deletion as at DSBs.
Next, metaphase spreads from TRF1F/F53BP1-/- MEFs were analyzed and
SAs and fragile telomeres scored (Fig. 3.13a). Interestingly, SAs were
significantly reduced when 53BP1 was absent (Fig. 3.13b). This is in agreement
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Figure 3.13 53BP1 S/TQ sites affect the frequency of SAs
F/F

-/-

(A) Examples of metaphase spreads of TRF1 53BP1 MEFs expressing indicated 53BP1 allele,
harvested 96 h after deletion of TRF1. (B) Frequency of SAs in TRF1

F/F

-/-

53BP1 MEFs expressing

the indicated 53BP1 allele, 96 h after the deletion of TRF1. Bars represent median % of SAs from
three independent experiments. Each dot represents a metaphase spread. (C) Analysis of
telomere fragility in the same metaphase spreads as in (B). Values represent means and SDs
from three independent experiments. P-values determined by a two-sided Students T-test (***
p<0.001, ns: not significant). (D) Western blot visualizing the equal expression of the indicated
53BP1 alleles in TRF1

F/F

-/-

53BP1 MEFs. Cells were harvested 72 h after deletion of TRF1.
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Figure 3.14 53BP1 S/TQ sites affect SAs in two additional cell lines
(A) Western blot visualizing the equal expression of the indicated 53BP1 alleles in two additional
TRF1

F/F

53BP1

-/-

MEF cell lines. Cells were harvested 72 h after deletion of TRF1. (B and C)

Frequency of SAs in TRF1

F/F

53BP1

-/-

cell line 2.5 (B) and 2.3 (C). Cells express the indicated

53BP1 allele and were harvested 96 h after the deletion of TRF1. Bars represent median % of
SAs from three independent experiments. Each dot represents a metaphase spread. (D) Analysis
of telomere fragility in cell line 2.3 on the metaphase spreads from (C). Values represent means
and SDs from three independent exepriments. P-values determined by a two-sided Students Ttest (* p<0.05, ** p<0.01, *** p<0.001, ns: not significant).
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with a previous report that noted reduced levels of sister chromatid fusion in
absence of 53BP1 (Martinez et al., 2012). The reduction in SAs appeared to be
dependent on phosphorylation of 53BP1 as 53BP1Δ28 displayed a similar
decrease in SAs as the empty vector control (Fig. 3.13b). There was no
difference between 53BP1ΔMOB and 53BP1ΔPTIP compared to 53BP1WT, indicating
that these domains play no role in the formation of SAs. However, cells
expressing 53BP1ΔRif1 displayed reduced levels of SAs similar to empty vector
control, suggesting that 53BP1 recruits Rif1 to help the formation of SAs.
Telomere fragility was also analyzed but no difference was observed with any of
the 53BP1 alleles (Fig. 3.13c).
To confirm these results, additional TRF1F/F53BP1-/- MEFs were made to
ascertain that this phenotype was not cell line specific. To generate MEFs,
TRF1F/F53BP1+/- mice were intercrossed to obtain TRF1F/F53BP1-/- genotypes.
MEFs were isolated from E12.5 embryos and immortalized through introduction
of the SV40 large T antigen. Two different TRF1F/F53BP1-/- cell lines were
analyzed (2.3 and 2.5) upon expression of the different 53BP1 alleles using the
same experimental conditions as used in Figure 3.13. Again, SAs were lowered
in absence of 53BP1 or when 53BP1Δ28 or 53BP1ΔRif1 was expressed (Fig. 3.14b
and c). Telomere fragility was not affected by any of the mutant 5BP1 alleles
indicating that 53BP1 has no role in their formation (Fig. 3.14d). Together, these
results suggest that 53BP1 promotes formation of SAs through the recruitment of
Rif1.
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3.2.7 Rif1 acts downstream of 53BP1 to promote Sister Associations
To

further

assess

the

function

of

Rif1

in

the

formation

of

SAs,

TRF1F/FRif1F/F53BP1-/- triple knockout cells were analyzed. If Rif1 is required
downstream of 53BP1, there should be no difference in the level of SAs between
any of the mutant 53BP1 alleles when Rif1 is absent. To create the
TRF1F/FRif1F/F53BP1-/- cell line, the 53BP1 locus was edited in TRF1F/FRif1F/F
MEFs using CRISPR/Cas9. Since 53BP1 is a large protein (encoded by 5760 bp
in 27 exons), early exons in the gene were targeted to maximize the chance of
deleting the entire protein instead of generating a possibly functional truncation
mutant (Fig. 3.15a). Three different guide RNAs (gRNAs) were designed
targeting exon 2 and exon 3 and TRF1F/FRif1F/F MEFs transiently transfected with
one of the gRNA vector together with Cas9. MEFs were subcloned and
subsequently screened via western blot for deletion of 53BP1. Several clones
were identified that lost expression of 53BP1 and two clones were picked for
further analysis (Fig. 3.15b). Sequencing confirmed a frame shift mutation in
clone g3#3 and g5#7, although for both clones only one allele variant was
detected (Fig. 3.15c). Possibly, the mutation in the second alleles is so
substantial that the PCR amplification required for sequencing failed or the
clones became hemizygous.
To address the role of Rif1 in the formation of SAs, selected 53BP1S/TQ
alleles were expressed in the TRF1F/FRif1F/F53BP1-/- MEF clones g3#3 and clone
g5#7. The mutant 53BP1 alleles were expressed equally as gleaned from
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Figure 3.15 CRISPR/Cas9 editing of 53BP1 in TRF1

F/F

Rif1

F/F

MEFs

(A) Schematic of the mouse 53BP1 locus on chromosome 2, only the first 5 exons (of 27) are
shown. The gRNAs target either exon2 or exon3 as indicated. (B) Immunoblot for 53BP1 in MEF
clones picked after targeting with the indicated gRNAs, showing several clones with deletion of
53BP1. Clone g3#3 and g5#7 (in red) were picked for further analysis. Immunoblot for TRF1 is
used as loading control. (C) DNA sequencing of clones g3#3 and g5#7. The reference sequence
shows the untargeted DNA with the gRNA sequence (red) and PAM (green). For both clones,
only one allele was found with sequencing (out of 11 or 12 sequences analyzed) suggesting the
other allele has a larger deletion that was not PCR amplified.
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F/F

Figure 3.16 Analysis of SAs and fragility in TRF1 Rif1
F/F

F/F

F/F

-/-

53BP1 MEFs

-/-

(A) Immunoblot of TRF1 Rif1 53BP1 MEFs clone g3#3 and g5#7. Cells were harvested 72 h
after Cre and analyzed with TRF1, Rif1 and 53BP1 reactive antibodies. (B) Frequency of SAs in
metaphase spreads from clone g3#3 (left) and clone g5#7 (right) expressing the indicated 53BP1
allele 96 h after Cre. Bars represent median % of SAs from three independent experiments. Each
dot represents a metaphase spread. (C) Analysis of telomere fragility on the metaphase spreads
from (B). Values represent means and SDs from three independent experiments. P-values
determined by a two-sided Students T-test (*** p>0.001, ns: not significant).
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western blot analysis (Fig. 3.16a). SAs and telomere fragility were analyzed in
metaphase spreads harvested 96 h after deletion of TRF1 and Rif1. Interestingly,
there was no longer a difference in the level of SAs in absence of 53BP1 (Fig.
3.16b). All mutant 53BP1 alleles displayed a similar frequency of SAs compared
to empty vector control. The results were comparable in the two CRISPR clones
analyzed substantiating this finding. Telomere fragility was also unaltered upon
expression of any 53BP1 allele (Fig. 3.16c).
These results strongly suggest that 53BP1 recruits Rif1 to aid the
formation of SAs. Of note, the overall levels of SAs are much lower in these
TRF1F/FRif1F/F53BP1-/- clones compared to other cell lines analyzed (median ~8%
versus ~15-20%) (Compare Figs 3.13/3.14 and 3.16b). It is interesting to
speculate that this lower level of SAs in TRF1F/FRif1F/F53BP1-/- MEFs is due to
the absence of Rif1 but it is also possible that this is a clonal effect. The
frequency of SAs changes slightly between the different cell types analyzed, with
wild type levels ranging from ~15-20%. It would be interesting to overexpress
Rif1 in TRF1F/FRif1F/F53BP1-/- MEFs cells to examine if this increases the
frequency of SAs. However, Rif1 is a large protein and difficult to express and
this experiment was therefore not attempted.
The main known function of Rif1 downstream of 53BP1 is to control end
resection via Rev7 (Callen et al., 2013; Di Virgilio et al., 2013; Zimmermann et
al., 2013; Boersma et al., 2015; Xu et al., 2015). If SAs are formed by a-NHEJ,
limited resection is required to expose the microhomology needed for the
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reaction to occur. It is therefore unclear why loss of Rif1 and 53BP1 reduces the
levels of SAs. Absence of these proteins increases the amount of end resection,
which should increase the prevalence of SAs instead of reducing them. Possibly,
the extensive end resection that occurs in absence of 53BP1/Rif1 instead
channels repair to HR.

3.2.8 A enigmatic role for Exo1 in the formation of Sister Associations
To better understand the role for end resection in the formation of SAs, the effect
of shRNAs against BLM and Exo1 was examined. At DSBs, end resection is
initiated by the MRN complex and CtIP, followed by more extensive resection by
Exo1, BLM, DNA2 and WRN (Sartori et al., 2007; Mimitou and Symington, 2008;
Nimonkar et al., 2008). Whether this process is similar at stalled replication forks
is not well understood.
To examine whether BLM and Exo1 are involved in the development of
SAs, TRF1F/F cells were treated with shRNAs against these proteins. Since cells
do not divide well after knockdown of either BLM or Exo1, MEFs were treated
with Cre prior to the shRNA infection to minimize effects on cell growth.
Metaphase spreads were analyzed 96 h after Cre infection, which corresponds to
72 h after the first shRNA infection. Two independent shRNA against BLM were
tested and both display reduced BLM expression by western blot (Fig 3.17a).
However, the frequency of SAs was not affected by BLM depletion (Fig. 3.17b).
This is not surprising since a previous paper already described that BLM has no
125

Figure 3.17 Analysis of SAs and fragility upon deletion of Exo1 or BLM
(A) Immunoblot of TRF1

F/F

MEFs treated with shRNA against BLM. Cells were harvested 72 h

after Cre and analyzed with TRF1 and BLM reactive antibodies. (B) Frequency of SAs in
metaphase spreads from TRF1

F/F

MEFs after depletion of BLM, 96 h after Cre. Bars represent

median % SAs from three independent experiments. Each dot represents a metaphase spread.
For MEFs treated with shBLM2, few metaphases were analyzed because cells were sick and not
many spreads were obtained. (C) Analysis of telomere fragility on the metaphase spreads from B.
Bars represent the median % of fragility from three independent experiments. (D) Immunoblot of
TRF1

F/F

MEFs treated with shRNA against Exo1. Cells were harvested 72 h after Cre and

analyzed with TRF1 and Exo1 specific antibodies. (E) Frequency of SAs in metaphase spreads
from TRF1

F/F

cells after depletion of Exo1, 96 h after Cre. Bars represent median % SAs from 4

independent experiments. (D) Analysis of telomere fragility on the metaphase spreads from E.
Bars represent the median % of fragile telomeres from 4 experiments. P-values determined by a
two-sided Students T-test (* p>0.05, *** p>0.001, ns: not significant).

126

127

effect on SAs (Zimmermann et al., 2014). As expected, telomere fragility was
slightly increased in absence of BLM consistent with its role in removing G4
structure in the lagging strand template (Fig. 3.17c).
Next, shRNA against Exo1 were examined. Knockdown of Exo1 by
shRNA was efficient as indicated by western blot and loss of Exo1 did not affect
telomere fragility (Fig. 3.17d and f). Surprisingly, the level of SAs was significantly
decreased upon knockdown of Exo1 (Fig. 3.17e). This is unexpected given the
finding the Rif1, an inhibitor of end resection, also reduces SAs (Fig. 3.13 and
3.14).

3.3 Summary of findings
The results in this chapter elucidate the molecular nature of SAs that arise when
replication stress occurs at telomeres upon loss of TRF1. The results indicate
that telomeres lacking TRF1 are subject to the a-NHEJ pathway and fusion of
sister chromatids, which are visible as SAs on metaphase spreads. The results
show that SAs are dependent on PARP1 as both shRNA and PARP1 inhibition
by olaparib reduced their appearance (Fig. 3.3b and e). Furthermore, depletion of
Lig3 also reduced the prevalence of SAs, further implicating that the a-NHEJ
pathway is involved (Fig. 3.4b). However, deletion of Ku70, a known inhibitor of
a-NHEJ, did not increase the level of SAs (Fig. 3.6b). Possibly, the interaction
between TRF2 and Ku prevents the latter from affecting a-NHEJ upon TRF1
deletion (Ribes-Zamora et al., 2013). Ku is strictly suppressed at telomeres by
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TRF2 to prevent c-NHEJ and telomere fusions. Thus, upon deletion of TRF1, Ku
is still bound by TRF2 and kept away from telomere ends. Therefore it is unable
to influence a-NHEJ, explaining why loss of Ku loss has no effect on SAs.
Consistent with SAs being formed by a-NHEJ, live cell imaging
experiments indicates mitotic abnormalities upon deletion of TRF1 (Fig. 3.7). The
fusion of sister chromatids creates dicentric chromosomes that form anaphase
bridges in mitotic cells. Indeed, around 70-80% of cells display this phenotype
upon deletion of TRF1 consistent with SAs representing fused telomeres.
Interestingly, PICH was also recruited to anaphase bridges (Fig. 3.8b). PICH is a
marker for UFBs that arise from centromeric regions and fragile sites, and are
thought to represent underreplicated regions or replication intermediates that
require additional processing for resolution during anaphase (Chan et al., 2007;
Chan et al., 2009). However, the anaphase bridges detected upon loss of TRF1
were mostly DAPI or H2B-venus positive indicating that they might not be true
UFBs. It is possible that the resolution of the live cell-imaging microscope was
not high enough to detect true UFBs in these cells. But, even though the
appearance of UFBs awaits further investigation, the results clearly show the
appearance of mitotic defects upon TRF1 loss.
The function of 53BP1 and Rif1 in the formation of SAs is more
complicated. The results indicate that 53BP1 recruits Rif1 to promote the
formation of SAs as loss of either protein reduces the frequency of SAs (Fig.
3.13b and 3.16b). However, if SAs are formed by a-NHEJ, there is a requirement
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for end-resection to expose the microhomology domains, a process inhibited by
53BP1 and Rif1. Therefore, the results are counterintuitive, as loss of 53BP1 and
Rif1 would be expected to promote resection and increase the levels of SAs.
Possibly, the resection occurring in absence of 53BP1/Rif1 is too extensive for aNHEJ and promotes HR-mediated repair instead. Alternatively, it could mean that
Rif1 has another function at the replication fork that is independent from
resection. On the other hand, the effect of Exo1 inhibition could be easily
explained if Exo1 is the main nuclease involved in the end-resection at telomeres
lacking TRF1. The defect in resection would be expected to result in a lack of 3’
overhangs that are used by a-NHEJ to form the SAs. Further studies are required
to fully understand the role of 53BP1/Rif1 and Exo1 at telomeres lacking TRF1.
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Chapter 4: Gen1 cleaves fused sister telomeres
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4.1 Introduction
Results from the previous chapter indicate that SAs are sister telomeres fused
via a-NHEJ. The level of SAs is around 15-20% and therefore most cells contain
5-10 SAs after deletion of TRF1 (SV-40 MEFs have variable chromosome
numbers). If these were covalently fused telomeres, more chromosomal
instability and mitotic defects would be expected than is reported for TRF1
deletion (Sfeir et al., 2009). Specifically, when sister telomeres fuse,
isochromosomes should appear in the next metaphase when the chromosome
with sister fusions mis-segregates into one daughter cell occurs and is replicated
(Fig. 3.2b). However, isochromosomes are not prominent upon deletion of TRF1.
To explain this discrepancy, we considered the possibility that the fused
sister telomeres are cleaved after metaphase. Fused telomeres are different from
chromosome internal fusions and translocations, as fusion of the repetitive
TTAGGG sequence always creates a palindromic sequence. Such palindromes
can form cruciform DNA structures (Leach, 1994) (Fig. 4.1a), which are similar to
a Holliday junction and might therefore be subject to cleavage by HJ resolvases.
Thus, it is possible that fused telomeres (SAs) are cleaved by HJ resolvases
during mitosis, resulting in their resolution and normal segregation of the two
sister chromatids. Some evidence for cleavage of fused telomeres exists from
studies in the budding yeast S. cerevisiae (Pobiega and Marcand, 2010). In these
experiments, the fate of dicentric chromosomes formed by telomere fusions was
followed. Interestingly, these dicentrics often break at the telomere fusion site
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Figure 4.1 A cruciform DNA structure from a telomere fusion and pathways of Holliday
Junction resolvases in mammalian cells
(A) Schematic of a fused sister telomere is shown on the left. Fusion junctions in a-NHEJ often
contain insertions/deletions that are depicted by xxx. The formation of a cruciform structure from a
telomere fusion is shown on the right. (B) Schematic of the function of mammalian HJ resolvases.
Based on an image from (Wyatt and West, 2014). BLM can dissolve a dHJ using its helicase
activity, resulting in only non-crossovers (left). SLX4/SLX1-Mus81/EME1 and Gen1 cleave the
junction (at arrows). Cleavage can yield crossovers or non-crossovers. The activity of the
resolvases during cell cycle progression is indicated at the bottom.
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during mitosis. However, dicentrics with fusions elsewhere in the chromosome
did not break and remained until after cytokinesis, indicating that a special
feature of telomeres caused it to be prone to breakage/cleavage (Lopez et al.,
2015). Since fused telomeres can form cruciform structures, HJ resolvases could
possibly act on them (Pobiega and Marcand, 2010).
Mammalian cells have three pathways for Holliday Junction processing
(Fig. 4.1b). The first pathway is mediated by BLM together with TopoIIa and
RMI1 and RMI2 and (BTR complex) (Wu and Hickson, 2003). This pathway
involves branch-migration of two HJs to produce a hemicatenane that can be
untangled by topoisomerase action. This is an error-free pathway resulting in
non-crossover products during HR. However, the dissolution pathway requires
double HJs, which are not expected at fused telomeres where only a single HJ
can be formed (Fig. 4.1a). Therefore, the BLM dissolution pathway is not
expected to be relevant for fused telomere resolution. In agreement with this,
shRNA mediated depletion of BLM did not affect the frequency of SAs in a TRF1
null setting (Fig. 3.15b). If BLM were indeed responsible for cleaving fused
telomeres, an increase in SAs would be expected in metaphase spreads upon
loss of BLM, but this is not observed. Furthermore, SAs are not increased in
TRF1F/FBLMF/F MEFs after Cre confirming the shRNA results (Zimmermann et
al., 2014).
Two additional HJ resolvase pathways function by endonucleolytic
cleavage of a single HJ structure, specifically Mus81 and Gen1 (Ciccia et al.,
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2003; Ip et al., 2008; Wyatt et al., 2013). Both these pathways can result in
crossover and non-crossover products. Mus81 belongs to the XPF family of
nucleases and forms a complex with its regulatory subunit EME1. Mus81 alone is
inefficient on intact HJs but works well on 3’-flaps, replication forks and nicked
HJs (Wyatt et al., 2013). Nicked HJs can be created by the nucleases SLX4 and
SLX1, which form a scaffold for Mus81. Cooperatively, the two complexes can
thus cleave intact HJs by a nick and counter-nick mechanism. Gen1 is also a
member of the XPG family of nucleases but unlike Mus81, it cleaves HJs
symmetrically (Ip et al., 2008; Rass et al., 2010). Contrary to Mus81, Gen1 has
no known interaction partners.
Recent studies have shown the temporal and spatial organization of HJ
resolvases during the cell cycle (Fig. 4.1b). Since dissolution of dHJs by BLM
results only in harmless non-crossovers, this appears to be the pathway of
choice for cells. BLM is active throughout S/G2 to untangle any dHJs that arise
through replication. However, BLM does not act on single HJs that are formed
during DNA repair and some dHJs might be refractory to its action. These HJs
require processing by Mus81 or Gen1. Since these resolvases can result in
crossovers, their action is limited to later stages of the cell cycle, possibly to allow
most processing to be done by BLM. At the onset of mitosis, high CDK1 activity
triggers the association of Mus81 with SLX4/SLX1 (Wyatt et al., 2013). How this
association is formed precisely is unclear but SLX4, Mus81 and EME1 are all
phosphorylated in a CDK1-dependent manner. Gen1 is even more restricted than
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Mus81, being actively excluded from the nucleus by a nuclear export signal
(Matos et al., 2011; Chan and West, 2014). Only upon nuclear envelope
breakdown does Gen1 gain access to any remaining HJs. This spatial and
temporal regulation of Gen1 and Mus81 may have evolved to ensure that dHJs
are preferentially untangled by dissolution (BLM) to prevent crossover formation
and potential loss of heterozygozity.
This chapter is focused on examining the function of the Holliday junction
resolvase Gen1, and to a lesser extent Mus81, at telomeres lacking TRF1 to
investigate whether they can cleave fused telomeres.

4.2 Results
4.2.1 Gen1 loss induces chromatin bridges after TRF1 loss
To examine the role of Gen1 at telomeres lacking TRF1, CRISPR/Cas9 was used
to edit the Gen1 locus in TRF1F/F cells. The gRNAs were designed to target exon
2 of the mouse Gen1 locus on chromosome 12 (Fig. 4.2a). Gen1 contains a
XPG-N terminal (XPG-N), XPG-Internal (XPG-I) and helix-hairpin-helix domain in
its N-terminus that are required for nuclease activity (Rass et al., 2010). The Cterminus of Gen1 contains a nuclear export signal but otherwise has no known
function (Chan and West, 2014). The designed gRNAs target the XPG-N domain
in the N-terminus and are thus expected to inactivate Gen1 even if an in-frame
deletion is generated (Fig. 4.2a). TRF1F/F cells were transiently infected with
Cas9 and two distinct gRNAs and then subcloned. Analysis of isolated clones by
136

Figure 4.2 CRISPR/Cas9 editing of Gen1 in TRF1

F/F

MEFs

(A) Schematic of the functional domains of mouse Gen1 with the nuclease domains in red and
blue boxes is shown on the left. A nuclear export signal (NES) is shown in yellow. A schematic of
the mouse Gen1 locus is shown on the right. The gRNAs 2 and 3 target exon 2, which
corresponds to part of the XPG nuclease domain. (B) Immunoblot for Gen1 in clones from
TRF1

F/F

cell line 20.6 targeted with gRNA 2 or 3. Clones in blue (control) and red (null) were used

for experiments. (C) DNA sequencing of control clone g2#7 and TRF1

F/F

Gen1

-/-

clones g3#11,

g2#8 and g3#20, the total number of sequences identified is shown on the right. The reference
sequence shows the untargeted DNA with the gRNA sequence (red) and PAM (green). No PCR
product was generated from clone g3#20, possibly because the deletions were too large.
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Figure 4.3 Growth curve
F/F

Growth curve of the TRF1 20.6Gen1 WT (blue) or TRF1

F/F

-/-

20.6Gen1 (red) clones before (solid

line) and after (dashed line) deletion of TRF1. Cre virus was added at day 1. The means and
SEM of two experiments is shown.
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Figure 4.4 Gen1 null cells display increased chromatin bridges after deletion of TRF1
F/F

-/-

(A) Example of chromatin bridges in TRF1 20.6Gen1 clones g2#8 (left) and g3#11 (right). Cells
were analyzed by IF-FISH 72 h after deletion of TRF1. Bridges often contain telomeric signals
(TelC, red). DNA is stained with DAPI and γH2AX in green. (B) Quantification of the percent of
cells with chromatin bridges in the indicated cell clones before and 72 h after the deletion of
TRF1. Clones in red are Gen1 null whereas the control is in blue. Results represent means and
SDs from three independent experiments. At least 200 cells were counted for each condition. Pvalues determined by a two-sided Student’s t-test (* p<0.05, ** p<0.01). (C) Immunoblot with
antibodies specific for TRF1, Gen1 and γTub from the cells in B. Cells were harvested 72 h after
deletion of TRF1.
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western

blot

indicated

efficient

editing

of

Gen1

(Fig.

4.2b).

One

TRF1F/F20.6Gen1+/+ control clone and three TRF1F/F20.6Gen1-/- clones from the
parental cell line 20.6 were selected for analysis and targeting of the Gen1 locus
was verified by sequencing (Fig. 4.2c). All TRF1F/F20.6Gen1-/- clones grew well
and showed no obvious phenotype (Fig. 4.3). This was expected, as Gen1 loss is
only lethal when combined with SLX4 or Mus81 depletion (Wechsler et al., 2011;
Garner et al., 2013).
TRF1 was deleted from the TRF1F/F20.6Gen1-/- and control clones and
cells were analyzed by IF-FISH for DNA damage markers 72 h later.
Interestingly, the TRF1F/F20.6Gen1-/- clones displayed significantly higher levels
of chromatin bridges after TRF1 deletion compared to the Gen1-proficient cells
(Fig 4.4a-c). Between 25-30% of Gen1 null cells contained these bridges
compared to only 10% of Gen1 positive control cells. Without TRF1 deletion,
chromatin bridges were rarely seen in any of the cells analyzed. The chromatin
bridges were different from the mitotic anaphase bridges described earlier as the
chromatin bridges in Gen1 null cells remained after mitosis into the next G1 and
were visible by a thin DAPI or Hoechst positive bridge (Fig.4.4a).
A second TRF1F/F parental cell line (9.3) was edited with the same gRNAs
targeting the Gen1 locus to verify the results in an independent cell line. Two
control TRF1F/F9.3Gen1+/+ and three TRF1F/F9.3Gen1-/- clones were picked based
on Gen1 expression analyzed by western blot (Fig. 4.5a). Targeting of the Gen1
locus was verified by sequencing (Fig. 4.5b). Again, 72 h after deletion of TRF1
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Figure 4.5 CRISPR/Cas9 editing of Gen1 in TRF1
(A) Immunoblot of isolated clones from TRF1

F/F

F/F

cell line 9.3

cell line 9.3 with antibodies specific for Gen1 or γ-/-

tubulin control. Clones in blue (control) and red (Gen1 ) were picked for further analysis. (B)
Schematic of the mouse Gen1 locus, as in Fig. 4.2. DNA sequencing of control clones (blue) and
Gen1

-/-

clones (red) is shown below. The reference sequence displays the untargeted DNA with

the gRNA sequence (red) and PAM (green). No PCR products were generated from clones g2#17
and g3#17, possibly because the deletion was too large. (C) Quantification of chromatin bridges
in the indicated cell clones before and 72 h after deletion of TRF1. Clones in red are Gen1 null
cells and controls are blue. Values represent means and SDs from three independent
experiments, at least 200 cells were counted per condition. P-values determined by a two-sided
Student’s t-test (* p<0.05, ** p<0.01, ns: not significant).
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the clones without Gen1 displayed a higher level of chromatin bridges (Fig. 4.5c).
The bridges were specific to the deletion of TRF1 as no defect was seen in
clones not treated with Cre. The chromatin bridges were often (partially) covered
by γH2AX staining indicating DNA damage signaling. A telomeric signal could
frequently be observed in these bridges, suggesting the presence of fused
telomeres (Fig. 4.4a). The results suggest that Gen1 indeed has an important
role in resolving chromatin bridges formed after deletion of TRF1

4.2.2 Aphidicolin does not induce chromatin bridges
To examine whether the chromatin bridges in Gen1 null cells are the result of
general replication stress at telomeres or specific to a particular phenotype that
occurs upon deletion of TRF1, cells were treated with the DNA polymerase
inhibitor aphidicolin. It is known that aphidicolin leads to CFS expression and
exacerbates the telomere fragility seen upon TRF1 deletion (Glover et al., 1984;
Martinez et al., 2009; Sfeir et al., 2009). Additionally, aphidicolin treatment
induces telomere fragility even in presence of TRF1. However, aphidicolin has no
effect on SAs and they remain absent when TRF1F/F cells are treated with
aphidicolin without TRF1 deletion (Sfeir et al., 2009). Therefore, this treatment
allows separating the effect of general replication stress at telomeres from the
SAs seen upon TRF1 deletion.
TRF1F/F20.6Gen1 CRISPR clones were treated with 0.5 μM aphidicolin for
16 h and harvested for IF analysis immediately after. Cells displayed a strong
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F/F

Figure 4.6 Aphidicolin treatment does not induce chromatin bridges in TRF1 Gen1

-/-

MEFs
(A) Representative images of indicated TRF1

F/F

-/-

20.6Gen1 (red) or control clones (blue) before

and 16 h after aphidicolin treatment (CRISPR clones from Fig. 4.2). Cells were stained with
Hoechst, 53BP1 (red) and γH2AX (green). (B) Quantification of chromatin bridges after
aphidicolin treatment. Clones in red are Gen1 null clones and blue are controls. Values represent
means and SDs from three experiments; at least 200 cells were counted per condition.
Differences are not significant.
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increase in the level of γH2AX upon aphidicolin treatment, indicative of
replication stress (Fig. 4.6a). However, chromatin bridges were not induced by
aphidicolin treatment (Fig. 4.6b). This suggests that the chromatin bridges seen
in TRF1F/FGen1-/- cells after Cre are the result of a TRF1 specific phenotype, in
agreement with the hypothesis that Gen1 acts on SAs.

4.2.3 Gen1 loss does not affect the frequency of SAs or telomere fragility
To determine whether the increase in chromatin bridges in Gen1 null cells is due
to an increase in SAs, metaphase spreads from TRF1F/F20.6Gen1 -/- clones were
analyzed 96 h after deletion of TRF1. A difference in the percentage of SAs was
observed between the different clones analyzed (Fig. 4.7a). However, the
difference did not correlate with the presence or absence of Gen1. For example,
Gen1-/- clone g3#11 had a higher level of SAs than the control clone whereas
Gen1-/- clone g3#20 had lower levels. This suggests that there is clonal variation
in the level of SAs but that Gen1 itself has no effect on their prevalence. Gen1 is
actively excluded from the nucleus until nuclear envelope breakdown and
therefore not expected to gain access to SAs before metaphase. Thus, the
absence of an effect of Gen1 on the level of SAs in metaphase is likely due to its
late action in the cell cycle. Telomere fragility was also analyzed on the same
metaphase spreads (Fig. 4.7b). As expected, Gen1 did not affect the level of
telomere fragility.
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Figure 4.7 SAs and telomere fragility in TRF1

F/F

-/-

20.6Gen1 clones

(A) Frequency of SAs in metaphase spreads 96 h after Cre. Clones in red are TRF1

F/F

20.6Gen1

-/-

cells and those in blue are control (CRISPR clones from Fig. 4.2). Bars represent the median %
of SAs from 3 independent experiments; each dot represents a metaphase spread. (B) Analysis
of telomere fragility on the metaphase spreads from A. Values represent mean and SDs from
three independent experiments. SAs and fragility were counted on the long arm only. P-values
determined by a two-sided Student’s t-test (* p<0.05, ** p<0.01, *** p<0.001, ns: not significant).
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4.2.4 Gen1 loss increases the frequency of isochromosomes
As argued in the introduction of Chapter 3, sister telomere fusions are expected
to result in isochromosomes in the following metaphase, but these are not
commonly observed after TRF1 loss (Sfeir et al., 2009). Their absence can be
explained if Gen1 cleaves the sister fusions to allow faithful chromosome
separation (Fig. 4.8a). If this model is correct, isochromosomes are expected to
arise in TRF1F/FGen1-/- cells, since cleavage of SAs would not occur. In absence
of Gen1, a chromosome with fused sister telomeres would have two fates (Fig.
4.8b). If the spindle forms correct attachments to the centromere, it will try to
separate

this

chromosome

into

two

daughter

nuclei

resulting

in

an

anaphase/chromatin bridge at the fused telomere, as frequently observed in
TRF1F/FGen1-/- cells. But if the spindle forms incorrect attachments or when for
another reason the entire chromosome is missegregated into one daughter cell,
an isochromosome would be formed after the next DNA replication (Fig. 4.8b). To
test whether the level of isochromosomes is indeed higher in Gen1 null cells,
metaphase spreads were analyzed in TRF1F/F20.6Gen1-/- cells after deletion of
TRF1.
Discriminating between isochromosomes and other types of chromosome
fusions in MEFs is not straightforward as many mouse chromosomes are of
similar size and all mouse chromosomes are acrocentric. The following criteria
were applied to identify isochromosomes. They should show either long arm to
long arm (L-L) fusions or short arm to short arm (S-S) fusions and the two long
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Figure 4.8 Faith of a sister fusion in absence of Gen1
(A) Upon deletion of TRF1, anaphase bridges can form when a chromosome with a sister
telomere fusion (red) is separated (top). Cleavage of the telomere fusion by Gen1 still allows
faithful chromosome segregation. When the spindle forms an incorrect attachment or loses its
connection (bottom), the entire chromosome is missegragated into one daughter cell. Cleavage
by Gen1 can prevent the formation of isochromosomes. (B) In absence of Gen1, a chromosome
with a sister fusion can follow two fates in mitosis. If the spindle forms a correct attachment, the
fused chromosome will form a chromatin bridge (top). When the spindle forms an incorrect
attachment or loses its connection, the entire chromosome is missegragated into one daughter
cell (bottom). Replication in the next S-phase will result in the formation of an isochromosome
(red).
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Figure 4.9 Verification of isochromosome analysis
(A) Schematics of different forms of fusions detected. Chromosomes fused via Long arm-Short
arm (L-S) are always regular fusions (left panel). Long arm-Long arm (L-L) or Short arm-Short
arm (S-S) are regular fusions if the arm lengths are unequal (left). However, S-S and L-L fusions
are scored as isochromosomes if the arm lengths are equal (right panel). (B) Examples of
different forms of fused chromosomes. The lines represent the arm lengths measured in image J,
which were used to calculate arm length ratio. (C) An example calculation of arm ratios from A is
shown in the table. For each chromosome, the values of arm A and B used to determine the ratio
between the longer and shorter arm (values >1). (D) The arm ratios of chromosome arms from
three independent experiments are shown. Long arm sister chromatids were compared on
unfused chromosomes as a control for the accuracy of the imageJ measurements. Chromosome
fusions after deletion of TRF2 were used to display the variability in arm length in regular fusions.
The blue dots represent the arm ratio of regular fusions in the indicated Gen1 WT (blue) or Gen1
/-

-

(red) cells 96 h after deletion of TRF1, which are either L-L, S-S or L-S as explained in A. The

arm ratio of chromosomes counted as isochromosomes is shown in green dots for each clone,
which are either L-L or S-S with equal arm length. Every dot represents a (fused) chromosome.
The average, SD and numbers (n) are shown in top of the graph. (E) The mean and SDs of the
arm ratios from D is shown. Values are from 3 independent experiments and 10 metaphase
spreads were analyzed per condition for the Gen1 CRISPR clones. For unfused and TRF2
fusions, only 2-5 metaphase spreads were analyzed per experiment since the number of
analyzable chromosomes (unfused or TRF2 fused resp) is much higher per spread. P-values
determined by a two-sided Student’s t-test (* p<0.05, ** p<0.01, *** p<0.001, ns: not significant).
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arms in the fusion should be of the same length (Fig. 4.9a). Fusion chromosomes
that fit these two criteria are scored as isochromosomes in this study. By
contrast, a chromosome that is fused long arm to short arm (L-S) is classified as
a regular type fusion as are L-L or S-S fusions with unequal arm length (Fig.
4.9a).
Isochromosomes were counted according to these visual criteria. To
ensure that the chromosomes visually counted as an isochromosome indeed
have equal arm lengths, these lengths were measured using Image J. A subset
of the analyzed metaphase spreads from TRF1F/F20.6Gen1-/- clone g3#11 and
control clone g2#7 were used for this Image J analysis. The measurements were
made using the following method. First, the arm length of both long arm (sister)
chromatids of unfused chromosomes was measured to identify the variability in
measuring arm length with imageJ (Fig. 4.9b-e) and the ratio between the longer
and the shorter value of the two sister chromatids was calculated (Fig. 4.9c). As
seen in Figure 4.9d, the ratio of the sister chromatids of unfused chromosomes is
close to 1 (average 1.067, SD 0.060 n=113). This controls for the variability in
measuring arm length using Image J. Next, the chromosome arm length of
telomere fusions detected upon TRF2 deletion were analyzed to visualize the
distribution of regularly fused chromosomes (Fig. 4.9b-e). As telomere fusion
after TRF2 deletion occurs primarily in G1, sister fusions and thus
isochromosomes will be infrequent. The length of the arms on either side of the
fusion was measured and the ratios calculated (Fig. 4.8c). As seen in Figure 4.8c
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and d, the ratios are widely distributed (average 1.488, SD 0.48, n= 94) as
expected based on random fusion of the telomeres of different chromosomes.
Next, fusions from TRF1F/F20.6Gen1-/- or TRF1F/FGen1+/+ MEFs were analyzed.
In these metaphase spreads, both regular fusions and isochromosomes are
observed, although TRF1F/FGen1+/+ MEFs have fewer isochromosomes. The arm
length on either side of the fusion was measured, similar as for the telomeres
fusions after TRF2 deletion (Fig. 4.9c). In the chromosomes that were considered
an isochromosome (L-L or S-S as explained in Figure 4.9a), the ratio is very
close to 1 similar to the unfused chromosomes suggesting that these are indeed
isochromosomes (Fig. 4.9d and e). Furthermore, arm ratios of regularly fused
chromosomes in these TRF1F/FGen1-/- or TRF1F/FGen1+/+ MEFs were analyzed
as well. A distinction was made between L-S fusions and L-L or S-S, as the latter
type of fusion could possibly be an isochromome (schematic 4.9a). However, the
ratios of L-L, S-S and L-S are widely distributed similarly to fused chromosomes
observed after TRF2 deletion, indicating that none of these are isochromosomes
(Fig. 4.9d and e). This approach verifies that the chromosomes visually counted
as isochromosomes indeed have arm ratios similar to unfused chromosomes,
strengthening assumption that they represent real isochromosomes. While the
isochromosomes

measured

using

this

method

visually

appear

as

isochromosomes, this cannot definitely be ascertained without chromosome paint
(SKY) analysis. Some of the chromosomes counted as isochromosomes might
therefore be regular fusions of two chromosomes of similar length. It is therefore
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Figure 4.10 Isochromosomes are increased in Gen1 null cells
(A) Examples of normal chromosome type fusions (left) and isochromosomes (right) in
metaphase spreads. Telomeres are in green, DAPI in red. (B) Percentage of telomeres in
isochromosomes in TRF1F/F20.6Gen1 CRISPR clones. The values represent mean and SDs
from 5 independent experiments. (C) Representation of the values from D as percent fusions in
isochromosomes, to correct for differences in overall telomere fusion rate. The values represent
mean and SDs from 5 experiments. Detailed explanation of isochromosome count can be found
in Figure 4.9. P-values determined by a two-sided Student’s t-test (* p<0.05, ** p<0.01, ***
p<0.001, ns: not significant).
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required to correct for the total number of chromosome type fusions between
clones, as this can influence the analysis. Accordingly, isochromosome
frequencies

are given both as

the percent of telomeres

present in

isochromosomes and as the percent of chromosome fusions that are
isochromosomes.
Using the described approach and rules, isochromosomes were counted
on metaphase spreads from the TRF1F/F20.6Gen1 CRISPR clones after deletion
of TRF1 (Fig. 4.10a-c). Interestingly, a 1.5-2fold increase in the number of
isochromosomes was observed in Gen1-/- clone g3#11 and g3#20 compared to
control cells. Clone g2#8 also showed an increase in the number of
isochromosomes but this increase was not significant. Possibly, this is due to the
slower growth of this particular clone, since the detection of isochromosomes
depend on the rate at which cells progress to the next mitosis (Fig. 4.3).
Combined, the results suggest that isochromosome formation in TRF1 KO cells
is indeed increased in absence of Gen1.

4.2.5 TRF1F/FGen1-/- cells display increased mitotic failure
The experiments using live cell imaging from chapter 3 showed that TRF1F/F cells
display high numbers of mitotic abnormalities when TRF1 is deleted from cells
(Fig. 3.7b). To examine the behavior of TRF1F/FGen1-/- cells during mitosis,
TRF1F/F9.3Gen1-/- clones were examined by live cell imaging. Cells were
retrovirally infected with the H2B-venus construct and a population of high
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Figure 4.11 Anaphase bridges in TRF1

F/F

-/-

Gen1 cells persist longer
F/F

Analysis of a live cell imaging experiment of indicated TRF1 9.3Gen1

-/-

or control clones

expressing H2B-venus (CRISPR clones from Figure 4.5). Cells were imaged on a spinning disk
confocal microscope and Z-stacks taken 4 minutes apart. At least 50 mitotic cells were followed
per condition and the time counted until an anaphase bridge disappeared. Mitotic cells without
anaphase bridges are counted as bridge resolved under 8 minutes.
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expressing cells isolated using FACS sorting to allow visualization of
chromosome dynamics. Cells were imaged with the same experimental setup as
used for the analysis of mitotic cells after TRF1 deletion (Chapter 3.2.4). Briefly,
cells were imaged 72 h after Cre using a Yokogawa spinning-disk confocal
system and images (Z-stacks) were acquired every 4 minutes. Analysis of mitotic
cells in the movies showed that there was no difference in the prevalence of
anaphase bridges between the Gen1 positive and negative clones, which is not
surprising given that they occur at 80% in Gen1 positive cells. However, there
was a substantial increase in the persistence of the bridges in Gen1 null cells
(Fig. 4.11). Whereas in two TRF1F/F9.3Gen1+/+ control clones the majority of the
bridges were resolved under 40 minutes, the majority of anaphase bridges in
TRF1F/F9.3Gen1-/- clones remained much longer or did not disappear for the
duration of the movie (Fig. 4.11). This supports the observation that chromatin
bridges are frequently observed between post-mitotic interphase cells in
TRF1F/FGen1-/- clones after deletion of TRF1 (Figs. 4.4b and 4.5c).

4.2.6 Overexpression of mutant Gen1 alleles in TRF1F/FGen1-/- MEFs
The persistent chromatin bridges in TRF1F/FGen1-/- cells upon deletion of TRF1
are a striking phenotype. This phenotype was observed in two separate cell lines
with two independent gRNAs against Gen1, strongly suggesting that the bridges
are due to the loss of Gen1 and not an off-target effect of the CRISPR/Cas9.
However, an attempt was made to rescue the phenotype by overexpressing
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Gen1 in the TRF1F/F20.6Gen1-/- cells. The catalytic activity of Gen1 is dependent
on its N-terminal XPG nuclease domain and a flanking helix-hairpin-helix domain
(Ip et al., 2008) (Fig. 4.12a, top). Previous in vitro experiments with a truncated
form of Gen1 (aa 1-527) indicated that the N-terminus contains all Holliday
junction resolvase activity (Rass et al., 2010). Although the C-terminus is not
needed for catalytic activity, it contains a nuclear export signal (NES) that is
required to actively keep Gen1 from accessing chromatin until nuclear envelope
breakdown in mitosis (Chan and West, 2014). Access of Gen1 to the nucleus in
interphase was accomplished by mutating both the NES and addition of a nuclear
localization signal.
To attempt to rescue the chromatin bridge formation in TRF1F/F20.6Gen1-/cells, plasmids were cloned containing an N-terminal RFP or GFP tag followed by
a catalytically active or inactive mouse Gen1 (mGen1) (Fig. 4.12a). For inactive
Gen1, either the E30A mutant or E134/E136A (EEAA) mutations was created
since these sites were previously shown to be required for the catalytic activity
(Chan and West, 2014). However, none of these constructs expressed well upon
retroviral infection of MEFs. Cells quickly lost the construct or died in antibiotic
selection medium. Since previous publications used human Gen1 (hGen1) in
overexpression experiments, N-terminal GFP tagged constructs were cloned with
hGen1, either the active or an inactive (EEAA) form. However, overexpression of
these constructs in MEFs resulted in a similar defect in expression. Since a
truncated version of Gen1 (Gen1527) contains all catalytic activity and was
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Figure 4.12 TRF1

F/F

-/-

Gen1 cells with overexpressed Gen1

(A) Schematic of wild type mouse Gen1 and a variety of tagged constructs (mouse and human).
Red and blue boxes in the schematic on top represent the domains of Gen1 required for nuclease
activity (XPG-N-terminal, XPG-Internal and Helix-hairpin-Helix). The EEAA mutants have
residues E134 and E136 mutated to alanine, the D30A has active site D30 mutated to alanine.
The constructs with a shorted Gen1 contain amino acids 1-527. Most constructs did not express
well, as indicated on the right. (B) Immunoblot showing the expression of a short form of hGen1
F/F

containing an N-terminal GFP tag in TRF1 20.6Gen1

-/-

clones g3#11 and g3#20 (CRISPR

clones from Figure 4.2). Cells were harvested 72 h after Cre. (C) Quantification of chromatin
bridges 72 h after Cre mediated deletion of TRF1 in TRF1

F/F

-/-

20.6Gen1 clones g3#11 and g3#20,

expressing the indicated hGen1 construct. Results represent the mean and SD from 4
experiments Expression level of constructs and the number of bridges varied widely and the
results are not significant.
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previously shown to rescue human Gen1-/- cells, this construct was cloned with
an N-terminal GFP tag. Upon retroviral infection of TRF1F/F20.6Gen1-/- clone
g3#20 and g2#8, the active and inactive versions of this construct were weakly
expressed (Fig. 4.12b). TRF1 was deleted in these cells using H&R Cre virus and
chromatin bridges analyzed by IF 72 h later. Interestingly, a slight rescue was
seen with the active version of Gen1 but not Gen1EEAA (Fig. 4.12c). However,
these experiments were not reproducible and expression levels of the constructs
varied indicating that cells still struggled keeping these constructs expressed.
Possibly, the N-terminal GFP or RFP tag interferes with the expression of
Gen1. Previous studies used C-terminally tagged protein and thus a construct
was cloned with a C-terminal myc tag. The truncated version of Gen1 was used
in this construct. Additionally, a 3xNLS was added to promote nuclear localization
of the construct (Chan and West, 2014). However, upon infection of MEFs with
this construct, no signal for myc was detected on Western blot (Fig. 4.12b).
Furthermore, no reduction in chromatin bridges was detected indicating that this
construct was not functional. Further attempts to rescue the TRF1F/FGen1-/clones were halted.

4.2.7 Chromatin bridges are not an SV40 artifact
Since rescue of the TRF1F/FGen1-/- clones was not possible, an additional control
experiment was done to verify that the chromatin bridges observed in Gen1 null
cells are not due to the experimental conditions used. Both TRF1F/F cell lines that
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were used for CRISPR/Cas9 mediated editing of the Gen1 locus were
immortalized using SV40 large T antigen. Since SV40 large T antigen may have
uncharacterized functions, it is not excluded that the phenotypes we detect are
due to the combined effect of TRF1 loss, Gen1 deficiency and SV40
immortalization. Therefore, an additional Gen1 knockout cell line was created in a
parental cell line that lacks p53 but does not express SV40 large T antigen. The
same gRNAs were used as described previously and several Gen1 null and
control clones were isolated from this TRF1F/Fp53-/- cell line (Fig. 4.13a,b).
Sequencing confirmed efficient targeting of the Gen1 locus in the Gen1-/- clones
g2#12, g2#13 and g3#12 whereas no PCR product was amplified from clone
g3#5, likely because the deletion is too large (Fig. 4.13c). Sequencing of the
control clone g3#8 confirmed that this clone only contains the unedited Gen1
sequence. However, control clone g2#1 is not completely wild type as it has lost
one allele due to a 7-nucleotide deletion and the other allele in this clone contains
a 9-nucleotide deletion. This 9 nt deletion does not disrupt protein expression but
the western blot signal for Gen1 in this clone is lower then in the other control
clones, confirming the loss of one allele. Next, TRF1 was deleted in these
TRF1F/Fp53-/-Gen1 clones and cells harvested for analysis of chromatin bridges
72 h later. Two separate experiments were done and although there was
variability between the experiments, the TRF1F/Fp53-/-Gen1-/- cells displayed a
higher frequency of bridges than the control clones (Fig. 4.13d and e). These
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Figure 4.13 CRISPR/Cas9 editing of Gen1 in TRF1

F/F

-/-

p53 MEFs

(A) Schematic of the Gen1 locus on chromosome 12, exon 2 was targeted with the same gRNAs
as in Fig. 4.2. (B) Western blot of indicated TRF1

F/F

-/-

p53 clones targeted with gRNA2 or gRNA3,

showing the deletion of Gen1. Clones in blue (control) and red (null) were used for experiments.
(C) DNA sequencing of the indicated clones showing targeting of the Gen1 locus. Clones g2#1
-/-

and g3#8 are control clones whereas clones g3#5, g3#12, g2#12 and g2#13 are Gen1 . (D)
-/-

Analysis of chromatin bridges in indicated Gen1 control (blue) and Gen1 (red) clones, 72 h after
Cre mediated deletion of TRF1. The percentage of bridges from two experiments is shown side
by side. The baseline levels of chromatin bridges between these experiments varied greatly thus
the results are shown separate. At least 200 cells were analyzed per condition. (E) The percent
-/-

chromatin bridges of Gen1 control (blue) and Gen1 (red) clones from the two experiments in D
-/-

were pooled as WT and Gen1 . The percent chromatin bridges of each clone were compared to
the level in control clone g3#8, which was set to 100. The values represent the mean and SDs of
all values from clones in D. P-values determined by a two-sided Student’s t-test (* p<0.05).
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experiments indicate that the phenotype of the Gen1-/- cells is unlikely due to
confounding effects of the SV40 immortalization.

4.2.8 PARP1 deletion rescues chromatin bridge formation
The results so far suggest that Gen1 plays a critical role at telomeres, where it is
required to cleave a structure formed upon deletion of TRF1 but not in response
to telomere fragility induced by aphidicolin. This suggests that Gen1 cleaves SAs
since they are induced specifically when TRF1 is deleted but not after aphidicolin
treatment. To further examine this, TRF1F/F20.6Gen1-/- cells were treated with
shRNAs against PARP1. As described in Chapter 3, SAs are formed via a-NHEJ
in a process dependent on PARP1 (Figs. 3.3b and e). Thus, blocking a-NHEJ in
TRF1F/FGen1-/- cells should reduce the prevalence of SAs. If Gen1 indeed acts by
cleaving SAs, chromatin bridges should be reduced upon treatment with PARP1
shRNAs. For these experiments, TRF1F/F20.6Gen1-/- clone g3#11 and control
clone g2#7 were used. In both cell lines, shPARP1 efficiently depleted PARP1 as
gleaned from western blot (Fig. 4.14a). Chromatin bridges were analyzed 48 or
72 h after deletion of TRF1. Interestingly, shPARP1 drastically reduced the
chromatin bridges, not only in the TRF1F/F20.6Gen1-/- cells but also partly in the
control cells (Fig. 4.14b). The results were more pronounced 72 h after deletion
of TRF1, when the percent of chromatin bridges was reduced to 10% in both
control and Gen1 null cells after PARP1 depletion. Metaphase spreads were
analyzed 96 h after Cre and as expected, shPARP1 significantly reduced the
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F/F

Figure 4.14 Knockdown of PARP1 reduces chromatin bridge formation in TRF1 Gen1

-/-

cells
(A). Immunoblot for PARP1 and TRF1 after shRNA mediated depletion of PARP1 (sh353). Cells
F/F

from TRF1 20.6Gen1

-/-

clone g3#11 (red) and control clone g2#7 (blue) were harvested 72 h

after deletion of TRF1 (CRISPR clones from Figure 4.2). (B) Frequency of chromatin bridges in
F/F

TRF1 20.6Gen1

-/-

clone g3#11 (red) and control clone g2#7 (blue). Bridges were analyzed in

fixed cells at different time points after Cre (0, 48, 72 h). Values represent mean and SDs from 4
independent experiments and at least 200 cells were counted per condition. (C) Frequency of
SAs in the indicated Gen1 clones treated with shRNA against PARP1. Metaphase spreads were
harvested 96 h after Cre. Bars represent median % of SAs from 3 independent experiments and
every dot represents a metaphase spread. SAs were counted on the long arm only. (D) Growth
F/F

curve of TRF1 20.6Gen1

-/-

clone g3#11 and control clone g2#7 after deletion of TRF1 and

depletion of PARP1. Values represent the means and SEMs from 4 experiments. (E) Mitotic index
of indicated cell clones before and 48 or 72 h after deletion of TRF1, treated with shRNA against
PARP1. Mitotic index was scored by IF in two experiments by staining with a pH3 specific
antibody. The values represent mean and SEM.
P-values determined by a two-sided Student’s t-test (* p<0.05, ** p<0.01, *** p<0.001, ns: not
significant).
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prevalence of SAs in both cell lines (Fig. 4.14c). These results strongly suggest
that Gen1 indeed cleaves SAs. One potential caveat of these experiments is that
the shRNA against PARP1 affects cell viability and defective cell cycle
progression could explain the reduced levels of chromatin bridges, as cells need
to go through mitosis for these bridges to form (Fig. 4.14d). However, the mitotic
index of cells treated with the shRNA, analyzed by counting pH3 positive mitotic
cells, showed no difference upon PARP1 depletion (Fig. 4.14e). Thus, although
there were fewer cells after treatment with the shRNA, there was no difference in
the percentage of cells in mitosis confirming that the reduced chromatin bridges
are the result of PARP1 loss. Combined, the results further confirm the
hypothesis that Gen1 cleaves SAs.

4.2.9 Mus81 depletion aggravates the Gen1-/- effect
Mammalian cells have another pathway that resolves HJs and replication
intermediates in mitosis that is dependent on Mus81 and not Gen1. As described
in the introduction to this chapter, the substrates for Mus81 are nicked HJs but
combined with the endonuclease activity of SLX4-SLX1, it is able to cleave intact
HJs. Interestingly, SLX4 is associated with telomeres through an interaction with
TRF2 (Svendsen et al., 2009).
To examine whether Mus81 can cleave SAs similar to Gen1, shRNAs
were used to deplete Mus81. This was done both in Gen1-proficient and deficient
cell lines. Antibodies to detect mouse Mus81 on western blot were not effective
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and knockdown of Mus81 was therefore analyzed by qPCR. Two primer pairs
showed substantial (60-80%) knockdown of Mus81 with two different shRNAs,
both in TRF1F/F20.6 Gen1-/- clone g3#11 and control clone g2#7 (Fig. 4.15a,b).
Cell viability was affected by the shRNAs against Mus81 as can be seen in a
growth curve (Fig. 4.16). However, this effect was not specific for deletion of
TRF1 as MEFs not treated with Cre show this loss of viability as well.
Next, chromatin bridges were analyzed by Hoechst staining, 72 h after
deletion of TRF1 (Fig. 4.17a-c). Interestingly, chromatin bridges were slightly
increased in both TRF1F/FGen1+/+ and TRF1F/FGen1-/- cells upon Mus81
depletion, although the increase was not statistically significant. Possibly, the
level of knockdown is not high enough to obtain higher levels of chromatin
bridges. However, the Mus81 depleted cells show a clear phenotype after
deletion of TRF1. Many cells appeared to have a clear segregation defect
containing multiple nuclei (Fig. 4.17a). This effect is seen both in TRF1F/FGen1+/+
and TRF1F/FGen1-/- clones although it was more apparent in TRF1F/FGen1-/- cells.
The observation that shMus81 increased the levels of chromatin bridges
and affects nuclear morphology in both TRF1F/FGen1+/+ and TRF1F/FGen1-/clones, suggests that it functions independently of Gen1. The activity of Mus81 is
induced at the onset of mitosis by high CDK1 activity, prior to nuclear envelope
breakdown (Wyatt et al., 2013). Therefore it is possible that Mus81 cleaves a
subset of the SAs and that Gen1 cleaves the remaining fusions after nuclear
envelope breakdown, explaining the additive effect.
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Figure 4.15 Quantification of Mus81 knockdown by qPCR
(A) qPCR for Mus81 in the indicated MEF clones treated with the indicated shRNA against Mus81
(sh64 or sh67, green bars). Two different exon spanning primer pairs were used and values were
normalized to GAPDH expression. RNA was isolated from samples before and 72 h after Cre
mediated deletion of TRF1 from TRF1

F/F

20.6Gen1

-/-

clone g3#11 (red) and control clone g2#7

(blue) as indicated (CRISPR clones from Figure 4.2). (B) Agarose gel with three samples of qPCR
amplified DNA from each primer pair, showing a single band of the expected size for GAPDH and
the Mus81 primer pairs indicating the specificity of the qPCR.
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Figure 4.16 Growth curve of Gen1 clones after depletion of Mus81
F/F

Growth curve of TRF1 20.6Gen1

+/+

(g2#7, blue) and TRF1

F/F

Gen1

-/-

(g3#11, red) cells before

(left panel) and after (right panel) deletion of TRF1. The shRNAs against Mus81 (dashed lines)
affect cell growth in both cell lines. The means and SEM of three experiments are shown.
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Figure 4.17 Chromatin bridges are increased after depletion of Mus81
(A) Examples of IF-FISH images from Gen1 positive (g2#7, left) and negative (g3#11, right)
F/F

TRF1 20.6 CRISPR clones, treated with the indicated shRNA against Mus81 (CRISPR clones
from Figure 4.2). Cells were fixed 72 h after deletion of TRF1. Cells were stained with Hoechst
(blue), γH2AX (green) and telomere FISH (red). Arrows point to chromatin bridges between cells.
(B) Example of a chromatin bridge in TRF1

F/F

-/-

20.6Gen1 clone g3#11 after Mus81 depletion with

sh64, 72 h after deletion of TRF1. The chromatin bridge is fully covered in γH2AX and contains
multiple telomeric signal, as is clear from the magnification on the right. (C) Quantification of
chromatin bridges in the indicated cell clones before and 72 h after deletion of TRF1. The values
represent mean and SDs from 4 independent experiments. At least 200 cells were analyzed per
condition. P-values determined by a two-sided Student’s t-test (* p<0.05, ns: not significant).
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Enlarged

To further understand whether Mus81 might cleave SAs, metaphase spreads
were analyzed. Since the activity of Mus81 is already induced at the onset of
mitosis, it should increase the prevalence of SAs in metaphase. Metaphase
spreads from TRF1F/FGen1-/- clone g3#11 and control clone g2#7 were analyzed
96 h after deletion of TRF1 (Fig. 4.18a). However, no difference in the level of
SAs was observed in either of the cell lines tested. There are several possible
explanations why no difference in SAs occurs. The most obvious explanation is
that Mus81 is not active on SAs. Mus81 cannot cleave intact HJs and needs its
associated SLX4 to create a nicked template. Possibly TRF2 blocks the nuclease
activity of SLX4 at telomeres since TRF2 is a known interacting factor (Svendsen
et al., 2009). Another explanation could be that the full activation of SLX4-Mus81
does not occur before metaphase. The precise timing of SLX4-Mus81 activity is
not very well understood. Experiments with nocodazole arrested cells suggested
that the complex is active at the time of prometaphase but this has not been
further studied (Wyatt et al., 2013). Therefore it cannot be excluded that Mus81
acts later in mitosis on SAs. It is also possible that the level of knockdown with
shRNAs was not sufficient to detect a phenotype on metaphase spreads. A
CRISPR/Cas9 knockout cell line would be useful but the combined deletion of
Gen1 and Mus81 is expected to affect cell viability and was therefore not
attempted (see growth curve Fig. 4.16 and (Wechsler et al., 2011)).
Telomere fragility was also assessed on the metaphase spreads from
Mus81 depleted cells. There was no difference in telomere fragility 96 h after
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Figure 4.18 Telomere SAs, fragility and isochromosomes after Mus81 depletion
(A). Frequency of SAs in metaphase spreads from TRF1

F/F

20.6 control (blue) and Gen1

-/- (

red)

MEFs before and 96 h after Cre, treated with the indicated shRNA against Mus81. Bars represent
the median % of SAs from 4 experiments and each dot represents a metaphase spread. (B)
Analysis of telomere fragility on the metaphase spreads from A. Bars represent the median % of
telomere fragility from 3 experiments. SAs and fragility were counted on the long arm only. (C)
Frequency of isochromosomes 96 h after deletion of TRF1 from the indicated Gen1 CRISPR
clones, given as a percentage fusions in isochromosome. Detailed explanation of isochromosome
count can be found in Figure 4.8. P-values determined by a two-sided Student’s t-test (* p<0.05,
*** p<0.001, **** p<0.0001, ns: not significant).
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deletion of TRF1 (Fig. 4.18b). Unexpectedly however, knockdown of Mus81
significantly increased telomere fragility when TRF1 was present. The levels
increased from around 3% to just below 10%. This increase in telomere fragility
was similar in Gen1 proficient and deficient cells and is reminiscent of a similar
defect seen in human cells upon deletion of Mus81 (Saint-Leger et al., 2014).
The reason for this increase in telomere fragility is not well understood. Possibly,
it is due to the ability of Mus81 to cleave stalled replication forks during S-phase
(Forment et al., 2011). Mus81 was shown to generate DSBs at stalled forks in
absence of ATR/Chk1 signaling or upon prolonged replication stress. At
telomeres, POT1a/b blocks ATR signaling under TRF1 proficient conditions,
possibly allowing Mus81 mediated cleavage and DSB dependent fork restart
when the replication machinery encounters a barrier (Zimmermann et al., 2014).
Absence of Mus81 could therefore result in abnormal fork restart at telomeres
resulting in fragility.

4.3 Summary of findings
A prominent phenotype observed after the deletion of TRF1 are SAs, which
represent telomeres fused via a-NHEJ, as shown in Chapter 3. The results in this
chapter describe an essential role for Gen1 in the resolution of these telomere
fusions. The results are consistent with the proposition that fused telomeres can
form cruciform DNA structures due to their repetitive nature, which are a
substrate for the Holliday junction resolvases Gen1 (Fig. 4.1). Absence of Gen1
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resulted in the appearance of chromatin bridges upon deletion of TRF1 (Fig. 4.4
b and 4.5c). These chromatin bridges were not induced by treatment of
TRF1F/FGen1-/- cells with aphidicolin, which results in fragile telomeres (Fig. 4.6)
(Sfeir et al., 2009). This suggests that the chromatin bridges are not related to the
telomere fragility seen in absence of TRF1 but due to SAs. Further evidence that
Gen1 cleaves SAs is provided by the observation that the percentage of
isochromosomes was increased upon TRF1 deletion in TRF1F/FGen1-/- cells (Fig.
4.10a-c). This indicates that Gen1 normally cleaves SAs thereby preventing the
accumulation of isochromosomes in wild type conditions.
As SAs are formed by a-NHEJ, the role of PARP1 on chromatin bridges in
Gen1 null cells was assessed. Since deletion of PARP1 reduces the level of SAs,
chromatin bridges should be reduced when PARP1 is deleted from TRF1F/FGen1/-

cells if Gen1 is responsible for cleaving these structures (Chapter 3.2.1, Figs.

3.3b and e). Indeed, deletion of PARP1 from TRF1F/FGen1-/- cells significantly
reduced the presence of chromatin bridges (Fig. 4.14b). This indicates that Gen1
is truly capable of cleaving SAs.
A second Holliday junction resolvase that could act on SAs is Mus81 (Fig.
4.1b). This nuclease was depleted using shRNA to analyze whether a similar
phenotype is observed as upon deletion of Gen1. Chromatin bridges were indeed
increased when Mus81 was depleted an additive effect was seen with the
combined deletion of Mus81 and Gen1 (Fig. 4.17c). The results were insignificant
however, possibly due to the limited knockdown of Mus81. This might also have
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affected the analysis of SAs on metaphase spreads, as no difference could be
seen in their levels upon depletion of Mus81 (Fig. 4.18a). Isochromosomes were
slightly increased upon the combined deletion of Mus81 and Gen1, but again, the
results were not significant (Fig. 4.18c). The data suggest that it is indeed
possible for Mus81 to cleave SAs in a similar fashion to Gen1, since chromatin
bridges are increased. However, the effect of Mus81 deletion upon TRF1 deletion
merits further analysis with better knockdown levels of the protein.
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Chapter 5: Discussion
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5.1 Dissociation of function mutants of 53BP1
5.1.1 Rif1 is the only factor downstream of 53BP1 inhibiting resection
Analysis of a panel of 53BP1 alleles with subsets of N-terminal S/TQ sites
mutated to alanine revealed insights into the mechanisms by which 53BP1
promotes NHEJ (Fig. 2.2). It has previously been shown that 53BP1 recruits Rif1
to inhibit CtIP-dependent and -independent resection at DSBs and dysfunctional
telomeres (Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Diaz et al.,
2013; Feng et al., 2013; Zimmermann et al., 2013; Kibe et al., 2016).
Additionally, PTIP has been suggested to play a role in blocking the resection
pathway downstream of 53BP1 at DSBs in PARPi-treated BRCA1-/- cells (Callen
et al., 2013). However, the results described here suggest that Rif1 is the only
factor downstream of 53BP1 required to inhibit resection at telomeres (Fig. 2.6b).
53BP1ΔRif1 displayed similar levels of resection upon deletion of TRF2 as the
53BP1Δ28 allele (Fig. 2.6b). Furthermore, 53BP1ΔPTIP behaved as wild type 53BP1
with regards to inhibition of resection. This is consistent with a recent study of
TRF2F/FPTIP-/- MEFs which did not show a telomere hyper-resection phenotype
(Lottersberger et al., 2015). Even though resection was not altered by PTIP, the
telomere fusions were slightly delayed in 53BP1ΔPTIP expressing cells lacking
TRF2 compared to cell with wild type 53BP1, similar to the situation in
TRF2F/FPTIP-/- MEFs (Fig. 2.7c) (Lottersberger et al., 2015). It is possible that this
reduction is due to the role of PTIP in recruiting the Artemis nuclease, which has
been shown to mediate end-trimming of obstructed ends (Wang et al., 2014). The
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Artemis nuclease activity can open hairpins at DNA ends during V(D)J
recombination to promote c-NHEJ (Ma et al., 2002). However, the telomeric
sequence is unlikely to form hairpins at the DNA end, suggesting this activity is
not responsible for the reduced level of telomere fusions in absence of PTIP.
Possibly, PTIP and Artemis are required for other types of nucleolytic processing
such as the removal G4 structures in the 3’ overhang, which can block Ku
loading and NHEJ. Importantly, the absence of PTIP merely caused a delay in
telomere fusions that is no longer observed at later time points after TRF2
deletion, suggesting that the activity of PTIP is redundant with other pathways
(Lottersberger et al., 2015).
It is unclear by which mechanism Rif1 prohibits end resection. It is unlikely
that Rif1 directly inhibits individual components of the resection pathway, such as
BLM, Exo1 or CtIP. First, Rif1 blocks resection at shelterin free telomeres
mediated by CtIP as well as BLM and Exo1 (Sfeir and de Lange, 2012;
Zimmermann et al., 2013). It could be argued that Rif1 only needs to inhibit the
initial resection step mediated by CtIP. However, this is unlikely since Rif1 was
also shown to inhibit CtIP-independent resection at telomeres after loss of TPP1
(Kibe et al., 2016). Thus, it is likely that the inhibition of resection by Rif1 occurs
on a broader scale, such as changes in the chromatin landscape or by binding
dsDNA as has been recently suggested by David Shore and colleagues (pers.
comm.).
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Recent papers have described Rev7 (also known as MAD2L2), a subunit
of the translesion polymerase zeta (polζ), as a factor required for inhibition of
resection downstream of 53BP1 and Rif1 (Boersma et al., 2015; Xu et al., 2015).
This was independent of the role of Rev7 in translesion synthesis, as depletion of
Rev3 or Rev1, the other polζ components, did not recapitulate the resection
phenotype. Rev7 was recruited to DSBs in a 53BP1- and Rif1-dependent manner
but a direct interaction could not be detected (Xu et al., 2015). However, loss of
Rev7 resulted in a similar reduction in telomere fusions after depletion of TRF2
as loss of 53BP1/Rif1 (Boersma et al., 2015). Furthermore, its knockdown
restored PARPi resistance in BRCA1 deficient cells similar to Rif1, providing
further evidence that Rev7 and Rif1 operate in the same pathway (Xu et al.,
2015). But the molecular mechanism by which Rif1 and Rev7 inhibit resection
remains the subject of ongoing investigation.

5.1.2 The connection between 53BP1 and the LINC complex
53BP1 promotes the mobility of telomeres after deletion of TRF2 (Dimitrova et
al., 2008). Experiments in the lab have shown that this mobility is dependent on
the LINC complex and kinesin-mediated movement on microtubules (explained in
Chapter 1.2.5). However, the question remains how 53BP1 mediates chromatin
mobility through Sun proteins and the rest of the LINC complex. The results
described here identified a 53BP1 dissociation of function mutant that harbors the
S/TQ sites needed to induce chromatin mobility (Fig. 2.8b-d). Dysfunctional
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telomeres in cells expressing 53BP1ΔMOB were unable to fuse to the same extent
as in cells expressing the wild type allele. Furthermore, this delay in fusion
frequency was dependent on Sun1 and Sun2 (Fig. 2.8c and d). Additionally, timelapse imaging showed that 53BP1ΔMOB was unable to promote the mobility of
dysfunctional telomeres, similar to 53BP1Δ28, confirming that this mutant is
deficient in inducing chromatin mobility (2.9c). The results also indicated that
53BP1ΔPTIP behaves as wild type 53BP1 with regards to mobility, similar to results
obtained in TRF2F/FPTIP-/- MEFs (Lottersberger et al., 2015).
It is unknown whether 53BP1 associates with the LINC complex. The fact
that uncapped telomeres do not show an obvious localization to the nuclear
periphery argues against a interaction. However, the MEFs analyzed are flat and
the precise localization of DSBs is difficulty to assess. Furthermore, nuclear
invaginations can position an internal telomere close to the nuclear envelope and
a connection can thus be envisioned (Fig. 5.1a). However, multiple co-IP
experiments, telomere ChIP, and co-IPs of crosslinked complexes failed to detect
an interaction between 53BP1 and Sun1, raising the possibility that there is no
physical interaction between 53BP1 and the Sun proteins (Fig. 2.10 to 2.13).
It is therefore possible that the influence of the LINC complex on DSB
mobility is indirect (Fig. 5.1b). One hypothesis is that the mobility domain of
53BP1 interacts with factor(s) that increase the flexibility of the chromatin
surrounding the uncapped telomere. Chromatin containing DSBs has been
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Figure 5.1 Models for the interaction between 53BP1 and Sun1
(A) The direct interaction model predicts an interaction between 53BP1 (red) and the LINC
complex (yellow) to permit the transfer of microtubule forces to the DSB. (B) In the indirect
interaction model, 53BP1 alters the chromatin structure surrounding the DSB, rendering it more
flexible. Random forces transmitted from the cytoplasm into the nucleus through the LINC
complex result in increased mobility at the DSB site, due to the altered chromatin structure.
Figure provided by F. Lottersberger.
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suggested to expand, as evidenced by EM experiments (Kruhlak et al., 2006). If
the chromatin near a DSB is more flexible, it is conceivable that the forces
exerted by the microtubules could induce mobility of DSBs whereas other regions
in the nucleus are less affected (Fig. 5.1).
It will be of interest to identify proteins that interact with the mobility
domain of 53BP1. Mass spectrometry could be used to identify proteins that
interact with this domain in a DNA damage inducible manner, similar to what was
done previously for the 53BP1 S/TQ sites in B-cells (Di Virgilio et al., 2013).
Possibly, nucleosome-remodeling complexes could be recruited or activated in a
process dependent on 53BP1. Alternatively, the pathway could be more
complicated if this domain interacts with a kinase or ubiquitin ligase, that can
activate entire signaling cascades. Monitoring the influence of 53BP1 on
chromatin status at telomeres would be helpful to address these questions.
Telomeric chromatin is heterochromatic and MNase digestion experiments
indicated that nucleosome density is not altered in response to DNA damage,
when measured after TRF2 loss (Wu and de Lange, 2008). This does not
necessarily argue against changes in chromatin structure surrounding DSBs. It is
possible that 53BP1 activity affects histone modifications that regulate the
flexibility of the chromatin fiber. The increased mobility of flexible chromatin at
DSB could be due to regular cytoskeletal forces transmitter through the LINC
complex. But it is also possible that DNA damage stimulates an increase in
forces on the nucleus. Nuclear invaginations and deformations have been
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observed upon etoposide treatment in human fibroblasts (Dellaire et al., 2009).
Furthermore, ATM dependent signaling through Chk2 and/or Chk1 could impact
the LINC complex directly, as was shown for C. elegans meiosis where Chk2
directly phosphorylates the Sun1 N-terminus (Penkner et al., 2009).

5.1.3 The function of chromatin mobility in response to damage
An outstanding question is the functional relevance of increased chromatin
mobility in response to DNA damage. Certainly the pathway has not evolved to
fuse dysfunctional telomeres. As discussed in Lottersberger et al. 2015, it is
possible that the mobility inhibits ectopic repair at sites of damage. In G1, DSBs
are quickly repaired by c-NHEJ in response to Ku binding. However, at some
DSBs, Ku binding or synapse might fail, resulting in two loose ends that become
spatially separated. The 53BP1 dependent mobility might help reconnect these
ends to promote their repair (Fig. 5.2a). A downside of this model is that it can be
argued that the mobility increases the chance of generating translocations, if the
DSB reconnects with an end on another chromosome. However, most cells do
not contain more than one persistent DSBs unless under an external genotoxic
insult (Wu et al., 2010). Therefore, the possibility that 53BP1 mediated mobility
promotes translocations is very limited in biological relevant settings.
Another setting where DSB mobility might play a protective function is at
sites of replication stress. A DSB generated at a collapsed fork can be repaired
by HR using the sister chromatid as a template. However, if the DNA end loses
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Figure 5.2 Proposed function of 53BP1-dependent mobility of DSBs
(A) In G1, the mobility of DNA ends that have become disassociated would promote their correct
rejoining by NHEJ. (B) In S/G2, a DNA end could lose its connection with the sister chromatid at a
DSB. Ectopic repair on another locus could be prevented by the 53BP1-dependent mobility
stimulating correct repair using HDR on the sister chromatid. Figure from Lottersberger et al.
2015 (Lottersberger et al., 2015).
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the connection with the sister chromatid, ectopic repair on another chromosome
can occur by strand invasion and microhomology. DNA mobility might be
required to tear apart these low affinity interactions to promote correct repair on
the sister chromatid (Fig. 5.2b). The use of chromosome mobility to disrupt
inaccurate chromosome pairing has previously been suggested to play a role in
C. elegans meiosis (Sato et al., 2009). Pairing and synapsis of chromosomes is
required to accurately separate homologous chromosomes in meiosis I. Synapsis
is promoted by a connection between telomeres (pairing centers in C. elegans)
and Sun1 in the nuclear envelope. Microtubule forces transmitted through the
LINC complex induce meiotic chromosome movement along the nuclear
envelope that promotes synapsis (Shibuya and Watanabe, 2014). This
movement was suggested to improve the accuracy of synapsis since pairing of
non-homologous chromosomes results in weaker interactions that can be
disrupted by the movement while paired homologues resist this force (Sato et al.,
2009). The situation at DBSs is different from meiosis since the damage sites do
not appear to connect directly at the nuclear envelope. However, the underlying
molecular mechanism to promote accurate pairing could be similar.

5.2 The fusion of sister telomeres by a-NHEJ and cleavage by Gen1
5.2.1 Telomeres are prone to a-NHEJ in absence of TRF1
It was long unknown what structure underlies the manifestation of SAs in
metaphase chromosomes. They are not dependent on c-NHEJ, since absence of
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Lig4 does not affect their prevalence. Furthermore, they are not related to the
telomere fragility that is observed after deletion of TRF1, as explained in detail in
Chapter 3.1. The results presented here strongly indicate that SAs are formed via
the a-NHEJ pathway since they are dependent on Lig3 and PARP1 (Fig. 3.2 and
3.3). Supporting this finding, SAs are also reduced from ~12% to ~5% in
TRF1F/FTRF2F/FLig4-/- MEFs after deletion of the entire shelterin complex in
response to shLig3 depletion (unpublished experiments from A. Sfeir). This
reduction is similar to the results reported here (Fig. 3.3). Furthermore, anaphase
bridges are seen in mitotic cells after loss of TRF1, indicating chromosome fusion
events (Fig, 3.7b). Unexpectedly, telomere fusions are not prominently detected
upon analysis of the telomeric restriction fragments from Cre-treated TRF1F/F
MEFs, even when mitotic cells are enriched (unpublished experiments from de
Lange lab). The absence of molecular evidence for telomere-telomere fusions
could be due to several reasons. First, the abundance of SAs might be too low
for detection. Upon TRF2 loss, telomere fusions are clearly visible in gels but the
percentage of fused telomeres is much higher in those cells (60% in TRF2F/F
versus 15% in TRF1F/F). Secondly, if SAs are resolved by Gen1 (or other
nucleases), their number would be reduced even further because the fusions
would be transient. Third, fusions via a-NHEJ are known to produce mutations at
the fusion site. Telomeric DNA is digested with AluI and MboI prior to PFGE,
which normally do not cleave fused telomeres. But after a-NHEJ, cleavage sites
for these enzymes may appear at the fusion site resulting in their cleavage due to
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de novo sequence insertions by PolQ (Mateos-Gomez et al., 2015). Therefore,
this observation that fused telomeres are not visible in telomeric gels does not
argue against a-NHEJ mediated fusion of sister telomeres upon loss of TRF1.

5.2.2 Incomplete DNA replication does not explain the appearance of SAs
Different models have previously been proposed for the events resulting in the
formation of SAs. It can be argued that SAs are sites of incomplete DNA
replication. Telomere replication is initiated primarily in the subtelomere from
where the replication fork progresses into the telomeric DNA. Replication
initiation within the telomeric sequence is infrequent (Sfeir et al., 2009). Telomeric
replication is furthermore not a late event but occurs throughout S phase (Ten
Hagen et al., 1990; Wright et al., 1999). It can be argued that the replication fork
in some replicating telomeres does not reach the telomere end, particularly upon
replication fork stalling in absence of TRF1, resulting in unfinished replication
leaving the sister chromatids bound together. A similar model for incomplete
replication exists for common fragile sites (CFS), regions of the genome that are
difficult to replicate and manifest as breaks and gaps on metaphase spreads
(Durkin and Glover, 2007). Replication at CFS was recently shown to continue
into the prophase, as evidenced by EdU incorporation after entry into mitosis
(Minocherhomji et al., 2015). Mitotic DNA synthesis was dependent on
Mus81/SLX4, Rad52 and POLD3, resulting in a model where cleavage of the
replication fork by Mus81/SLX4 allows D-loop formation by Rad52 on the sister
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template and initiation of DNA synthesis by POLD3 (Minocherhomji et al., 2015;
Bhowmick et al., 2016). It is possible that SAs at telomeres represent similar
areas of incomplete replication after deletion of TRF1, resulting in the
appearance of ‘fused’ telomeres. However, several arguments counter this
hypothesis.
First, in contrast to telomeres, most CFSs replicate late in S-phase
explaining why they remain incompletely replicated, especially after aphidicolin
treatment (Le Beau et al., 1998). Telomeric replication is likely to be finished at
the end of S-phase, since they replicate throughout S-phase, even in absence of
TRF1 (Wright et al., 1999; Sfeir et al., 2009).
Secondly, EdU incorporation in mitosis could not be detected at telomeres,
in absence of TRF1 suggesting that DNA replication has finished in this setting
(unpublished experiments). It is possible that the amount of EdU incorporation at
telomeres was too limited for detection. However, treatment of cells with
aphidicolin treatment did result in EdU signals at or near telomeres (unpublished
data Z. Yang). This further suggests that telomeres are fully replicated after TRF1
deletion, except when cells are treated with aphidicolin. Since SAs are not seen
at telomeres after aphidicolin treatment, this argues that they do not represent
sites of unfinished replication (Sfeir et al., 2009).
Third, Mus81 was shown to be required for mitotic DNA replication, which
occurs in prophase but before prometaphase (Minocherhomji et al., 2015). If SAs
represent areas of unfinished replication, depletion of Mus81 should have some
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effect on the prevalence of SAs since they are visualized in metaphase after
mitotic DNA replication has occurred. But the frequency of SAs was not altered in
MEFs in absence of Mus81 upon deletion of TRF1 (Fig. 4.16a).
Finally, CFS expression as a consequence of incomplete replication is
associated with an increase of UFBs in anaphase cells (Ying et al., 2013). Thus,
UFBs should be clearly visible in anaphase cells after deletion of TRF1, if SAs
indeed represent sites of unfinished replication. Although the resolution of the
microscope was not ideal, there was no indication for high levels of UFBs in
TRF1F/F MEFs after deletion of TRF1, as gleaned from PICH recruitment in timelapse imaging experiments (Fig. 3.8). Although many anaphase bridges were
detected upon loss of TRF1, they were almost always DAPI positive suggesting
that they represent real fusions instead of sites of unfinished replication (Fig. 3.7b
and 3.8d).
Additionally, whereas the reduction of SAs by PARP1 inhibition could
potentially be explained by its many distinct functions at the replication fork, the
reduction of SAs by Lig3 does not make sense if the SAs represent incompletely
replicated telomeres. Combined, the results argue that (at least some of the) SAs
are telomeres fused by a-NHEJ and do not represent sites of unfinished
replication.
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5.2.3 Cohesin defects cannot explain SAs
Another possible model for the molecular nature of SAs could be defective
removal of cohesin at telomeres in absence of TRF1. Sister chromatids are held
together after replication by cohesin until their separation in mitosis (Nasmyth
and Haering, 2009). Most cohesin is removed during prophase but a small
amount remains at the centromeres to allow accurate chromosome alignment
and spindle formation. At the onset of anaphase, all sister chromatid cohesion is
destroyed by the action of separase, allowing chromosomes to fully separate
(Nasmyth and Haering, 2009). Telomeres are held together by the SA1-cohesin
complex, which in human cells requires the shelterin associated protein
tankyrase for its removal from telomeres. Absence of tankyrase-1 was shown to
result in persistent telomere associations mediated by SA1 (Dynek and Smith,
2004; Canudas et al., 2007). It is therefore possible that SAs represent sister
telomeres from which SA1-cohesion has not properly been removed. Indeed,
sister chromatid fusions were seen in human cells after tankyrase depletion
(Hsiao and Smith, 2009). However, other studies argue against SAs being merely
cohered telomeres. Sister telomere coherence mediated by SA1 is a noncovalent interaction that is destroyed by the hypotonic treatment used for
metaphase spread analysis (Dynek and Smith, 2004). This coherence is
therefore only seen upon direct fixation of mitotic cells. However, SAs upon TRF1
loss are refractory to hypotonic swelling since they are detected in regular
metaphase spreads, indicating that they do not represent associations mediated

193

by

SA1-cohesion.

Furthermore,

the

tankyrase-SA1

mediated

telomere

associations in human cells are dependent on an interaction between tankyrase
and TRF1. However, mouse TRF1 does not interact with tankyrase, indicating
that SAs are distinct from a telomere cohesion defect (Donigian and de Lange,
2007).
Interestingly however, telomeric cohesion is required for accurate telomere
replication. An SA1 knockout mouse displayed defective telomere replication
indicated by the appearance of fragile telomeres (Remeseiro et al., 2012). Loss
of SA1 did not affect centromeric cohesion but telomeres are seen as doublets in
IF analysis representing defective coherence. The level of telomere fragility is of
a similar level as induced by TRF1 deletion (20-25%), but SAs were not
described. Telomeric sister chromatid exchanges (T-SCE) are decreased in
absence of SA1. The reduced level of T-SCE suggests that SA1 facilitates HRmediated repair of stalled forks by keeping sister telomeres close together. It
would be interesting to analyze SAs in TRF1F/F MEFs after depletion of SA1 to
see if their levels are altered by loss of cohesion.

5.2.4 Telomere entanglements in yeast
The anaphase bridges seen upon loss of TRF1 are reminiscent of the telomere
‘entanglements’ observed on gel analysis of fission yeast cells lacking the
TRF1/2 ortholog taz1 (Miller and Cooper, 2003). When taz1Δ cells are exposed
to cold temperatures (20°C) they undergo replication stress similar to the
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situation in TRF1 knockout MEFs (Miller et al., 2006). Importantly, taz1Δ cells
display segregation defects such as anaphase bridges, which are dependent on
progression through S-phase (Miller and Cooper, 2003). This segregation defect
was independent of Ku or Lig4, indicating that the defect is not the result of
telomere fusion by c-NHEJ. It is possible that the telomere entanglements
represent telomeres fused by a-NHEJ similar to the SAs in MEFs, but deletion of
Lig3 was not tested in these yeast experiments. The cold-sensitivity of taz1Δ
cells was improved by deletion of topoisomerase II and it was suggested that
inappropriate cleavage and rejoining of DNA strands was a causative factor for
the appearance of entangled telomeres (Miller and Cooper, 2003). But telomere
fusions were not observed in PFGE electrophoreses gels, suggesting that the
telomere entanglement were not covalently attached. The molecular nature of
these entanglements thus remains unknown.
Intriguingly, subsequent experiments showed that deletion of yeast Rif1
(rif1+) rescued the cold sensitivity of taz1Δ cells implicating rif1+ contributes to
the formation of telomere entanglements (Miller et al., 2005; Zaaijer et al., 2016).
Fission yeast Rif1+ is different from mammalian Rif1 in that is does not affect cNHEJ or the 3’ overhang at the telomere end. Furthermore, Rif1+ binds to yeast
telomeres in a taz1 dependent manner indicating that its role in preventing the
cold sensitivity of taz1Δ cells is independent of its localization to telomeres. Later
experiments showed that Rif1+ localizes to the anaphase mid-region in fission
yeast during mitosis suggesting that it prevents untangling at this site (Zaaijer et
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al., 2016). Recently, Rif1 was also detected at UFBs during mitosis in
mammalian cells (Hengeveld et al., 2015). However, in contrast to telomere
entanglements, resolution of UFBs was worse in absence of Rif1 suggesting that
Rif1 performs a function that helps resolve UFBs (Hengeveld et al., 2015; Zaaijer
et al., 2016). These contradicting functions of Rif1 at telomeres and UFBs could
be explained if the telomere entanglements are structurally different from UFBs,
for example, if the telomere entanglements actually represent fused sister
telomeres, similar to the SAs in TRF1 null cells. In agreement with this
hypothesis, SAs were prevented in TRF1F/F53BP1-/- MEFs expressing the
53BP1ΔRif1 allele, suggesting a similar function of mammalian Rif1 in promoting
telomeric SAs as in fission yeast (Fig. 3.13 and 3.14). However, the role for Rif1
described in this thesis is downstream of 53BP1 in contrast to fission yeast,
where Rif1+ localizes independently. It is possible that the 53BP1 dependent
recruitment of mammalian Rif1 evolved later, in agreement with the observation
that fission Rif1+ does not play a role in telomeric overhang regulation. Further
experiments are needed to determine whether yeast telomere entanglements are
similar to the SAs in TRF1 null cells and what function Rif1 plays at these sites. It
is possible that Rif1 is required to promote topoisomerase mediated untangling of
UFBs during mitosis. This could explain why Rif1 promotes untangling of
replication intermediates but has detrimental consequences at entangled
telomeres if these sites represent telomere fusions, since topoisomerase function
would not resolve these structures (Hengeveld et al., 2015; Zaaijer et al., 2016).
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Intriguingly, Rif1 is known to interact with BLM at stalled replication forks,
independent from 53BP1, where it prevents the accumulation of stalled forks (Xu
et al., 2010). Although the recruitment of Rif1 to UFBs is independent of BLM, it
is possible that they act in the same pathway to untangle replication
intermediates (Hengeveld et al., 2015).

5.2.5 What is the substrate for a-NHEJ at sister telomeres?
A major question arising from this work is what specific substrate allows a-NHEJ
to take place between sister telomeres after deletion of TRF1. SAs are not seen
after TRF2 loss, even when fusions are limited to S/G2 such as in TRF2F/FATMF/F
or TRF2F/FNBS1F/F MEFs (Dimitrova and de Lange, 2009). Instead, leadingleading chromatid type fusions are observed in these cells. Lagging strand
telomeres are protected from these fusions since telomere processing, formation
of the 3’ overhang, and binding of the POT1 proteins are thought to be
incompatible to c-NHEJ. However, replication of the leading strand telomere
yields a blunt end. Normally, ATM activation in response to TRF2 removal results
in resection of the leading end, providing a 3’ overhang incompatible to c-NHEJ
in S/G2. But in TRF2F/FATMF/F (or NBS1F/F) MEFs, ATM dependent-resection is
inhibited leaving blunt ended telomeres resulting in leading-leading chromatid
fusions. Nevertheless, SAs are not observed upon loss of TRF2 indicating that a
TRF1 specific event is required. Given that TRF1 is required for telomere
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Figure 5.3 Model for the fork stabilization in absence of TRF1
(A) When the replication fork reaches the end of the telomere, TRF1 might promote the
disassembly of the replisome. (B) In absence of TRF1, the disassembly of the replisome might
not occur efficiently. Furthermore, activation of ATR stabilizes the replication fork even more,
which could lead to fork regression.
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replication, possibly an event at the terminal replication fork provides the
substrate for a-NHEJ.
While many studies focus on understanding the initiation of replication,
termination of the fork is not very well understood. It is thought to require
topoisomerase function and polyubiquitiniation, suggesting an active process
(Fachinetti et al., 2010; Moreno et al., 2014; Bailey et al., 2015). This has mainly
been studied at converging forks at chromosome internal locations. How
replication fork dismantling occurs at a DNA end such as a telomere is unknown.
Possibly, one of the functions of TRF1 is to promote replication fork disassembly
once the fork has reached the end of the DNA (Fig. 5.3a and b). In absence of
TRF1, ATR is activated which has a stabilizing function on the replisome (Lopes
et al., 2001; Tercero and Diffley, 2001; Cobb et al., 2003; Lucca et al., 2004). It is
therefore possible that the replisome remains associated at the telomere after
DNA replication in TRF1 null cells. Stalled replication forks can give rise to
abnormal DNA structures such as reversed forks, which form cruciform structures
(Neelsen and Lopes, 2015). At chromosome internal locations, the reversed forks
can help replication fork restart or bypass of DNA lesions. But at the telomere
there is just the DNA end and repair would not be possible.
What could occur at these terminal forks was assessed in a study
examining the fate of a replication fork reaching a DSB, not unlike the situation at
a chromosome end (Doksani et al., 2009). It was speculated that the combined
action of MRN, CtIP and ATM prevents the formation of pathological chicken-foot
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structures at the stalled fork encountering the DSB, allowing disassembly of the
replication complex. In absence of these proteins, fork reversal and the
accumulation of cruciform structures were observed at the fork, which was
speculated to be a substrate for sister fusion. Although the situation at telomeres
is not exactly similar to internal DSBs, it is possible that a comparable process
occurs in absence of TRF1 (Fig. 5.4). Initially, the situation is similar to fork
reversal at replication forks elsewhere in the genome, resulting in a regressed
fork. Resection of the newly replicated 5’ end by nucleases such as Exo1, Dna2
or WRN takes place, creating a 3’ overhang at the reversed end. What is unique
at telomeres is that this overhang generates a potential substrate for a-NHEJ
because there is already a 3’ overhang present nearby at the unreplicated
telomere end. This ssDNA at the chromosome end contains microhomology with
the newly generated overhang (AT-TA). When these 3’ overhangs anneal, fusion
by a-NHEJ could occur resulting in sister telomere fusion (Fig. 5.4). An
interesting experiment to test the requirement for TRF1 loss in the formation of
SAs would be to treat Pot1a null cells with aphidicolin. This would result in ATR
activation, due to the unprotected 3’ overhang, together with aphidicolin induced
replication stress at the telomere. An increase in SAs in this setting would argue
against a direct effect of TRF1 on the terminal replication fork, but indicate that
ATR activation at the terminal fork by itself is sufficient to induce sister fusions.
Interestingly, there is experimental evidence suggesting that sister
telomere fusions occur when there is complementarity in the telomeric sequence
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Figure 5.4 Model for the formation of sister telomere fusions upon TRF1 loss
A schematic of the terminal replication fork is shown (Shelterin and replisome are not included for
clarity). In absence of TRF1, the replication fork would stall at the telomere end. Unwinding of the
newly synthesized DNA strands would occur resulting in fork regression. At the reversed fork, the
nucleases (Exo1/Dna2 or WRN) would act on the 5’ end resulting in a 3’ overhang. Since there is
already a 3’ overhang present at the telomere end, annealing can occur between the overhangs
due to the microhomology present in the telomeric sequence, resulting in a-NHEJ mediated by
PARP1 and Lig3. How and where PARP1 is activated is not known.
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(Stohr et al., 2010). An experiment with a mutated telomerase enzyme that
incorporates different ‘telomeric’ sequences to the DNA end than the typical
TTAGGG sequence has provided evidence for this. A telomerase enzyme
incorporating “TATATATA” caused sister telomere fusions and isochromosomes,
which occurred in an ATM independent manner. However, incorporation of
TTTGGG sequences did not have this effect and solely led to chromosome type
telomere fusions, that required ATM (likely because telomeres become uncapped
since TRF2 does not bind this sequence). These experiments suggest that
microhomology within the telomeric sequence might indeed be required for SAs,
in support of the model presented here.
While this model can explain how sister fusions are formed, several
questions remain unanswered. How is PARP1 activated at the regressed fork
and why is its activation not inhibited by TRF2? Does TRF1 indeed promote the
disassembly of the replication fork? And if so, does TRF1 promote replisome
disassembly through preventing ATR activation? Is the RNA primer at the lagging
strand removed prior to fork stalling? How is 53BP1/Rif1 involved in this
process? Future experiments should attempt to answer these questions.

5.2.6 The role of Ku in preventing a-NHEJ at telomeres
An interesting observation is that Ku70/80 did not prevent SAs after
deletion of TRF1 (Fig. 3.6b). This was surprising given that Ku can block a-NHEJ
upon loss of TRF2 or the entire shelterin complex (Celli et al., 2006; Sfeir and de
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Lange, 2012). Ku is thought to block a-NHEJ by competing with PARP1 for DNA
ends (Wang et al., 2006). One explanation for why Ku does not inhibit a-NHEJ in
the TRF1 null setting is that TRF2 is still present. In vitro experiments suggested
that TRF2 directly interacts with Ku to prevent it from stimulating NHEJ. Thus,
upon deletion of TRF1, Ku may still be inhibited by TRF2 explaining why loss of
Ku does not result in higher levels of SAs. Arguing against this hypothesis is the
fact that Ku appears to prevent SAs in a TRF1F/FTPP1F/F setting. When Ku is
deleted from these MEFs, the level of SAs increases from 13 to 30%
(unpublished data from T. Kibe). These results raise the possibility that POT1a/b
limits the activity of Ku in the formation of SAs. Possibly, the ssDNA binding
capability of POT1a/b limits the accessibility of Ku for the DNA end. Although the
levels of the TIN2/TPP1/POT1a/b axis of shelterin are reduced when TRF1 is
missing, enough residual POT1a/b remains to protect the 3’ overhang since a
POT1a/b null phenotype is not observed in absence of TRF1 (Frescas and de
Lange, 2014). It would be interesting to analyze the contribution of Ku to SAs in a
POT1aF/FTRF1F/F setting.
An alternative explanation for the lack of suppression of SAs by Ku could
simply be the structure of the DNA end. We do not know on a molecular level
what structure gives rise to a-NHEJ in absence of TRF1. Possibly, the end is
incompatible to Ku loading, thus explaining why its loss does not affect SAs.
However,

this

cannot

explain

the

TRF1F/FTPP1F/FKu-/- setting.
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5.2.7 Gen1 cleaves SAs
The results in Chapter 4 revealed a unique mechanism for cleavage of sister
telomere fusions by the HJ resolvases Gen1 (Fig. 5.5a-c). Since telomere fusions
create a palindromic sequence, a Holliday junction can be formed which can be
cleaved by HJ resolvases. The absence of Gen1 results in the accumulation of
chromatin bridges, but only when TRF1 was removed from telomeres. It is
unclear from the results presented here whether Gen1 is the only HJ resolvase
capable of cleaving fused telomeres. Whereas Mus81 loss increased the
percentage of chromatin bridges, it cannot be ascertained that this is due to a
TRF1 specific effect or because of its role at CFS throughout the genome. An
additive effect was seen for Gen1 and Mus81 depletion, but the results were not
significant. This could be due to the inefficiency of the shRNAs against Mus81,
which led to only a 60-80% reduction in expression levels. However, it is also
possible that Mus81 is not as efficient as Gen1 in cleaving telomeres. Mus81
requires a nicked substrate for HJ cleavage, which might not be efficiently
generated at telomeres (Wyatt et al., 2013). Interestingly, a recent paper
analyzed the sequence specificity of Gen1. Even though it shows broad cleavage
activity on a variety of sequences, it preferentially cleaves TTxGG substrates,
suggesting that telomeric TTaGGg sequences form an ideal substrate for Gen1
(Shah Punatar et al., 2017). A remaining question is whether Gen1 cleaves all
types of telomere fusions or just the ones arising through a-NHEJ. Preliminary
experiments indicate that Gen1 does not cleave telomere fusions that occur after
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Figure 5.5 Model for the role of Gen1 at telomeres fused by a-NHEJ.
(A) Schematic of a fused sister telomere is shown on the left. Fusion junctions in a-NHEJ often
contain insertions/deletions that are depicted by xxx. The formation of a cruciform structure from a
telomere fusion is shown on the right. (B) Upon deletion of TRF1, anaphase bridges can form
when a chromosome with a sister telomere fusion (red) is separated (top). Cleavage of the
telomere fusion by Gen1 still allows faithful chromosome segregation. When the spindle forms an
incorrect attachment or loses its connection (bottom), the entire chromosome is missegragated
into one daughter cell. Cleavage by Gen1 can prevent the formation of isochromosomes. (C) In
absence of Gen1, a chromosome with a sister fusion can follow two fates in mitosis. If the spindle
forms a correct attachment, the fused chromosome will form a chromatin bridge (top). When the
spindle forms an incorrect attachment or loses its connection, the entire chromosome is
missegragated into one daughter cell (bottom). Replication in the next S-phase will result in the
formation of an isochromosome (red).
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expression of a dominant negative TRF2 allele, TRF2ΔBΔM, which results in
chromatid type telomere fusion in human cells (van Steensel et al., 1998). The
level of telomere fusion was not increased in Gen1 null cells, suggesting it is not
capable of cleaving these fusions (unpublished data S. Dewhurst). Possibly,
Gen1 only cleaves fusions formed via a-NHEJ. This pathway is known to
promote mutations and insertions at the fusion site and the mismatches could
help to destabilize the helix and promote protrusion of the cruciform DNA
structure. Cruciform DNA structures are energetically unfavorable and do not
form easily. However, increasing their length or by introducing negative
supercoiling, their extrusion can be promoted (Mizuuchi et al., 1982; Gellert et al.,
1983). This opens the possibility that transcription of TERRA, the telomeric RNA,
promotes the expression of the cruciform, since transcription induces negative
supercoiling (Gilbert and Allan, 2014). Alternatively, perhaps the activities of BLM
and PICH during anaphase promote the protrusion of cruciform structures.

5.2.8 Critically short telomeres in human cells fuse via a-NHEJ
The results presented here are relevant with regard to telomere shortening in
human cancer. Studies have shown that fusions of critically short telomeres in
human cells occur via sister chromatid fusion and are dependent on a-NHEJ
(Letsolo et al., 2010; Jones et al., 2014; Liddiard et al., 2016). Microhomology is
also observed at telomere fusion sites in cancer, consistent with a-NHEJ (Lin et
al., 2010). In a system of experimentally induced telomere erosion, telomere
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fusions in surviving Lig4-/- cells were predominantly intra-chromosomal consistent
with Lig3-mediated sister chromatid fusion (Jones et al., 2014). Conversely, Lig4
facilitated inter-chromosomal fusions, indicating they are formed by c-NHEJ.
Interestingly, the inter-chromosomal fusions often retained telomeric repeats at
the fusion sites whereas intra-chromosomal fusions (Lig3) involved the
subtelomeric region (Letsolo et al., 2010; Jones et al., 2014). Given the results
presented here, it is interesting to speculate that sister telomere fusions by aNHEJ in the telomeric region are cleaved by Gen1, until the degradation reaches
into the subtelomeric region where a substrate for a cruciform DNA structure no
longer exists. In agreement with this, escape from telomere-driven crisis is
dependent on a functional Lig3, suggesting that cells with a-NHEJ mediated
sister fusions have a mechanisms to survive (Jones et al., 2014).
Liddiard et al. suggested that the basis for intra-chromosomal fusions lies
in interplay with the DNA replication machinery, consistent with the model
presented here (Liddiard et al., 2016). Critically short telomeres were inferred to
contain an average of 6 TTAGGG repeats at the time of stable fusion product
formation (Capper et al., 2007). This might not be enough for efficient telomere
protection by shelterin but telomeres of this size are still thought to contain a 3’
overhang (Jones et al., 2014). Therefore it is possible that our model for the
generation of sister fusions at the terminal replication fork takes place at critically
short telomeres after DNA replication. The short telomere tract no longer contains
enough TRF1 to promote disassembly of the replication machinery resulting to
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fork stalling and reversal. Since the 3’ overhang is still formed at these critically
short telomeres, a-NHEJ mediated fusion can occur. But further studies are
required to test this hypothesis.
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Chapter 6: Materials and Methods
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6.1 Cell culture techniques
6.1.1 Mammalian cell culture
MEFs were cultured in DMEM (GIBCO) supplemented with 15% fetal bovine
serum (GIBCO), 2 mM L-glutamine, 100 U/ml penicillin (Sigma), 0.1 mg/ml
streptomycin (Sigma), 0.1 mM nonessential amino acids (Invitrogen), 1 mM
sodium pyruvate (Sigma) and 50 mM β-mercaptoethanol (Chemicon). Primary
MEFs were isolated from E13.5 embryos using standard techniques. Primary
MEFs were immortalized at PD2 or 3 by retroviral infections with pBabe-SV40-LT
(a gift from G. Hannon) and cultured additionally for 10-15 PDs to achieve
immortalization. Human 293T and Phoenix packaging cell lines were grown in
DMEM supplemented with 10% bovine calf serum (Hyclone), 2 mM L-glutamine,
100U/ml

penicillin

(Sigma),

0.1

mg/ml

streptomycin

(Sigma),

0.1

mM

nonessential amino acids (Invitrogen) and 1 mM sodium pyruvate (Sigma). For
subculturing, cells were washed with PBS pH 7.4, trypsinized and resuspended
in fresh serum containing medium to inactivate trypsin. Cells passaged 1:5 or
plated as required and when necessary, counted with a Coulter Z1 counter. All
cell lines were grown at 37°C with 5% CO2.
293T and Phoenix cells were grown in 10% bovine serum (GIBCO), 2 mM
L-glutamine, 100 U/ml penicillin (Sigma), 0.1 mg/ml streptomycin (Sigma), 0.1
mM nonessential amino acids (Invitrogen) and 1 mM sodium pyruvate (Sigma).
Cells were passaged 1:10 or plated as required. Cells were used for a maximum
of 15-20 passages. A list of cell lines used is found in Chapter 6.4.
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6.1.2 Calcium phosphate precipitation transfection of 293T and Phoenix cells
3-5X106 293T or Phoenix cells were seeded in 10 cm dishes 20-24 h prior to
transfection. For each plate, plasmid DNA (10-20 μg) was combined with 50 μl of
2.5 M CaCl2 and ddH2O in a total volume of 500 μl. The solution was incubated
for 1-2 minutes at room temperature after which 500μl of 2x HBS (50 mM HEPES
pH 7.05, 10 mM KCL, 12 mM dextrose, 280 mM NaCl, 1.5 mM Na2PO4) was
added dropwise while airing the solution with a pipet. The solution was incubated
for 1-2 minutes and carefully added to the 10 cm dish containing 293T or Phoenix
cells. Medium was exchanged 12-16 h after transfection.

6.1.3 Retroviral gene delivery
For retroviral gene delivery, 3-5X106 Phoenix packaging cells (ATCC) were
transfected with 10-20 μg of plasmid using calcium phosphate precipitation. After
12-16 h, medium was replaced by MEF medium. Virus particles were first
collected 48 h after transfection, filtered through a 0.45 μM filter and
supplemented with 4 μg/ml polybrene before infecting target MEFs that were
seeded 12 h prior in a 10 cm dish (3-5X105 cells/plate). The Phoenix cell media
was replenished and infections repeated every 12 h for a total of 3 or 4 infections.
For selection, MEFs were collected 12 h after the last infection and
seeded in fresh medium containing the appropriate antibiotics (1.5-2 μg/ml
puromycin, 90 μg/ml hygromycin). Cells were maintained in selection until
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uninfected control cells were dead. A list of shRNA targets is provided in Chapter
6.5.

6.1.4 Lentiviral gene delivery of shRNAs
Lentiviral PLKO vectors were used for shRNA-mediated knockdown of protein
expression in MEFs, except for BLM as discussed below. Briefly, 4-5X106 293T
cells were seeded in 10 cm dishes 24 h prior to transfection. Calcium phosphate
precipitation was used to transfect 10 μg shRNA plasmid together with plasmids
encoding viral packaging proteins (5 μg RRE, 3 μg VSV, 2.5 μg REV). Medium
was exchanged 12 h after transfection and replaced with MEF medium. Virus
was collected as described in Chapter 6.1.3 with the first collection and infection
36 h after transfection of 293Ts. MEFs were infected 3 times total 12 h apart.
Selection of MEFs was done as described in 6.1.3, but only when the shRNA did
not strongly affect cell viability (TopBP1, Ligase 1). When shRNA resulted in a
rapid drop in cell viability, the selection process was omitted and Cre infection
done 12 h after the last shRNA infection, to ensure cells remained healthy
throughout the experiment (Mus81, PARP1, CCDC124, CCDC9, CCDC79). For
the shRNA against Exo1 and Lig3, the shRNA infection had such a strong effect
on cell viability that the Cre infection was done prior to shRNA infection. Where
possible, efficient shRNA mediated knockdown was checked by western blot or
qPCR.
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For BLM depletion, a retroviral expression vector was used (pSuperior) as
described in Zimmermann et al. 2014 (Zimmermann et al., 2014). For the
experiment, 3-5x106 Phoenix cells were transfected with 10 μg shBLM or control.
Media exchanged for MEF media 12 h after transfection and virus was collected
as described in Chapter 6.1.3, with the first collection 36 h after transfection. As
for shExo1, target MEFs were first infected with Cre virus, immediately followed
by 2 shRNA infections to increase cell viability after BLM depletion.

6.1.5 Cre mediated gene deletion
For Cre recombinase mediated gene deletion, MEFs seeded at 2-5x105 cells in a
10 cm dish and infected 3 times using a pMMP Hit&Run Cre retrovirus. Infections
were done 12 h at room temperature in media containing 4 μg/ml polybrene. For
timed experiments, time point zero was set at the time of the 2nd Cre infection.
For Cre-ER inducible cell lines, Cre expression was activated by addition of 1μM
4OH-tamoxifen to the cell growth media and exchanged for regular media 12-24
h later. Addition of 4OH-tamoxifen was set at time point zero for timed
experiments.

6.1.6 Generation of CRISPR/Cas9 knockout cell lines
Target sequences for CRISPR/Cas9 mediated gene knockouts were identified by
ZiFit (http://zifit.parners.org, see list below). Targets were cloned into an AfIIIlinearized gRNA cloning vector (Addgene) by Gibson Assembly. gRNA plasmids
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were transiently co-transfected with a hCas9 expression plasmid into target MEF
cell lines using nucleofection (Lonza) using the MEF2 nucleofection kit. Briefly, 24X106 cells were collected and mixed with electroporation buffer, 5 μg Cas9
plasmid and 5 μg gRNA plasmid and electroporated using program A023. Cells
were rapidly transferred into a 10 cm dish containing pre-warmed media and,
which was refreshed 12 h afterwards to remove dead cells. The transfection was
repeated after 48 h to obtain maximum efficiency of the CRISRP/Cas9 system.
After the second round of transfection, cells were left to recover for 24-48 h and
subcloned into 96-well plates at several dilutions ranging from 1 to 0.05 cells per
well. After two weeks, multiple (~30-50) clones were grown to confluence in a 6well plate and clones screened for gene deletion by immunoblotting. Targeting
was further verified by sequencing clones of TOPO-TA cloned PCR products
according to manufactures’ instructions (Thermo Fisher).

Target of gRNAs for mouse 53BP1:
gRNA2-GAGAATCTTCTATTATC
gRNA3-GCATCTGCAGATTAGGA
gRNA5-GTCTTTTTCAGATCCTG

Target of gRNAs for mouse Gen1:
gRNA2-GAGGACTCAGACTCGTTA
gRNA3-GACTCGTTACGGGCCTTC
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TOPO-TA sequencing primers mouse 53BP1:
FW: CTCGATCTCACACTTCCGCC, RV: TCTTTGGGATGAATCAGCAGGT
TOPO-TA sequencing primers mouse Gen1:
FW: TGTCATATGCTTGCCTGGTCT, RV: TCAAGTCCCTACCACGGGTT

6.1.7 PARPi treatment of cells
For PARP inhibitor treatment (olaparib AZD2281 Selleck chemicals), MEFs were
first infected with Cre virus in 10 cm dished as described previously. Olaparib
was dissolved in DMSO and added to cells in fresh media at a final concentration
of 2 μM. Treatment lasted for the final 24-48 h of the experiment until colcemid
was added for 45 minutes prior to harvest. To control for PARPi efficiency,
western blot analysis was done in MEFs grown separately in 6 cm dished and
treated with Olaparib as above. To promote parsylation, MEFs were treated
with/without H2O2 (2.55 μl in 5 ml media, 5 mM) for 20 minutes immediately prior
to harvest for western blot.

6.2 Molecular techniques
6.2.1 Cloning techniques
53BP1 mutant alleles were generated via Gibson cloning (Gibson et al., 2009)
(Fig. 2.1). 53BP1DB (wild type 53BP1 lacking the C-terminal BRCT domains) or
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53BP1Δ28 in a PMX backbone were used as template for the reactions (Bothmer
et al., 2011). All PCR reactions were done with PfuUltra II Fusion polymerase
(Agilent). Briefly, the domain of 53BP1 containing the mutated STQ residues was
PCR amplified from 53BP1Δ28. The remainder of 53BP1 and the backbone PMX
vector were PCR amplified from the 53BP1DB plasmid using primers that are the
reverse complement of the primers used on 53BP1Δ28 creating a homologous
sequence on either end of the PCR products. PCR products were gel-purified
and

combined

using

Gibson

cloning.
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This

Gibson

mix

contains

a 5’ exonuclease that generates ssDNA at the homologous sequences on either
end of the PCR products enabling them to ligate together. A taq ligase and
phusion polymerase fills in the gaps creating a full-length plasmid composed of
both PCR fragments. The 53BP1ΔoligoΔ28 mutant was created in a similar fashion.
First, a PCR around the 53BP1Δ28 vector was done with primers that were
targeted to each side of the oligomerization domain (amino acids 1231-1270)
creating a long PCR product lacking this domain. Next, a second PCR was done
on the same template using primers with extension that overlapped on either side
of the deletion. The final PCR product was then ligated together using the Gibson
mix. The other 53BP1 oligomerization mutants were created as described for the
53BP1-S/TQ mutants using 53BP1ΔoligoΔ28 and 53BP1DB as templates.
GFP-PICH and RFP-PICH constructs were created using Gateway cloning
according to manufacturers protocol (Clontech). Briefly, mouse PICH cDNA was
amplified and cloned into a pDONR vector. The construct was then shuttled into
an N-terminal GFP or RFP retroviral destination vector (pQCXIP). Mouse and
human Gen1 constructs were cloned from cDNA into pQCXIP retroviral vectors
using Gateway cloning, as described for PICH. Mutations of the active sites were
made using quickchange mutagenesis on the cDNA in the pDONR vector, prior
to shuttling to the pQCXIP destination vector. The C-terminally myc tagged
hGen1-3xNLS-PLPC constructs were made using Infusion cloning (Clontech)
using the manufactures instructions. First, the 3xNLS sequence was inserted
upstream of the myc tag using an EcoRI site using annealed oligos to create a
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PLPC-3xNLS-Myc construct. Then, the PCR amplified hGEN1 amino acids 1-527
were inserted using BAMH1/EcoRI sites by Infusion cloning.

6.2.2 Co-immunoprecipitation in 293T cells
6
To examine the interaction between Sun1, PTIP and 53BP1, 4-5x10 293T cells
were plated in a 10 cm dish 20-24 h prior to transfection by CaPO4 precipitation
using 10 μg each plasmid DNA as indicated. Medium was changed 12 h after
transfection and 24-28 h later cells were incubated with 100 μg/ml zeocin
(Invitrogen) for 20 min, harvested by scraping in cold PBS on ice, and collected
by centrifugation. For irradiation experiment, cells were irradiated with 10 Gray,
left to recover for 1 h and harvested by scraping in cold PBS on ice and collected
by centrifugation. Cells were lysed in lysis buffer (20 mM Tris pH 8.0, 0.5% NP40, 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 1 mM EDTA, Complete protease
inhibitor mix (Roche) and PhosSTOP phosphatase inhibitor mix (Roche)) for 30
minutes on ice, and centrifuged at 15,000 rpm in an tabletop eppendorf
centrifuge for 10 min at 4°C. Lysate was incubated with beads for
immunoprecipitation for 1 h with 50 μl pre-blocked Protein G beads per 1 ml of
lysate. For myc: 1.2 μl antibody (9B11) was used per co-IP. For FLAG,
preconjugated M2-sepharose beads were used (Sigma). For experiments using
FLAG magnetic beads, M-270 Epoxy beads were conjugated with anti-FLAG M2
antibody (Sigma) as described (Subbotin and Chait, 2014)).
An alternative lysis condition was used in some experiments with similar
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results. After collection, cells were resuspended in 0.5 ml hypotonic lysis buffer
(10% glycerol, 10 mM KCl, 10 mM Hepes (pH 7.9), 0.1 mM EDTA, 0.5% NP-40,
1.5 mM MgCl2, Complete protease inhibitor mix (Roche), and PhosSTOP
phosphatase inhibitor mix (Roche)). The KCl concentration was then raised to
400 mM and samples sonicated for 1 min in water bath solicitor and equal
amount of lysis buffer, without KCl, was added to reduce KCl concentration to
200 mM. After centrifugation at 15,000 rpm in a tabletop eppendorf centrifuge or
10 min at 4°C, the IP was done as described above. Beads were washed 7 times
with the lysis buffer containing 150 mM KCl and immunoprecipitated proteins
were eluted with 50 ml of 2xLaemmli buffer. Samples were boiled for 5 min
before separation on SDS-PAGE.
To test the interaction between Sun1 and 53BP1, several experiments
were done using the two cell lysis methods described above with untagged Sun1
or myc-tagged Sun1 and FLAG tagged 53BP1. Additional, the following lysis
buffers were tested using the first protocol described above.
-

RIPA lysis buffer (150 mM NaCl, 1% NP-40, 0.5% Sodium deoxycholate,
0.1% SDS, 50 mM Tris pH 8.0 + Complete protease inhibitor mix and
PhosSTOP phosphatase inhibitor mix)

-

DNAse treatment (100 mM NaCl, 1.5 mM MgCl2, 1.5 mM CaCl2, 20 mM
Tris pH 8.0, 0.5% NP-40 + Complete protease inhibitor mix and
PhosSTOP phosphatase inhibitor mix supplemented with 5 units
DNaseI/500 μl (Promega)
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6.2.3 Co-immunoprecipitation of endogenous Sun1 from MEFs
To test the interaction between FLAG-53BP1 and endogenous Sun1, MEFs were
infected with 53BP1 constructs as described. Cells were collected 72 h after Cre
by scraping, one confluent 15 cm dish per condition was used. Where indicated,
cells were treated prior to scraping with DSP crosslinker for 15 minutes in 10 ml
media containing 1 mM DSP (Thermo Scientific, 50 mM stock in DMSO), which
was quenched by addition of 20 ml Tris pH 7.4 buffer. Cells were either lysed
whole or nuclei pre-isolated prior to lysis. For nuclear isolation, cells were
incubated for 10 min in hypotonic lysis buffer (10 mM Hepes pH 7.9, 10 mM Kcl,
0.1 mM EGTA, 10% Glycerol, 1.5mM MgCl2, 0.1% NP-40, Complete protease
inhibitor mix (Roche), and PhosSTOP phosphatase inhibitor mix (Roche)), and
centrifuged to collect nuclei. Cells or isolated nuclei were then resuspended in
500 μl hypotonic lysis buffer (10% glycerol, 10 mM KCl, 20 mM Hepes (pH 7.9),
0.1 mM EDTA, 0.5% NP-40, 1.5 mM MgCl2, Complete protease inhibitor mix
(Roche), and PhosSTOP phosphatase inhibitor mix (Roche)) and the KCl
concentration raised to 400 mM. Cells were lysed by 1-5 min sonication in a
waterbath. Equal amounts of lysis buffer without KCl, was added to reduce KCl
concentration to 200 mM and after centrifugation at 16,000 rpm for 10 min at 4°C,
the IP was done as described in Chapter 6.2.3 using magnetic beads conjugated
to M2 FLAG antibody. Beads were washed 7 times with the lysis buffer
containing 150 mM KCl and immunoprecipitated proteins were eluted with 50 ml
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of 2xLaemmli buffer containing 50 mM DTT. Samples were boiled for 5 min
before separation on SDS-PAGE.

6.2.4 Western blotting
Western blot was performed using standard methods. Briefly, cells were lysed in
2X laemmli buffer (100 mM Tris pH 6.8, 20% Glycerol, 4% SDS, 0.04%
bromophenol blue, 5% 2-mercaptoethanol) at 5x103 cells/μl and the lysate
denatured for 10 min at 100°C before shearing with a 28 ½ gauge insulin needle.
Lysate was briefly centrifuged to remove debris and subsequently resolved using
SDS/PAGE and transferred to a nitrocellulose membrane. For large proteins
(53BP1 and Rif1), transfer was done overnight in a cold room to enhance transfer
efficiency. Membranes were blocked in 1-5% milk in PBS with 0.1% Tween-20
and incubated with primary antibody for 1 h at room temperature or overnight at
4°C. Membranes were washed 3x in PBS-T and incubated for 1 h at room
temperature with horse-radish-peroxidase-conjugated sheep anti-mouse or
donkey anti-rabbit secondary antibodies. After three washes in PBS-T,
membranes developed using enhanced chemiluminescence (Amersham). For
phosphor-specific antibodies, TBS-T was used instead of PBS-T and membranes
were blocked in 5% BSA.
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6.2.5 List of antibodies used
TRF1 (1255 de lange lab), TRF2 (1499 de lange lab), Rif1 (de lange lab), 53BP1
(175933 abcam or 612522 BD Biosciences or 100-304A Novus Biologicals),
γH2AX (JBW301 Millipore), Ku70 (m19 Santa Cruz), γTubulin (GTU88 Abcam),
Sun1 (ab74758 Abcam), Sun2 (ab87036 Abcam), Ligase 3 (611876 BD
Biosciences), Ligase 1 (18051 Proteintech), pSTQ ATR/ATM substrate (2851
Cell Signaling), BLM (2179 Abcam), Ku70 (m19 Santa Cruz), PARP1 (C2-10
Enzo life sciences), Anti-Poly(ADP-ribose) (4335 Trevigen), TopBP1 (ab2402
Abcam), Exo1 (Bethyl), Gen1 (kind gift from Steve West lab), FLAG epitope (M2
FLAG Sigma), myc tag (9B11 Cell Signaling), GFP tag (50430 Proteintech)

6.2.6 Chromatin immunoprecipitation (ChIP)
ChIP was performed as previously described (Loayza and de Lange,
2003). Briefly, cells were fixed 1% paraformaldehyde/culture medium for 60 min
at room temperature. Glycine was added to 0.2 M to stop the cross-linking. Cells
were pelleted by centrifugation and washed with ice-cold PBS, followed by a final
wash in PBS/1 mM PMSF. The cells were resuspended in cell lysis buffer (1%
SDS, 10 nM EDTA pH 8.0, 50 mM Tris-HCl pH 8.0, 1 mM PMSF, protease
inhibitor cocktail from Roche), incubated on ice for 15 min and sonicated for 10
min (30 sec on/30 sec off) in a water-bath sonicator. Supernatants of lysates
were incubated with antibody at 4 °C overnight. Following antibodies were used:
TRF1 (1449 crude serum), 53BP1 (ab175933, Abcam), Sun1 (ab74758, Abcam),
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Sun2 (ab87036, Abcam). ChIP-grade protein G magnetic beads were added for
45 minutes (Dynal, Invitrogen). Immunoprecipitated DNA was washed, eluted
from the beads, and precipitated with ethanol after reversal of the cross-links and
Proteinase K treatment. The DNA samples were dissolved in water, boiled and
loaded on dot blots, and hybridized with the Sty11 probe (telomeres) or BAMHI
probe labeled with 32P-alpha CTP using Klenow. Signal intensity measured by
ImageQuant software was normalized to the signals of the input DNA on the
same blot.

6.2.7 Telomere overhang analysis
1x106 cells were harvested by trypsinization, resuspended in PBS, mixed 1:1
with 2% agarose in PBS and cast into plugs. The plugs were then digested
overnight at 50°C with 1 mg/ml Proteinase K (Roche) in 10 mM Tris HCl pH 8.0,
250 mM EDTA, 0.2% sodium deoxycholate and 1% sodium lauryl sarcosine. The
next day, the plugs were washed five times for 1 h each with TE (1 mM PMSF
was added to the fourth wash) and once with sterile water (20 min). DNA in the
plugs was subsequently digested by AluI and MboI (NEB; 60 U of each per plug,
in 500 μl cutSMART buffer) overnight at 37°C shaking. The next morning, plugs
were washed once with 1 ml TE and equilibrated with 1 ml 0.5x TBE. The
samples were loaded onto a 1% agarose/0.5x TBE gel and run on a CHEFTDRII
pulse field electrophoresis apparatus (BioRad). The electrophoresis parameters
were as follows: Initial pulse: 5 s, final pulse: 5 s, voltage: 6 V/cm, run time: 24 h.
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The gel was then dried and pre-hybridized with Church mix for 1 h at 50°C. DNA
in the gel was hybridized overnight at 50°C in Church mix with 50 ng of 32P endlabeled [AACCCT]4 probe. After hybridization, the gel was washed three times
30 min with 4x SSC at 55°C, once with 4xSSC/0.1% SDS and exposed to a
phosphoimager screen overnight or longer. After exposure, the screen was
scanned on a STORM phosphoimager (Molecular Dynamics) and the gel was
denatured in 0.5 M NaOH, 1.5 M NaCl for 30 min, neutralized twice (15 min
each) with 0.5 M Tris HCl pH 7.5, 3 M NaCl, pre-hybridized in Church mix (0.5 M
Na+ phosphate pH 7.2, 1 mM EDTA, 1% BSA, 7% SDS) for 1 h at 55°C and
hybridized overnight with the same probe as above at 55°C. The next day, the
gel was washed and exposed as above. The ssDNA and dsDNA signals were
quantified using ImageQuant software (Molecular Dynamics). The telomeric 3’
overhang signal was quantified based on the signal obtained after annealing a
labeled CT strand telomeric oligonucleotide to native telomeric DNA. The ssDNA
signal was normalized to the total telomeric DNA signal in each lane obtained
after in situ denaturation of the DNA and re-hybridization with the same probe.
The normalized signals are then compared between samples to determine the
effect of genotypes or treatments on the relative normalized 3’ overhang signals.
To determine if the telomeric ssDNA signal in the in-gel hybridization assay
represented a bona fide terminal 3’ overhang structure, the DNA in agarose plugs
were digested with the E. coli 3’ exonuclease ExoI prior to restriction digest. After
the plugs had been washed 5x in TE as described above, they were washed with
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ddH2O and 1x ExoI buffer (NEB) for 1 h each. The DNA in the plugs was
digested with 100 units ExoI in 300 μl 1x ExoI buffer per plug overnight at 37°C.
The next day, 60 units of fresh ExoI was added and the plugs were digested for
an additional 2 h. After the digestion, the plugs were washed 2 times with TE for
1 h each and loaded onto a 1% agarose gel as described above.

6.2.8 Quantitative PCR analysis
For qPCR analysis, RNA was isolated from MEFs using a Qiagen RNA
isolation kit (invitrogen). cDNA was prepared from 1 µg of total RNA by using
Thermoscript Reverse Transcriptase (Invitrogen). Quantitative PCR reactions
were performed using Life Technologies SYBR Green Master Mix on an Applied
Biosystems 7900HT Sequence Detection System. Differences between samples
were calculated using QuantStudio software (Applied Biosystems) using the ΔCT
method and were normalized to GAPDH. For Mus81, two different primers pairs
were designed, both spanning an exon-exon junctions to prevent amplification of
genomic DNA. Primers used:
Mus81_FW_1: TCGTGTTTCAAAAGGCATTGC
Mus81_RV_1 TCACCGCCTGATGCTAGGT
Mus81_FW_2: TGCTGCAACTCTACAGGGAG
Mus81_RV_2: GCCGATGCGTTCCAAGGAT
GAPDH_FW: GGGTGAGGCCGGTGCTGAGTAT (from H. Takai)
GAPDH_RV: CCTTCCGTGTTCCTACCCCCAA (from H. Takai)
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6.3 Imaging techniques
6.3.1 IF and IF-FISH
IF and IF-FISH were conducted as previously described (Dimitrova and de
Lange, 2006). Briefly, cells grown on coverslips were fixated for 10 min in 3%
paraformaldehyde and 2% sucrose in PBS at room temperature, followed by
three PBS washes. Coverslips were incubated in blocking solution (1 mg/ml BSA,
3% goat serum, 2% donkey serum, 0.1% TritonX-100, 1 mM EDTA in PBS) for
30 min, followed by incubation with primary antibodies diluted in blocking solution
for 1 h at room temperature. Cells were washed three times for 5 min with PBS
and then incubated with secondary antibodies diluted in blocking solution for 30
min at room temperature. For IF, samples were washed in three 5-min washes
with PBS. DNA was stained with DAPI or Hoechst33342 (Tocris, Fisher
Scientific) in the PBS washes and coverslips were mounted using antifade
reagent ProLong Gold from Life Technologies. For IF-FISH, coverslips were
washed after the secondary antibody incubation and fixed for an additional 10
min in 3% paraformaldehyde. After 3 additional 5-min PBS washes, coverslips
were dehydrated with 70%, 95% and 100% ethanol and allowed to dry.
Hybridizing solution (70% formamide, 0.5% blocking reagent from Roche, 10 mM
Tris-HCl pH 7.2 and 488-OO-[CCCTAA]3 or Cy3-OO-[TTAGGG]3 PNA or AF647OO-[TTAGGG]3 probe from Applied Biosystems) was added to each coverslip
and denatured at 80ºC for 5 min, followed by a 1h incubation at room
temperature. Two 15-min washes in 70% formamide/10 mM Tris-HCl pH 7.2 and
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three 5-min washes with PBS were performed. DNA was stained with DAPI or
Hoechst 33342 in the PBS washes and coverslips were mounted using antifade
reagent ProLong Gold from Life Technologies. Images were captured using a
Zeiss AxioPlan II microscope with a Hamamatsu C4742-95 camera using
Volocity software from Perkin Elmer or with an image restoration system
(DeltaVision; Applied Precision) equipped with a cooled charge-coupled device
camera (CoolSnap QE; Photometrics), a PlanApo 60x 1.40 NA objective
(Olympus America, Inc) and SoftWoRx software.
Primary antibodies used for IF: Rif1 (de lange lab), 53BP1 (175933 Abcam or
612522 BD Biosciences) FLAG epitope (M2 FLAG Sigma), MYC tag (9B11 Cell
Signaling). Secondary antibodies used for IF: AF488 Goat-αMouse (Invitrogen),
AF555 Goat-αRabbit (Invitrogen), AF647- Goat-αRabbit (Invitrogen).

6.3.2 Chromatin bridge analysis
To analyze chromatin bridges between nuclei, cells grown on coverslips were
fixed for 10 min in 3% paraformaldehyde/2% sucrose at room temperature,
followed by three PBS washes. Cells were either processed for regular IF as
described in 6.3.1. Alternatively, coverslips were directly incubated for 5 min in 5
μg/ml Hoechst 33342 or DAPI and washed three times in PBS. Coverslips were
then mounted using antifade reagent ProLong Gold from Life Technologies.
Coverslips were analyzed using a Zeiss AxioPlan II microscope with a
Hamamatsu C4742-95 camera. Since the intensity of many bridges is too low to
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capture by camera, bridges were counted manually at the microscope. For each
coverslip, at least 200 cells were counted in fields next to each other and the
percent of cells with a bridge was counted (every cell that has a bridge protruding
from it is counted as positive, independent of whether the cell on the other end of
the bridge was visible in the field of view).

6.3.3 Metaphase telomeric FISH
Telomeric FISH was conducted as previously described (van Steensel et
al., 1998; Celli et al., 2006). Briefly, colcemid was added to cells 0.75-1 hour prior
to harvest. Cells were collected by trypsinization, swollen in 0.075 M KCl and
fixed overnight at 4ºC in methanol:acetic acid (3:1). Metaphase spreads were
dropped on glass slides and aged overnight. Slides were hybridized with AF488OO-[CCCTAA]3 or Cy3-OO-[TTAGGG]3 PNA probe in hybridizing solution,
denatured at 80ºC for 10 min and incubated for 2 h at room temperature. Two 15min washes in 70% formamide/10 mM Tris-HCl pH 7.2 and three 5 min PBS
washes. Slides were dehydrated in 70%, 95%, and 100% ethanol and mounted
using Vectashield mounting medium with DAPI from Vector Laboratories. Images
were captured using a Zeiss AxioPlan II microscope with a Hamamatsu C474295 camera using Volocity software from Perkin Elmer.
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6.3.4 Isochromosome analysis
Isochromosomes were counted on metaphase spreads based on their visual
appearance. The details of the analysis are fully described in Chapter 4.2.4.

6.3.5 Live-cell imaging for chromatin mobility analysis
Dysfunctional telomeres were visualized using mCherry-BP1-2 (h53BP1, amino
acid 1220-1711) as described previously (Dimitrova et al., 2008). Cre-treated
TRF2F/F cells were plated onto MatTek glass bottom plates and grown for 2 days
before imaging. An hour before imaging, cells were changed into Leibovitz’s L-15
medium (Gibco) supplemented with 15% FBS, non-essential amino acids, Lglutamine, penicillin/streptomycin and 50 mM β- mercaptoethanol, and allowed to
equilibrate for one hour. Imaging was done at 37°C using an environmental
chamber using a DeltaVision microscope system (Applied Precision) with a
PlanApo 60x 1.40 NA objective lens (Olympus America, Inc.). 5 μm Z-stacks at
0.5 μm steps were acquired using SoftWoRx software with 50 msec exposure
time, every 30 sec over 10 min (t=20 frames) at 2 x 2 binning with 512 x 512
pixels in final size. Images were deconvolved and 2D-maximum intensity
projection images were obtained using SoftWoRx software. Tracking of mCherryBP1-2 foci was performed with ImageJ software for at least 10 cells per
condition. Cells were registered by the StackReg plugin using Rigid Body
(Thevenaz et al., 1998). Next, particles were detected and tracked using the
Mosaic Particle Detector and Tracker plugin (Sbalzarini and Koumoutsakos,
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2005) with the following parameters: radius=1-2 pixels; cutoff=1-2 pixels;
percentile=1-6; link range=1; displacement=5 pixels. The x and y coordinates of
each trajectory were output for further calculation. Per cell, all mCherry-BP1-2
foci that were continuously tracked for at least 19 of the 20 frames were
analyzed. The analysis of the eGFP-TRF1-marked telomeres was similarly
conducted using the following parameters: radius=1 pixels; cutoff=1 pixels;
percentile=8-12; link range=1; displacement=5 pixels. Distorted nuclei were
discarded based on the methods described in Lottersberger et al. 2015
(Lottersberger et al., 2015).
6.3.6 Live-cell imaging for mitotic abnormalities
Live cell imaging was performed as described in (Maciejowski et al., 2015).
Briefly, cells were plated onto 35 mm glass bottom dishes (MatTek) 48 h before
imaging. One hour before imaging, cell culture media was replaced with phenol
red-free DMEM medium. Live cell imaging was performed using a CellVoyager
CV1000 spinning disk confocal system (Yokogawa, Olympus) equipped with 445,
488, and 561 nm lasers, a Hamamatsu 512 x 512 EMCCD camera. Pinhole size
was 50 μm. Images were acquired at the indicated intervals using a UPlanSApo
60x/1.3 silicone oil objective with the correction collar set to 0.17. The pixel size
in the image was 0.27 μm. The following emission filters were used for image
acquisition: 525/488 for Venus- tagged proteins, and 617/61 for RFP-tagged
proteins. 12 μm z-stacks were collected at 2.0 μm steps. Temperature was
maintained at 37°C in a temperature-controlled enclosure with CO2. Maximum
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intensity projection of z-stacks and adjustment of brightness and contrast were
performed using Fiji software. Image stitching was done with the Fiji plugin
Grid/Collection stitching (Preibisch et al., 2009) with 20% tile overlap, linear
blending, a 0.30 regression threshold, a 2.50 max/avg. displacement threshold,
and a 3.50 absolute displacement threshold. Images were cropped and
assembled into figures using Fiji and Photoshop CS5.1 (Adobe).

6.4 Lists of cell lines used

Genotype

Source

293T

ATCC

Phoenix cells

ATCC

TRF2F/F Rosa26 Cre-ERT2

De Lange lab

TRF2F/F53BP1-/-Lig4-/-Rosa26 Cre-ERT2 De Lange lab

Cell line #

78600.1

TRF2F/F53BP1-/-

De Lange lab

TRF2F/F53BP1-/-Sun1-/-Sun2-/-

De Lange lab

60318.7

TRF2F/F53BP1-/-Sun1+/+Sun2+/+

De Lange lab

53618.4

TRF1F/F53BP1-/-late passage

De Lange lab

76565.5

TRF1F/F53BP1-/-

This work

78882.3

TRF1F/F53BP1-/-

This work

78882.5

TRF1F/F

De Lange lab

9.3

This work

g3#13, g3#14

TRF1F/FGen1+/+ CRISPR
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TRF1F/FGen1-/- CRISPR

This work

g3#17,g2#16,g2#17

De Lange lab

39020.6

TRF1F/FGen1+/+ CRISPR

This work

g2#7

TRF1F/FGen-/- CRISPR

This work

g2#8, g3#11, g3#20

De Lange lab

65.8

This work

g3#3, g5#7

TRF1F/FmTR+/-

De Lange lab

370.5

TRF1F/FmTR+/+

De Lange lab

370.2

TRF1F/FTIN2+/+Ku70-/-

De Lange lab

82263.2

TRF1F/FTIN2+/+Ku70+/+

De Lange lab

82263.8

TRF1F/FTRF2F/+Lig4-/-

De Lange lab

305-1

TRF1F/Fp53-/-

De Lange lab

75023.9

TRF1F/F

TRF1F/FRif1F/F
53BP1-/- CRISPR

6.5 List of shRNA used

Target

TRC

Backbone

Target sequence

CCDC9

TRCN0000250760 PLKO

GGACGTGAGTGAAGATGTTAC

CCDC79

TRCN0000113325 PLKO

CGGTCCTTTGTTTGGACTCTT

TRCN0000113326 PLKO

CCTGAGGTAATTCGACCTATA

TRCN0000113327 PLKO

CCTGTAGAAGAAGACAACTTT

TRCN0000181504 PLKO

GAAGGAGCTGGAAGATGCTTA

TRCN0000181941 PLKO

GCTGGAAGATGCTTACTGGAA

CCDC124
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Gen1

PARP1

Mus81

Lig3

Lig1

TopBP1

shBLM

TRCN0000181879 PLKO

GCCACTGGAAGAGAACCTTAA

TRCN0000181658 PLKO

GAAACAGAAGGAGCTGGAAGA

TRCN0000181793 PLKO

GCTGATGCCAAGAAACAGAAG

TRCN0000246735 PLKO

ATGTTGACTGTTACACGATAT

TRCN0000246737 PLKO

TGAACGTAATGGATGCATATT

TRCN0000246738 PLKO

GGCATCAGACAGACCATAATA

TRCN0000353959 PLKO

GAGTACATTGTCTACGACATT

TRCN0000325059 PLKO

GCCCTTGGAAACATGTATGAA

TRCN0000241267 PLKO

TAGTGCCTGGAAGTTCGAAAC

TRCN0000241266 PLKO

CCAGTCTGTGCGAGAAGTATT

TRCN0000241264 PLKO

CAGAAATGCTCCGAGAGTTAC

TRCN0000070979 PLKO

GCAATGAAGAAGTGTCCCAAT

TCRN0000070980 PLKO

CCAGTGAAAGGTGCTTCGTTT

TRCN0000071154 PLKO

CCTTGGATGTTGATGCCACTT

TRCN0000071155 PLKO

CCTTCCAAGAATAACTATCAT

TRCN0000071157 PLKO

CGAGAGTGATTCTCCAGTGAA

TRCN0000124220 PLKO

GCTCTTAGAAACTGCGAGAAT

TRCN0000124223 PLKO

GCCAGAAGAGTTTCCTTGTTT

from Michal

pSuperior

GCATCCTAATAAAGAGTTA

from Michal

pSuperior

GGAGGGTTATTATCAAGAA
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